{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 探索的可視化と仮説の設定"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 進捗状況\n",
    "- データの前処理、整形\n",
    "\n",
    "## ToDO\n",
    "- (データの整形)\n",
    "- タグの見方の確認\n",
    "- 探索的可視化\n",
    "- 文書全体の処理、可視化"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Electronic Common Technical Document (eCTD)\n",
      "The eCTD is the standard format for submitting applications, amendments, supplements, and reports to FDA's Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER).\n",
      "Important Dates\n",
      "Reminder: Per eCTD Guidance, NDA, BLA, ANDA, and Commercial IND submissions must include a FDA fillable form (e.g. 356h, 1571, 2252). FDA plans to implement a validation check for the fillable form beginning July 27, 2018. Submissions which fail this validation will be subject to rejection. Please see the eCTD Guidance and the eCTD Validation Criteria (error code 7) for details.\n",
      "After the dates listed below, eCTD requirements for submissions to CDER and CBER will go into effect and submissions that do not use eCTD will not be filed or received.\n",
      "May 5, 2017:\n",
      "New Drug Applications (NDAs), Abbreviated NDAs (ANDAs), and Biologics License Applications (BLAs), must be submitted using eCTD format.\n",
      "May 5, 2018:\n",
      "Commercial Investigational New Drug Applications (INDs) and Master Files must be submitted using eCTD format.\n",
      "Please refer to the eCTD Guidance for the complete details to meet the eCTD requirement.\n",
      "Visit our Submit Using eCTD page to learn how to submit an application using eCTD and obtain an ESG account.\n",
      "To view all eCTD Submission Resources, visit our eCTD Resources page.\n",
      "Types of Submissions Subject to eCTD Requirement\n",
      "Electronic submission requirements will apply to the following types of submissions to CDER/CBER:\n",
      "NDAs\n",
      "ANDAs\n",
      "BLAs\n",
      "Commercial IND applications (for products that are intended to be distributed commercially)\n",
      "All subsequent submissions to these types of applications, including amendments, supplements, and reports, even if the original submission was filed before the requirements went into effect\n",
      "Master files, such as DMFs, which are considered to be submissions to an IND, an NDA, an ANDA, or a BLA\n",
      "Electronic submission standards will be optional but encouraged for the following categories:\n",
      "Noncommercial INDs, such as investigator-sponsored INDs and expanded-access INDs\n",
      "Submissions for blood and blood components, including source plasma\n",
      "Submissions for promotional materials for human prescription drug\n",
      "Current Versions and Updates\n",
      "Electronic submissions must use the version of eCTD currently supported by FDA, which is specified in the FDA Data Standards Catalog on the Study Data Standards Resources page. Updates to the standard will be announced on the FDA website and published in the Federal Register. The notices will include the date on which the new versions will go into effect.\n",
      "For a listing of Specifications, Supportive Files, M1 versions 1.3 and 2.3 documents related to eCTD, please refer to eCTD Submission Standards (XLS - 57KB) or eCTD Submission Standards (PDF - 91KB).\n",
      "Notices\n",
      "Notice 1/30/2019\n",
      "FDA Extends Compliance Date for Submitting DMF Type lll in eCTD format\n",
      "The FDA extended the compliance date for submitting DMF Type lll in eCTD format to May 5, 2020. See the FDA guidance document for additional information on the compliance date and FDA's Drug Master File page for additional information on DMFs.\n",
      "Notice 11/30/2018\n",
      "FDA plans to accept eCTD sequences with an eCTD submission type of “REMS Supplement” in the future. Implementation date is TBD. See submission-type.xml and M1 Specifications (located in the eCTD Submission Standards) for details.\n",
      "Notice 6/1/2018\n",
      "Please be advised that the FDA's eCTD Access Data Website will update ciphers and SSL protocols in Production on September 1, 2018\n",
      "Please make sure your system used to connect with the FDA's eCTD Access Data website can connect with compatible secure ciphers and SSL protocols listed below.\n",
      "SSL Protocols / Cipher Suites\n",
      "TLS 1.1 or higher\n",
      "Example links to eCTD Access Data Website:\n",
      "http://www.accessdata.fda.gov/static/eCTD/us-regional-v3-3.dtd\n",
      "http://www.accessdata.fda.gov/static/eCTD/us-regional.xsl\n",
      "What action do you need to take?\n",
      "If you want to continue to access the eCTD Access Data website, you need to ensure your browser(s)/Servers have TLS 1.1 or higher enabled. If your browser or Servers do not have TLS 1.1 or higher enabled after FDA makes this change, then you will NOT be able to access these eCTD websites.\n",
      "Backend servers that communicate with the eCTD Access Data Website links should also be communicating using TLS 1.1 or higher. Please contact your IT System Administrators or Technology Support personnel for appropriate methods to enable/upgrade your servers.\n",
      "Notice 4/24/2018\n",
      "FDA Extends Compliance Date for Submitting DMF Type lll in eCTD format\n",
      "The FDA extended the compliance date for submitting DMF Type lll in eCTD format to May 5, 2019. See the FDA guidance document for additional information on the compliance date and FDA's Drug Master File page for additional information on DMFs\n",
      "Important Notice 5/18/2016\n",
      "Third Acknowledgement for Successful eCTD Submissions\n",
      "Beginning May 31, 2016, CDER will begin issuing an acknowledgement to FDA Electronic Submissions Gateway (ESG) users when their NDA, ANDA, BLA, IND, or DMF submission has successfully completed validation and processing and is available to the assigned review division. This acknowledgement is in addition to the ESG Message Delivery Notification acknowledgement (first acknowledgement) and the Official Center acknowledgement (second acknowledgement) and is referred to as the “third acknowledgement.”\n",
      "For additional notices, please see eCTD Important Notices.\n",
      "Stay Connected\n",
      "If you have questions for CDER, please contact the CDER Electronic Submission (ESUB) Support Team at esub@fda.hhs.gov.\n",
      "If you have questions for CBER, please contact the CBER ESUB Support Team at esubprep@fda.hhs.gov.\n",
      "\n",
      "Overview of Device Regulation\n",
      "Introduction\n",
      "FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices sold in the United States. In addition, CDRH regulates radiation-emitting electronic products (medical and non-medical) such as lasers, x-ray systems, ultrasound equipment, microwave ovens and color televisions.\n",
      "Radiation-emitting Electronic Products\n",
      "Medical devices are classified into Class I, II, and III. Regulatory control increases from Class I to Class III. The device classification regulation defines the regulatory requirements for a general device type. Most Class I devices are exempt from Premarket Notification 510(k); most Class II devices require Premarket Notification 510(k); and most Class III devices require Premarket Approval. A description of device classification and a link to the Product Classification Database is available at \"Classification of Medical Devices.\"\n",
      "The basic regulatory requirements that manufacturers of medical devices distributed in the U.S. must comply with are:\n",
      "Establishment registration,\n",
      "Medical Device Listing,\n",
      "Premarket Notification 510(k), unless exempt, or Premarket Approval (PMA),\n",
      "Investigational Device Exemption (IDE) for clinical studies\n",
      "Quality System (QS) regulation,\n",
      "Labeling requirements, and\n",
      "Medical Device Reporting (MDR)\n",
      "Establishment Registration - 21 CFR Part 807\n",
      "Manufacturers (both domestic and foreign) and initial distributors (importers) of medical devices must register their establishments with the FDA. All establishment registrations must be submitted electronically unless a waiver has been granted by FDA. All registration information must be verified annually between October 1st and December 31st of each year. In addition to registration, foreign manufacturers must also designate a U.S. Agent. Beginning October 1, 2007, most establishments are required to pay an establishment registration fee.\n",
      "Establishment Registration\n",
      "U.S. Agents\n",
      "Medical Device Listing - 21CFR Part 807\n",
      "Manufacturers must list their devices with the FDA. Establishments required to list their devices include:\n",
      "manufacturers,\n",
      "contract manufacturers that commercially distribute the device,\n",
      "contract sterilizers that commercially distribute the device,\n",
      "repackagers and relabelers,\n",
      "specification developers,\n",
      "reprocessors single-use devices,\n",
      "remanufacturer\n",
      "manufacturers of accessories and components sold directly to the end user\n",
      "U.S. manufacturers of \"export only\" devices\n",
      "Medical Device Listing\n",
      "Premarket Notification 510(k) - 21 CFR Part 807 Subpart E\n",
      "If your device requires the submission of a Premarket Notification 510(k), you cannot commercially distribute the device until you receive a letter of substantial equivalence from FDA authorizing you to do so. A 510(k) must demonstrate that the device is substantially equivalent to one legally in commercial distribution in the United States: (1) before May 28, 1976; or (2) to a device that has been determined by FDA to be substantially equivalent.\n",
      "Premarket Notification 510(k)\n",
      "On October 26, 2002 the Medical Device User Fee and Modernization Act of 2002 became law. It authorizes FDA to charge a fee for medical device Premarket Notifcation 510(k) reviews. A small business may pay a reduced fee. The application fee applies to Traditional, Abbreviated, and Special 510(k)s. The payment of a premarket review fee is not related in any way to FDA's final decision on a submission.\n",
      "510(k) Review Fees\n",
      "Most Class I devices and some Class II devices are exempt from the Premarket Notification 510(k) submission. A list of exempt devices is located at:\n",
      "510(k) Exempt Devices\n",
      "If you plan to send a 510(k) application to FDA for a Class I or Class II device, you may find 510(k) review by an Accredited Persons beneficial. FDA accredited 12 organizations to conduct a primary review of 670 types of devices. By law, FDA must issue a final determination within 30 days after receiving a recommendation from an Accredited Person. Please note that 510(k) review by an Accredited Person is exempt from any FDA fee; however, the third-party may charge a fee for its review.\n",
      "Third Party Review\n",
      "Premarket Approval (PMA) - 21 CFR Part 814\n",
      "Product requiring PMAs are Class III devices are high risk devices that pose a significant risk of illness or injury, or devices found not substantially equivalent to Class I and II predicate through the 510(k) process. The PMA process is more involved and includes the submission of clinical data to support claims made for the device.\n",
      "Premarket Approval\n",
      "Beginning fiscal year 2003 (October 1, 2002 through September 30, 2003), medical device user fees apply to original PMAs and certain types of PMA supplements. Small businesses are eligible for reduced or waived fees.\n",
      "PMA Review Fees\n",
      "Investigational Device Exemption (IDE) - 21CFR Part 812\n",
      "An investigational device exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a Premarket Approval (PMA) application or a Premarket Notification 510(k) submission to FDA. Clinical studies with devices of significant risk must be approved by FDA and by an Institutional Review Board (IRB) before the study can begin. Studies with devices of nonsignificant risk must be approved by the IRB only before the study can begin.\n",
      "Investigational Device Exemption\n",
      "Quality System Regulation (QS regulation) - 21 CFR Part 820\n",
      "The quality system regulation includes requirements related to the methods used in and the facilities and controls used for: designing, purchasing, manufacturing, packaging, labeling, storing, installing and servicing of medical devices. Manufacturing facilities undergo FDA inspections to assure compliance with the QS requirements.\n",
      "Quality System\n",
      "Labeling - 21 CFR Part 801\n",
      "Labeling includes labels on the device as well as descriptive and informational literature that accompanies the device.\n",
      "Labeling\n",
      "Medical Device Reporting - 21 CFR Part 803\n",
      "Incidents in which a device may have caused or contributed to a death or serious injury must to be reported to FDA under the Medical Device Reporting program. In addition, certain malfunctions must also be reported. The MDR regulation is a mechanism for FDA and manufacturers to identify and monitor significant adverse events involving medical devices. The goals of the regulation are to detect and correct problems in a timely manner.\n",
      "Medical Device Reporting\n",
      "Additional Information\n",
      "Code of Federal Regulations (CFR)\n",
      "CDRH Freedom of Information (FOI) Reference Sheet\n",
      "\n",
      "FACT SHEET: Biogas Opportunities Roadmap: Voluntary Actions to Reduce Methane Emissions, Increase Energy Independence and Grow the Economy\n",
      "Posted August 1st, 2014 for United States Department of Agriculture\n",
      "President Obama's Climate Action Plan\n",
      "In his Climate Action Plan, released in June 2013, President Obama directed the Administration to develop a comprehensive, interagency strategy to reduce methane emissions and promote cutting-edge technologies that help farmers, energy companies, and communities convert methane into a renewable energy source and grow America's biogas energy industry.\n",
      "As part of its \"all-of-the-above\" energy strategy, the Obama Administration has pursued policies and technologies to diversify the nation's energy portfolio, making America more secure by increasing energy independence.\n",
      "Strategy to Reduce Methane Emissions\n",
      "In March, the White House released a Climate Action Plan Strategy to Reduce Methane Emissions and help provide greater incentives to spur the creation of more cost-effective biogas energy technologies. This included a Biogas Roadmap, a voluntary strategy created by the U.S. Department of Agriculture, Department of Energy, and the Environmental Protection Agency for the agriculture sector to reduce methane emissions.\n",
      "Experts agree that any comprehensive plan to confront climate change must address methane as well as carbon emissions. Methane is the second most prevalent greenhouse gas (GHG) emitted in the United States from human activities. Pound for pound, the impact of methane on climate change is over 20 times greater than carbon dioxide.\n",
      "Biogas typically contains 50-70% methane. As well as being a greenhouse gas, methane can also an energy source. Biogas systems enable the recovery and productive use of methane to generate renewable energy from the decomposition of organic materials, reducing direct emissions into the atmosphere and reducing GHGs by replacing fossil fuels (e.g., coal, natural gas) used for traditional energy generation.\n",
      "The Biogas Opportunities Roadmap builds on progress made to date to identify voluntary actions that can be taken to reduce methane emissions through the use of biogas systems and outlines strategies to overcome barriers limiting further expansion and development of a robust biogas industry in the United States. Biogas is a proven source of energy used in the United States and around the world for decades. As such, biogas systems can and should be an integral part of America's energy strategy moving forward.\n",
      "This Roadmap is also a deliverable of a Dairy Industry and USDA partnership which was requested by the industry to assist in achieving their 2008 goal of supply chain GHG emission reductions of 25% by 2020. It reflects a commitment by USDA, DOE and EPA to continue working with industry stakeholders on identifying steps to reduce emissions and expand the biogas industry, including through the development of new technologies.\n",
      "How Biogas Energy is Used\n",
      "Many communities, farms and businesses are already capitalizing on new technologies that capture biogas and convert it to power.\n",
      "Farmers in particular stand to benefit from the advancement of biogas energy technology—as methods for converting farm waste into energy evolve and become more cost-effective, more farmers can use biogas to power their own farms at a reduced cost and sell energy and non-energy products created on their farms to produce additional revenue sources.\n",
      "There are 239 biogas livestock systems currently operating in the U.S. These projects provide enough renewable energy to power the equivalent of almost 70,000 average American homes. They reduce methane emissions by the equivalent of approximately 2 million metric tons of carbon dioxide. If the full potential was realized, a cost-effective biogas industry could produce energy to power 1 million American homes.\n",
      "Opportunities for Growth\n",
      "There is tremendous opportunity for growth in biogas systems. The Roadmap found that with the proper support, more than 11,000 additional biogas systems could be deployed in the United States. If fully realized, these biogas systems could produce enough energy to power more than 3 million American homes and reduce methane emissions equivalent to 4 to 54 million metric tons of greenhouse gas emissions in 2030, the annual emissions of between 800,000 and 11 million passenger vehicles.\n",
      "With cost-effective technology deployment to utilize biogas, operations can continue that trend of improved efficiency while providing farmers increased revenues, making America more energy independent and reducing emissions that significantly contribute to climate change-offering a \"win-win\" for farmers, communities, the country and the planet.\n",
      "Efforts to reduce methane emissions are already producing results in the fight against climate change: Since 1990, methane emissions in the United States have decreased by 11%, even as many activities that can produce methane have increased; emissions intensity of the production of meat and milk in the U.S. is much lower today that it was even a few decades ago because of research that has resulted in improved efficiencies in production; North American production of milk and beef is among the most efficient in the world in terms of the GHG emissions per unit of production.\n",
      "Federal Support for Advancing Methane Energy Technology\n",
      "Biogas has proven to be a reliable resource for energy, but is underdeveloped in the U.S. To address this, the Opportunities Roadmap identifies government actions which can help encourage technology deployment.\n",
      "To accelerate the use of cost-effective methane energy technology, the Opportunities Roadmap details a number of steps USDA, DOE, and EPA will take to help improve return on investment and expand America's biogas industry. These include:\n",
      "Promoting Biogas Utilization through Existing Agency Programs:\n",
      "USDA, DOE, and EPA will use their existing programs as a vehicle to enhance the utilization of biogas systems in the U.S by ensuring that existing criteria for technical and financial assistance considers the benefits of biogas systems, leveraging over $10 million in research funding to enhance the economic viability and surrounding benefits of the biogas systems and co-products, and strengthening programs that support the use of biogas for clean energy, transportation fuel, renewable chemicals and biobased products.\n",
      "Fostering Investment in Biogas Systems:\n",
      "To help overcome financial barriers to the widespread investment in biogas systems, USDA will lead efforts to improve the collection and analysis of industry financial and technical data needed to track the performance of anaerobic digesters, evaluate current loan and grant programs for opportunities to broaden the financing options available for biogas systems, and review Federal procurement guidelines to ensure that products of biogas systems are eligible for and promoted by applicable government procurement programs.\n",
      "Strengthening markets for biogas systems and system products:\n",
      "To strengthen U.S. markets for renewable energy and value-added non-energy products from biogas systems, USDA, DOE, and EPA will review opportunities to overcome barriers to integrating biogas into electricity and renewable natural gas markets, for example, though modernizing existing Federal incentives provided for renewable energy generation. USDA, EPA, and DOE will also drive the creation of tools to help industry broaden the market development for energy and non-energy biogas systems products.\n",
      "Improving communication and coordination:\n",
      "In order to implement the strategies laid out in this document and promote strong coordination and messaging across Federal agencies, USDA will establish a Biogas Opportunities Roadmap Working Group that will include participation from DOE and EPA, as well as the dairy and biogas industries. The Working Group will collaborate with industry to publish a progress report in August 2015, which identifies and prioritizes policies and technology opportunities to expand the biogas industry and reduce greenhouse gas emissions.\n",
      "\n",
      "Berkadia Completes Sale and Financing of The Rockland\n",
      "Posted October 16th, 2019 for Berkadia\n",
      "October 16, 2019\n",
      "18238\n",
      "Disposition of prime student housing asset near University of Kansas\n",
      "BOCA RATON, Fla. (Oct. 16, 2019)\n",
      "Diversified, multi-strategy real estate and private equity investment firm Pebb Capital announced today it has completed the sale of The Rockland in Lawrence, Kan. to NB Private Capital (NBPC).\n",
      "Kevin Larimer and Greg Gonzalez of Berkadia's Student Housing team facilitated the sale. Berkadia's Ed Kim and Jie Lee also arranged the financing on behalf of buyer Orange County-based NBPC. Kapp Morrison LLP served as counsel for Pebb Capital in the transaction.\n",
      "The firm acquired the distressed asset for $16 million in November 2014, at which time Pebb Capital engaged in an extensive rehabilitation of the 17.0-acre property. This entailed renovating the 372 one- and two-bedroom units, totaling 647 beds and 313,912 square feet of rentable space. The Rockland offers furnished and unfurnished units, customizable furniture packages, high-speed internet, fully equipped kitchen, wood flooring, a full-sized washer and dryer and convenient trash valet service.\n",
      "Pebb Capital also significantly upgraded The Rockland's community amenities, adding additional clubhouse and outdoor recreational space. Improvements included an updated resort-style pool and hot tub; 24-Hour business center with free printing; 24-hour fitness center; common room with gaming station and pool table; complimentary tanning facilities; outdoor barbecue area with grilling area and fire pit; coffee bar; professional-sized sports field with AstroTurf; indoor and outdoor basketball courts; in addition to a dog park and playground.\n",
      "“We were successful in the complete conversion of this distressed property, transforming it into a stabilized asset in a high-density, student-driven market,” said Todd Benson, managing director of development and asset management with Pebb Capital. “This sale allows for a renewed focus on other projects, such as our ground-up student housing development of 415W120 underway in New York City, as well as other strategic investment opportunities.”\n",
      "“We were excited to work with Pebb to market this exceptional property,” said Larimer. “KU is the state's largest university and has consistently strong enrollment. Pebb recognized the opportunity to transform this property, creating a student focused property that is positioned to remain in high demand and deliver exceptional returns well into the future.”\n",
      "The property, built in 1986, is conveniently located 0.4 miles from the University of Kansas, the state's top university, and is within a two-mile radius of national retailer, such as Target, Starbucks, CVS, Aldi, Kohl's, T.J. Maxx and Ross Dress for Less. The Rockland also sits along University of Kansas' bus route.\n",
      "Since 2014, Pebb Capital has acquired more than 5,500 student housing beds, exceeding $300 million of transaction volume across over 12 universities in five states.\n",
      "\n",
      "EPRI, Utilities, Auto Manufacturers to Create an Open Grid Integration Platform for Plug-in Electric Vehicles\n",
      "Posted July 29th, 2014 for Electric Power Research Institute\n",
      "PALO ALTO, Calif.\n",
      "(July 29, 2014)\n",
      "The Electric Power Research Institute, 8 automakers and 15 utilities are working to develop and demonstrate an open platform that would integrate plug-in electric vehicles (PEV) with smart grid technologies enabling utilities to support PEV charging regardless of location.\n",
      "The platform will allow manufacturers to offer a customer-friendly interface through which PEV drivers can more easily participate in utility PEV programs, such as rates for off-peak or nighttime charging. The portal for the system would be a utility's communications system and an electric vehicle's telematics system.\n",
      "As the electric grid evolves with smarter functionality, electric vehicles can serve as a distributed energy resource to support grid reliability, stability and efficiency. With more than 225,000 plug-in vehicles on U.S. roads -- and their numbers growing -- they are likely to play a significant role in electricity demand side management.\n",
      "The platform enables integration across multiple communication pathways, such as automated metering infrastructure (AMI), home area networks, building energy management systems, and third party entities that aggregate energy management services for commercial and industrial power customers.\n",
      "Researchers anticipate that grid operators in the future may call on electric vehicles to contribute to grid reliability by balancing solar and wind generation, mitigating demand charges and providing ancillary services such as frequency regulation and voltage support.\n",
      "Utilities and regional transmission organizations participating and supporting in the software and hardware development and demonstration include DTE Energy Company, Duke Energy, PJM Interconnection LLC, CenterPoint Energy, Inc., Southern Company, Northeast Utilities, Southern California Edison, Pacific Gas & Electric Company, San Diego Gas & Electric, Commonwealth Edison, TVA, Manitoba Hydro, Austin Energy, Con Edison and CPS Energy.\n",
      "Auto manufacturers are American Honda Motor Co., BMW Group, Chrysler Group LLC, Ford Motor Company, General Motors Co., Mercedes-Benz Research & Development North America, Inc., Mitsubishi Motors Corporation, and Toyota Motor Engineering & Manufacturing North America, Inc.\n",
      "\"A key aspect of the platform's benefits will be giving customers flexibility and choices,\" said Dan Bowermaster, EPRI manager of Electric Transportation. \"It can help the PEV customer determine the value of using their parked vehicle as a grid resource, and help the industry develop a convenient, user-friendly customer interface. We see this as the foundation for future developments to integrate PEVs with the grid.\"\n",
      "Additionally, it could increase service reliability to customers by helping to mitigate the impact of strain on the grid during peak periods and could contribute to curbing greenhouse gas emissions. Utilities might benefit by better managing their loads and avoiding upgrades to infrastructure --savings that can be passed onto utility customers.\n",
      "Sumitomo Electric will develop the core platform technology on the first phase of the project.\n",
      "This software platform aligns with the Vehicle Grid Integration (VGI) Roadmap Initiative of the California Public Utilities Commission and the California Independent System Operator, as well as conforming with standards set by IEEE, IEC/ISO, and SAE, and Open ADR Alliance, making it globally applicable.\n",
      "About EPRI:\n",
      "The Electric Power Research Institute, Inc. (EPRI, www.epri.com) conducts research and development relating to the generation, delivery and use of electricity for the benefit of the public. An independent, nonprofit organization, EPRI brings together its scientists and engineers as well as experts from academia and industry to help address challenges in electricity, including reliability, efficiency, affordability, health, safety and the environment. EPRI's members represent approximately 90 percent of the electricity generated and delivered in the United States, and international participation extends to more than 30 countries. EPRI's principal offices and laboratories are located in Palo Alto, Calif.; Charlotte, NC; Knoxville, Tenn.; and Lenox, Mass.\n",
      "\n",
      "Nappy Cat Launches First Title, a Physics Based Sling and Capture Monster Game Dubbed ‘Slingsters'\n",
      "Posted January 7th, 2020 for Nappy Cat\n",
      "Slingsters is an interactive physics based logic game consisting of fun-filled puzzles with multiple levels and gameplay in which gamers sling cute mysterious monsters of varied abilities across the screen to capture and package them in a box for delivery.\n",
      "CHICAGO, IL\n",
      "Monday, January 6th, 2020\n",
      "/PressReleasePoint/\n",
      "Launching globally today, January 6th, Slingsters is Nappy Cat's First title to hit the App Stores.\n",
      "Slingsters is an interactive physics based logic game consisting of fun-filled puzzles with multiple levels and gameplay in which gamers sling cute mysterious monsters of varied abilities across the screen to capture and package them in a box for delivery.\n",
      "No matter how cute these monster pets are, they will not willingly comply and dive into a box to be captured!\n",
      "Gamers have to playfully and strategically sling and capture each new monster into it's box.\n",
      "“We are extremely excited to bring Slingsters to the world, and for taking this first step of releasing our first title among the host of games they plan to release soon!”- Stan Nesi (Technical Artist, Nappy Cat)\n",
      "The game is free to play, and the company is currently working on new updates with more levels and gameplay. A version for Amazon App Store is set for release at a later date. Slingsters is also available in French and Spanish.\n",
      "Slingsters! is now available for iOS and Android as FREE download. View the launch trailer\n",
      "For more information:\n",
      "Website: http://slingsters.com\n",
      "Facebook: https://facebook.com/slingsters\n",
      "Instagram: https://instagram.com/slingsters.game\n",
      "Twitter: https://twitter.com/slingsters\n",
      "YouTube: https://youtube.com/channel/UCmkmBQYB7vGmbUGwKlVFLvw\n",
      "Press Info\n",
      "Press kit with screenshots and video gameplay at https://nappycat.net/press-kit\n",
      "About Nappy Cat:\n",
      "Nappy Cat is a global gaming company with the focus of creating FUN games engulfed with IMAGINATION, INNOVATION, and QUALITY. Nappy Cat want to enrapture life with FUN, and they are just getting started. Nappy Cat is an independent, privately owned, global gaming company based in Chicago, IL. They currently ship products to all major App Stores including: iTunes App Store, Google Play and Amazon App Store. Find out more at https://nappycat.net and follow on Twitter, YouTube, Instagram or Facebook.\n",
      "Press Contact:\n",
      "Stan Nesi\n",
      "Nappy Cat\n",
      "Chicago, IL 60609 USA\n",
      "1 312-650-9668\n",
      "*****@**p**c**.net\n",
      "https://www.nappycat.net/\n",
      "Contact Stan Nesi\n",
      "\n",
      "FANUC Introduces New Food Grade Delta Robot\n",
      "Posted October 17th, 2019 for FANUC America\n",
      "by FANUC America Oct 18, 2019\n",
      "FANUC's DR-3iB food-grade delta robot sets a new standard for robotic food handling in terms of payload, speed, reach and sanitation.\n",
      "ROCHESTER HILLS, MI\n",
      "(Sept. 23, 2019)\n",
      "FANUC America, the leading supplier of CNCs, robotics and ROBOMACHINEs has introduced the next generation DR-3iB food grade delta robot. The DR-3iB sets a new standard for robotic food handling in terms of payload, speed, reach and sanitation. It made its debut to the packaging industry at Pack Expo 2019, Sept. 23-25.\n",
      "FANUC DR-3iB Delta Robot Series\n",
      "The new DR-3iB delta robot is FANUC's latest solution for picking and packing primary and secondary food products. Rated IP69K, the robot meets the strictest food handling regulations. Its design features corrosion-resistant materials, an unpainted finish, and a fully enclosed body allowing it to tolerate high pressure/temperature and sanitizer wash down environments.\n",
      "A powerful four-axis design and higher wrist inertia allows the DR-3iB/8L to handle 8kg payloads at very high speeds. Improved repeatability maximizes accuracy, and a hollow wrist design keeps all gripper wires and piping tucked inside.\n",
      "A large work envelope featuring a 1600mm reach (500mm height) allows it to handle applications that require more range such as reaching into tall boxes or handling product on wide conveyors.\n",
      "The DR-3iB operates with FANUC's latest R-30iB Plus controller with integrated intelligent functions such as iRVision®, Force Sensing, Robot Link, Collision Guard and Zero Down Time (ZDT).\n",
      "Pack Expo Demonstration\n",
      "FANUC's new DR-3iB/8L delta robot uses 2D iRVision and iRPickTool line tracking software to pick randomly oriented product from a continuous infeed conveyor. Equipped with a multi-pick gripper, the robot picks three packages and places them into a box on an outfeed fixed station to simulate case packing. The products recirculate and the cycle repeats. The cell features high-speed picking/packing with product re-orientation.\n",
      "DR-3iB Delta Robot Features and Benefits for the Food Industry:\n",
      "Standard IP69K rating for the entire robot means it is waterproof and can withstand harsh environments, including high temperature and high-pressure cleaning.\n",
      "An unpainted surface prevents paint chips from falling and contaminating food.\n",
      "No springs, stickers or pocketed fasteners eliminate the potential for bacterial growth.\n",
      "Self-draining and angled surfaces prevent product or liquid collection.\n",
      "Viewing window for grease detection and easy maintenance.\n",
      "DR-3iB/8L has an 8kg payload, four-axis design optimized for high speed picking and packing.\n",
      "DR-3iB/8L features a 1600mm reach (500mm height) allowing it to easily handle applications that require more range.\n",
      "A hollow wrist enables internal cable and hose routing, minimizing wear and tear and improving sanitation.\n",
      "Food option features food grade grease and a special coating to handle acid and alkaline disinfectants.\n",
      "Ability to work with primary (unpackaged) or secondary (packaged) food products.\n",
      "Supports FANUC's latest intelligent features including iRVision and force sensing.\n",
      "Collision Guard detects robot collisions with external objects, minimizing damage to the part and robot.\n",
      "Robot Link controls and coordinates up to ten robots through a network exchange of robot positional data.\n",
      "The new DR-3iB/8L will be available Q1 2020.\n",
      "About FANUC America Corporation\n",
      "FANUC America Corporation is a subsidiary of FANUC CORPORATION in Japan, and provides industry-leading robotics, CNC systems, and factory automation. FANUC's innovative technologies and proven expertise help manufacturers in the Americas maximize productivity, reliability and profitability.\n",
      "FANUC embraces a culture of “Service First” which means that customer service is our highest priority. We are committed to supplying our customers with parts and support for the life of their FANUC products.\n",
      "FANUC America is headquartered at 3900 W. Hamlin Road, Rochester Hills, MI 48309, and has facilities in: Auburn Hills, MI; Atlanta; Boston; Charlotte; Chicago; Cincinnati; Cleveland; Houston; Huntington Beach, CA; Los Angeles; Minneapolis; Montreal; Pine Brook, NJ; Pontiac, MI; Birmingham AL; San Francisco; Seattle; Toronto; Buenos Aires, Argentina; Sao Paulo, and Manaus, Brazil; and Aguascalientes, Monterrey, and Queretaro, Mexico. For more information, please call: 888-FANUC-US (888-326-8287) or visit our website: https://www.fanucamerica.com/. Also, connect with us on YouTube, , , LinkedIn and Instagram.\n",
      "\n",
      "NETA Reaches Across Industries Looking To Advance Electrical Power Safety And Reliability\n",
      "Posted July 16th, 2014 for International Electrical Testing Association\n",
      "Portage, Michigan, July 16, 2014\n",
      "NETA, the InterNational Electrical Testing Association, is reaching across industries to develop alliances and raise awareness about the importance of acceptance and maintenance testing of electrical power equipment and systems.\n",
      "At this year's International Conference of Doble Clients, held in Boston, Massachusetts, April 6-11, 2014, NETA met its goal of building and reinforcing relationships within the power generation and transmission industry. The conference is considered one of the world's leading events for the electrical power systems industry.\n",
      "\"The Doble show is a big opportunity for NETA to meet new people, build new relationships and fortify existing ones,\" said Jayne Tanz, NETA Executive Director. \"We approach this annual opportunity fully prepared to inform, educate, and inspire all attendees to follow the ANSI/NETA standards to ensure a safe and sustainable power generation and transmission industry.\"\n",
      "Representatives from NETA Accredited Companies (including American Electrical Testing Co., Inc., Magna Electric Corporation, and Western Electrical Services, Inc.) connected with professionals involved with North American Electric Reliability Corporation (NERC) standards development, demonstrating NETA's support for the electrical power generation and transmission industry.\n",
      "NETA also joined more than 9,700 risk and insurance executives recently at the RIMS 2014 Annual Conference and Exhibition held in Denver, Colorado, from April 27 - 30, 2014, hosted by the Risk Management Society.\n",
      "NETA's mission is to create electrical testing standards that promote electrical power system safety and reliability, ultimately reducing risk and liability for companies. Recognizing that insurance industry shares the same goals the association sent three representatives to the conference: Ron Widup, Shermco Industries CEO; Jean-Pierre Wolff of Applied Engineering Concepts; and Jill Howell, NETA Market Manager. NETA's focus at RIMS was to establish new alliances, advocating for electrical power systems testing and routine maintenance as a means to mitigate risk, and to explore synergies between NETA and insurance industry leaders.\n",
      "The NETA representatives met with executives from a number of industry leaders in attendance, including FM Global, Hartford Steam Boiler, Chubb, Zurich, Alliant, AIG, and AON. The initial response from all parties was encouraging.\n",
      "At both events, NETA invited attendees and industry leaders to preview and purchase the NETA standards for acceptance and maintenance testing of electrical power equipment and systems, as well as consult with NETA representatives.\n",
      "In the coming months, NETA will also take its safety and reliability message, promoting acceptance and maintenance testing to other industry events as well, including:\n",
      "2014 Petroleum and Chemical Industry Technical Conference (IEEE PCIC)\n",
      "September 8 - 10, 2014 - San Francisco, CA\n",
      "International Facility Management Association (IFMA) World Workplace Conference and Expo 2014\n",
      "September 17 - 19, 2014 - New Orleans, LA\n",
      "Rocky Mountain Electrical League (RMEL) Spring Management, Engineering, and Operations Conference\n",
      "May 17, 2015 - St. Louis, MO\n",
      "ABOUT NETA\n",
      "NETA is an ANSI Accredited Standards Developing Organization that creates and maintains standards for electrical maintenance and acceptance testing for electrical power equipment and systems, as well as a standard that addresses the certification of electrical testing technicians. NETA is an association of leading electrical testing companies comprised of visionaries committed to advancing the industry standards for power system installation and maintenance to ensure the highest level of reliability and safety.\n",
      "www.netaworld.org\n",
      "\n",
      "Online Technical Writing: Comparison Example\n",
      "by David McMurrey\n",
      "Comparison of Nuclear Reactors\n",
      "A nuclear power reactor uses fission reactions to produce thermal energy that is converted to electrical energy. One common class of nuclear reactor is the light water reactor which uses light water as a moderator and as a coolant. There are two types of light water reactors: the pressurized water reactor and the boiling water reactor.\n",
      "Note:\n",
      "This information is derived from a report written in the mid-1980s. Move your mouse pointer over the thin dotted line links to see discussion.\n",
      "Basic Operation\n",
      "Basically, the operations of the pressurized water reactor (PWR) and the boiling water reactor (BWR) are similar as Figure 1 shows. Water flows through the reactor core, steam is produced, the steam proceeds to turn a turbine-generator, electricity is produced, the steam is converted back to water, and the process is repeated.\n",
      "Figure 1.\n",
      "Basic Operation of Pressurized Water and Boiling Water Reactors\n",
      "Comparison of PWR and BWR\n",
      "The differences in the operations of the two light water reactors involve (a) the method in which the steam is produced, (b) the pressure in the system, and (c) the process through which the steam goes through after being produced.\n",
      "Steam Production.\n",
      "In a pressurized water reactor, the primary coolant, after passing through the core and absorbing heat, proceeds to a secondary system consisting of a steam generator. The primary coolant then flows through many hundreds of small stainless-steel tubes in the heat-exchangers, which are part of the steam generator. These heat-exchanger tubes are surrounded by the water of the secondary system which is heated by the primary coolant in the tubes. Wet steam is then produced [4:72].\n",
      "Unlike the pressurized water reactor, the steam in a boiling water reactor is introoduced directly into the core. Jet pumps circulate the coolant water along the individual fuel rods in each fuel assembly in the core where it boils and becomes a two-phase steam-water mixture [1:21].\n",
      "Pressure in the System..\n",
      "The pressure in a pressurized water reactor varies from the primary to the secondary system. In the primary system, the pressure is maintained at about 2250 pounds per square inch to prevent steam from forming. The pressure is then lowered for steam, at 600 pounds per square inch, to form. The pressure is controlled by a pressurizer [2:81].\n",
      "In contrast, the boiling water reactor operates at constant pressure. The primary system operates at pressure about one-half that of a pressurized water reactor's primary system while producing steam of equal quality [3:1995].\n",
      "Process of Generated Steam.\n",
      "After the wet steam is formed in a pressurized water reactor, it passes upward through the risers and enters the steam-separator portion of the steam generator. Here the moisture is removed and returned to the heat-exchanger portion of sections through the downcomers. The dry and saturated steam leaves the top of the steam separator and goes to the turbine [4:72].\n",
      "The wet steam formed in a boiling water reactor leaves the core and also goes through a steam separator. However, unlike the pressurized water reactor, the steam goes through a steam dryer, where additional moisture is removed [1:18]. The steam then proceeds to the turbine. This steam, unlike that of the pressurized water reactor, is radioactive [2:100].\n",
      "Conclusion\n",
      "Thus, even though the pressurized water reactor and the boiling water reactor are generally similar in operation, there are four main differences between the two systems.\n",
      "The steam in a pressurized water reactor is produced in a secondary system while the steam in boiling water reactor is produced directly in the reactor core. The pressure of a pressurized boiling reactor varies from the primary system to the output steam while the pressure of a boiling water reactor remains constant. The steam in a pressurized water reactor after coming out of the steam separator proceeds directly to the turbine while the steam in a boiling water reactor, after coming out of the steam separators, proceeds to a steam dryer and then to the turbine. The steam produced in a boiling water reactor is radioactive, whereas the steam produced in a pressurized water reactor is not.\n",
      "Table 1.\n",
      "Summary of Differences between the PWR and the BWR\n",
      "Pressurized Water Reactor\n",
      "Boiling Water Reactor\n",
      "Steam production\n",
      "In secondary reactor reactor core\n",
      "Directly in the system\n",
      "Pressure\n",
      "Varies, 2250 psi then lowered\n",
      "Constant, 1040 psi\n",
      "Produced steam\n",
      "Goes through steam separators then to turbine; nonradioactive.\n",
      "Goes through separators then through steam dryers then to turbine; radioactive.\n",
      "\n",
      "Standard 4.2.5\n",
      "PRIMARY PRODUCTION AND PROCESSING STANDARD FOR eggs AND EGG PRODUCT\n",
      "(Australia only)\n",
      "Purpose and commentary\n",
      "This Standard sets out a number of food safety requirements for the primary production and processing of eggs, egg pulp and other egg product for human consumption. At the primary production stage, businesses that produce eggs must implement measures to control the food safety hazards and must be able to trace their individual eggs for sale. Businesses that process eggs or egg product must control their food safety hazards and must be able to trace their individual eggs and the egg pulp. It is the responsibility of these businesses not only to comply with this Standard but also to be able to demonstrate compliance.\n",
      "Table of Provisions\n",
      "Division 1 – Preliminary\n",
      "1 Application\n",
      "2 Interpretation\n",
      "Division 2 – Primary production of eggs\n",
      "3 General food safety management\n",
      "4 Inputs\n",
      "5 Waste disposal\n",
      "6 Health and hygiene requirements\n",
      "7 Skills and knowledge\n",
      "8 Design, construction and maintenance of premises, equipment and transportation vehicles\n",
      "9 Bird health\n",
      "10 Traceability\n",
      "11 Sale or supply\n",
      "Division 3 – Processing of eggs and egg pulp\n",
      "12 Application\n",
      "13 General food safety management\n",
      "14 Receiving unacceptable eggs\n",
      "15 Inputs\n",
      "16 Waste disposal\n",
      "17 Skills and knowledge\n",
      "18 Health and hygiene requirements\n",
      "19 Design, construction and maintenance of premises, equipment and transportation vehicles\n",
      "20 Traceability\n",
      "21 Processing egg product\n",
      "22 Storing and transport of processed egg product\n",
      "23 Sale or supply\n",
      "Clauses\n",
      "Division 1 – Preliminary\n",
      "1 Application\n",
      "This Standard does not apply to retail sale or catering activities other than the direct sale of eggs to the public by an egg producer.\n",
      "2 Interpretation\n",
      "(1) Unless the contrary intention appears, and subject to Standard 4.1.1, the definitions in Chapter 3 of this Code apply in this Standard.\n",
      "(2) In this Standard –\n",
      "cracked egg means an egg which has a cracked shell which is visible, or visible by candling or other equivalent methods, and includes a broken egg.\n",
      "dirty egg means an egg that has visible faeces, soil or other matter on it.\n",
      "egg means an egg from any avian (bird) species, except ratites.\n",
      "egg producer means a business, enterprise or activity that involves the production of eggs, whether or not the business grades, packs, washes, candles or assesses for cracks, oils, pulps for supply to the processor for pasteurisation or stores or transports eggs or egg pulp.\n",
      "egg processor means a business, enterprise or activity that involves – (a) pulping, separating, grading, packing, washing, candling, assessing for cracks or oiling eggs received from an egg producer; or (b) storing or transporting eggs in association with any of the activities in paragraph (a); or (c) processing egg product under clause 21 of this Standard.\n",
      "egg pulp means the contents of an egg, which may contain sugar or salt.\n",
      "food safety management statement means a statement, which at a minimum, has been approved or recognised by the relevant authority and subjected to ongoing verification activities by an egg producer or egg processor and the relevant authority.\n",
      "Editorial note:\n",
      "‘Authority' is defined in Standard 4.1.1.\n",
      "liquid egg white means the white of egg separated as effectively as practicable from the yolk in liquid form.\n",
      "liquid egg yolk means the yolk of egg separated as effectively as practicable from the white in liquid form.\n",
      "premises means an egg production premises or a processing premises.\n",
      "unacceptable refers to unacceptable eggs.\n",
      "unacceptable egg means – (a) a cracked egg or a dirty egg; or (b) egg product which has not been processed in accordance with clause 21; or (c) egg product which contains a pathogenic micro-organism, whether or not the egg product has been processed in accordance with clause 21.\n",
      "Editorial note:\n",
      "Standard 1.1.2 defines ‘egg product' as the contents of an egg in any form including egg pulp, dried egg, liquid egg white and liquid egg yolk.\n",
      "Division 2 – Primary production of eggs\n",
      "3 General food safety management\n",
      "(1) An egg producer must systematically examine all of its production operations to identify potential hazards and implement control measures to address those hazards.\n",
      "(2) An egg producer must also have evidence to show that a systematic examination has been undertaken and that control measures for those identified hazards have been implemented.\n",
      "(3) An egg producer must operate according to a food safety management statement that sets out how the requirements of this Division are to be or are being complied with.\n",
      "4 Inputs\n",
      "An egg producer must take all reasonable measures to ensure inputs do not make the eggs unsafe or unsuitable.\n",
      "Editorial note:\n",
      "See the definitions of ‘safe' and ‘suitable' in Standard 3.1.1.\n",
      "See the definition of ‘inputs' in Standard 4.1.1 which includes feed, water and chemicals used in or in connection with the primary production activity.\n",
      "5 Waste disposal\n",
      "(1) An egg producer must store, handle or dispose of waste in a manner that will not make the egg unsafe or unsuitable.\n",
      "(2) For subclause (1), waste includes sewage, waste water, used litter, dead birds, garbage and eggs which the proprietor, supervisor or employee of the egg producer knows, ought to reasonably know or to reasonably suspect, are unsafe or unsuitable.\n",
      "6 Health and hygiene requirements\n",
      "(1) A person involved in egg production must exercise personal hygiene and health practices that do not make the eggs unsafe or unsuitable.\n",
      "(2) An egg producer must take all reasonable measures to ensure that personnel and visitors exercise personal hygiene and health practices that do not make the eggs unsafe or unsuitable.\n",
      "7 Skills and knowledge\n",
      "An egg producer must ensure that a person who engages in or supervises the primary production of eggs has – (a) skills in food safety and food hygiene; and (b) knowledge of food safety and food hygiene matters; commensurate with their work.\n",
      "8 Design, construction and maintenance of premises, equipment and transportation vehicles\n",
      "An egg producer must – (a) ensure that premises, equipment and transportation vehicles are designed and constructed in a way that minimises the contamination of the eggs, allows for effective cleaning and sanitisation, and minimises the harbourage of pests and vermin; and (b) keep premises, equipment and transportation vehicles effectively cleaned, sanitised and in good repair to ensure the eggs are not made unsafe or unsuitable.\n",
      "9 Bird health\n",
      "(1) An egg producer must not obtain eggs for human consumption from birds if the proprietor, supervisor or employee of the egg producer knows, ought to reasonably know or to reasonably suspect, the bird is affected by disease or a condition that makes the eggs unsafe or unsuitable.\n",
      "(2) The definition of ‘condition' in Standard 3.2.2 does not apply to this clause.\n",
      "10 Traceability\n",
      "(1) An egg producer must not sell eggs unless each individual egg is marked with the producers' unique identification.\n",
      "(2) An egg producer who supplies egg pulp must mark each package or container containing the pulp with the producers' unique identification.\n",
      "(3) Subclauses (1) and (2) do not apply to eggs or egg pulp sold or supplied to an egg processor (the supplied product) if that egg processor complies with clause 20 in respect of the supplied product.\n",
      "(4) In addition to subclauses (1) and (2), an egg producer must have a system to identify to whom eggs or egg pulp is sold or supplied.\n",
      "11 Sale or supply\n",
      "(1) An egg producer must not sell or supply eggs or egg pulp for human consumption if it knows, ought to reasonably know or to reasonably suspect, that the eggs are unacceptable.\n",
      "(2) Subclause (1) does not apply to an egg producer that sells or supplies unacceptable eggs to an egg processor for processing in accordance with clause 21.\n",
      "Editorial note:\n",
      "‘Supply' is defined in Standard 4.1.1 as including intra company transfers of product.\n",
      "Division 3 – Egg Processing\n",
      "12 Application of Food Safety Standards\n",
      "Standards 3.2.2 and 3.2.3 apply to processing under clause 21 and storage and transport under clause 22, but not to any other processing activities.\n",
      "13 General food safety management\n",
      "(1) An egg processor must systematically examine all of its processing operations to identify potential hazards and implement control measures to address those hazards.\n",
      "(2) An egg processor must also have evidence to show that a systematic examination has been undertaken and that control measures for those identified hazards have been implemented.\n",
      "(3) An egg processor must operate according to a food safety management statement that sets out how the requirements of this Division are to be or are being complied with.\n",
      "14 Receiving unacceptable eggs\n",
      "An egg processor must not receive unacceptable eggs for human consumption unless – (a) in the case of dirty eggs, they are to be cleaned; (b) in the case of cracked eggs, they are to be processed in accordance with clause 21; or (c) in the case of egg pulp, the product is to be processed in accordance with clause 21.\n",
      "15 Inputs\n",
      "An egg processor must take all reasonable measures to ensure inputs do not make the eggs or egg product unsafe or unsuitable.\n",
      "Editorial note:\n",
      "See Standard 4.1.1 for the definition of ‘inputs'.\n",
      "16 Waste disposal\n",
      "(1) An egg processor must store, handle or dispose of waste in a manner that will not make the eggs or egg product unsafe or unsuitable.\n",
      "(2) For subclause (1), waste includes sewage, waste water, unacceptable eggs or egg product and garbage.\n",
      "17 Skills and knowledge\n",
      "An egg processor must ensure that persons undertaking or supervising the processing of eggs or egg product have – (a) skills in food safety and food hygiene; and (b) knowledge of food safety and food hygiene matters; commensurate with their work.\n",
      "18 Health and hygiene requirements\n",
      "(1) A person involved in egg processing must exercise personal hygiene and health practices that do not make the eggs or egg product unsafe or unsuitable.\n",
      "(2) An egg processor must take all reasonable measures to ensure that personnel and visitors exercise personal hygiene and health practices that do not make the eggs or egg product unsafe or unsuitable.\n",
      "19 Design, construction and maintenance of premises, equipment and transportation vehicles\n",
      "An egg processor must – (a) ensure that premises, equipment and transportation vehicles are designed and constructed in a way that minimises the contamination of the eggs or egg products, allows for effective cleaning and sanitisation, and minimises the harbourage of pests and vermin; and (b) keep premises, equipment and transportation vehicles effectively cleaned, sanitised and in good repair to ensure the eggs or egg products are not made unsafe or unsuitable.\n",
      "20 Traceability\n",
      "(1) An egg processor must not sell eggs unless each individual egg is marked with the processor's or producer's unique identification.\n",
      "(2) An egg processor must not sell or supply egg product unless each package or container containing the egg product is marked with the processor's or the producer's unique identification.\n",
      "(3) In addition to subclauses (1) and (2), an egg processor must have a system to identify – (a) from whom eggs were or egg pulp was received; and (b) to whom eggs or egg product was supplied.\n",
      "21 Processing egg product\n",
      "(1) An egg processor must process egg product by – (a) pasteurising; or (b) heating using any other time and temperature combination of equivalent or greater lethal effect on any pathogenic micro-organisms in the egg product; or (c) using any other process that provides an equivalent or greater lethal effect on any pathogenic micro-organisms in the egg product.\n",
      "(2) For paragraph (1)(a), the egg product listed in Column 1 of the Table to this clause must be pasteurised to the time and temperature combinations in Column 2, Column 3 and Column 4.\n",
      "(3) A process described in paragraph 1(b) or (c), if used, must be validated by the egg processor.\n",
      "(4) In this clause – validate means – (a) confirming a control measure for a critical control point or process is effective to minimise a food safety hazard; and (b) providing objective evidence to confirm paragraph (a).\n",
      "Table to clause 21\n",
      "Column 1\n",
      "Column 2\n",
      "Column 3\n",
      "Column 4\n",
      "Egg product\n",
      "Retention temperature to be no less than (oC)\n",
      "Retention time to be no less than (minutes)\n",
      "Maximum temperature to be immediately rapidly cooled to (oC)\n",
      "Egg pulp (without any sugar or salt)\n",
      "64\n",
      "2.5\n",
      "≤ 7\n",
      "Liquid egg yolk\n",
      "60\n",
      "3.5\n",
      "≤ 7\n",
      "Liquid egg white\n",
      "55\n",
      "9.5\n",
      "≤ 7\n",
      "Editorial note:\n",
      "For subclause 21(1), Standard 1.6.1 specifies microbiological limits for processed egg products for sale.\n",
      "22 Storage or transport of processed egg product\n",
      "A processor must ensure that egg product processed under clause 21 is stored or transported under time and temperature conditions that control the growth of pathogenic micro-organisms.\n",
      "23 Sale or supply\n",
      "(1) An egg processor must not sell or supply eggs or egg product for human consumption if the processor knows, ought to reasonably know or to reasonably suspect, that the eggs or egg product are unacceptable.\n",
      "(2) Subclause (1) does not apply to an egg processor that sells or supplies unacceptable eggs to an egg processor for processing in accordance with clause 21.\n",
      "(3) An egg processor must not sell liquid egg white or liquid egg yolk unless it is processed in accordance with clause 21.\n",
      "Editorial note:\n",
      "Schedule 9 requires unpasteurised egg products to be labelled with a statement that the product is unpasteurised.\n",
      "Amendment History\n",
      "The Amendment History provides information about each amendment to the Standard. The information includes commencement or cessation information for relevant amendments.\n",
      "These amendments are made under section 92 of the Food Standards Australia New Zealand Act 1991 unless otherwise indicated. Amendments do not have a specific date for cessation unless indicated as such.\n",
      "About this compilation\n",
      "This is compilation No. 2 of Standard 4.2.5 as in force on 29 November 2018 (up to Amendment No. 182). It includes any commenced amendment affecting the compilation to that date.\n",
      "Prepared by Food Standards Australia New Zealand on 29 November 2018.\n",
      "Uncommenced amendments or provisions ceasing to have effect\n",
      "To assist stakeholders, the effect of any uncommenced amendments or provisions which will cease to have effect, may be reflected in the Standard as shaded boxed text with the relevant commencement or cessation date. These amendments will be reflected in a compilation registered on the Federal Register of Legislative Instruments including or omitting those amendments and provided in the Amendment History once the date is passed.\n",
      "The following abbreviations may be used in the table below:\n",
      "ad = added or inserted\n",
      "am = amended\n",
      "exp = expired or ceased to have effect\n",
      "rep = repealed\n",
      "rs = repealed and substituted\n",
      "Standard 4.2.5 was published in the Food Standards Gazette No. FSC65 on 26 May 2011 (to take effect on 26 November 2012) (F2011L00860) and has been amended as follows:\n",
      "Clause affected\n",
      "A'ment No.\n",
      "FRLI registration Gazette\n",
      "Commencement (Cessation)\n",
      "How affected\n",
      "Description of amendment\n",
      "21\n",
      "149\n",
      "F2014L01037\n",
      "29 July 2014\n",
      "FSC91\n",
      "31 July 2014\n",
      "31 July 2014\n",
      "rs\n",
      "Editorial note following the clause.\n",
      "Subclause 2(2)\n",
      "182\n",
      "F2018L01594\n",
      "23 Nov 2018\n",
      "FSC123\n",
      "29 Nov 2018\n",
      "29 Nov 2018\n",
      "am\n",
      "Editorial note following standard update\n",
      "Clause 23\n",
      "182\n",
      "F2018L01594\n",
      "23 Nov 2018\n",
      "FSC123\n",
      "29 Nov 2018\n",
      "29 Nov 2018\n",
      "am\n",
      "Editorial note following standard update\n",
      "\n",
      "Equipment Authorization – Grantee Code\n",
      "Products subject to certification are required to be uniquely identified by an identifier known as FCC ID. The FCC ID consist of two parts: (1) grantee code; and (2) product code.\n",
      "The grantee code, as specified in Section 2.926, is a three or five character alphanumeric string representing the Grantee / Applicant for certified products.\n",
      "Grantee Codes that begin with an alpha character (A-Z) consist of three characters.\n",
      "Grantee Codes that begin with a number (2-9) consist of five characters.\n",
      "The grantee code does not contain the numbers “one” and/or “zero”. The grantee code is assigned by the Commission permanently to a company for use in the identification of radio frequency equipment authorized under the certification procedure.\n",
      "The product codes are uniquely established by the Grantee to identify each product approved by a Telecommunication Certification Body (TCB). The product code can be up to 14 alpha numeric characters. Hyphens (–) separated by an alpha numeric character are permitted; consecutive hyphens (-) are not permitted.\n",
      "For information on how to obtain a grantee code, manage grantee code information (company name, address and contact information), recover a lost grantee code's registration number, see KDB Publication 204515.\n",
      "Bureau/Office:\n",
      "Engineering & Technology\n",
      "Tags:\n",
      "Devices - Devices, Engineering & Technology\n",
      "\n",
      "How to Create an iPhone in Cinema 4D: Part 2\n",
      "by Jonathan Lam\n",
      "17 Dec 2018\n",
      "Difficulty: Intermediate\n",
      "Length: Medium\n",
      "Languages: English\n",
      "3D\n",
      "3D Models\n",
      "3D Rendering\n",
      "3D Games\n",
      "3D Graphics\n",
      "Cinema 4D\n",
      "Illustration\n",
      "Digital Art\n",
      "Graphic Design\n",
      "Rendering Pipelines\n",
      "Modeling\n",
      "iPhone\n",
      "Apple\n",
      "What You'll Be Creating\n",
      "Follow this tutorial step-by-step to create a 3D iPhone model to use in video games, graphic design and illustration projects whilst learning Cinema 4D quickly.\n",
      "Some of the skills you'll learn in this tutorial include creating basic 3D modelling, importing reference images, adding lighting to the scene and basic rendering techniques.\n",
      "In the first part of the two-part tutorial, I showed you how to:\n",
      "How to Import Reference Images\n",
      "How to Prepare for Modelling\n",
      "How to Model the iPhone\n",
      "In this, the second part of the the tutorial series, I'll show you how to:\n",
      "How to Create Coloured Materials\n",
      "How to Add Lighting to the Scene\n",
      "How to Render the iPhone\n",
      "9. How to Create a New Material\n",
      "Step 1\n",
      "Located near the bottom of the screen there is a material selection window. Click on Create > New Material to create a new material to use that you can edit.\n",
      "Materials are used to colour in the various objects and parts of the iPhone.\n",
      "Select New Material from the menu\n",
      "Step 2\n",
      "Double click on the new material icon (displayed as a sphere). This will bring up the Material Editor, where you can adjust the various properties of the material such as the colour, transparency and reflectance.\n",
      "For this particular style we will only be interested in flat colour (Luminance).\n",
      "Open the Material Editor\n",
      "Step 3\n",
      "Tick the button for Luminance and untick the boxes for Colour and Reflectance. This will give the cel shaded look for the final image.\n",
      "Select Luminance\n",
      "Step 4\n",
      "Colour the iPhone body by adding the material to the object. Drag and drop the material to the object using the mouse. You can also drag and drop the material onto the object listed on the right of the screen.\n",
      "Drag new material on to the 3D model\n",
      "10. How to Adjust the Material Properties\n",
      "Step 1\n",
      "In the Material Editor, click on the arrow button next to Texture and select Sketch and Toon > Cel from the menu.\n",
      "Select Sketch and Toon and Cel from the menu\n",
      "Step 2\n",
      "Click on the new Cel button that appears next to Texture to bring up a new menu.\n",
      "Click on the Cel button\n",
      "Step 3\n",
      "In this new menu, adjust the settings as follows:\n",
      "Change the Diffuse to match the image at below.\n",
      "It should be grey scale with the colour getting light from left to right.\n",
      "Untick Camera.\n",
      "Tick Lights.\n",
      "Tick Shadows\n",
      "Select Multiply from the drop down menu.\n",
      "Adjust the settings in the editor\n",
      "Step 4\n",
      "Select a colour by double-clicking on the colour option box .\n",
      "The Material Editor gives many different options for choosing and picking colours. These include RGB, HSV and so on. Choose whichever option you are most familiar with as a flat colour. Because of the Multiply shading mode, the different colour shades will also appear in the material.\n",
      "If the material has already been applied to the model, the colour of the model will automatically be adjusted to the new material colour. This is useful if you change your mind on a certain colour or a certain part of the iPhone model.\n",
      "Pick a colour\n",
      "Step 5\n",
      "Because we've already applied the material to the model, the colour of the iPhone will automatically be adjusted to the new material colour.\n",
      "11. How to Adjust the Shading\n",
      "Step 1\n",
      "To get a better idea of the shading and how our render will turn out as we work on it, click and hold on the Render Button and select Interactive Render Region from the menu.\n",
      "Select Interactive Render Region\n",
      "Step 2\n",
      "Use the mouse to adjust the window so that it fits around the iPhone model. Look for the very small arrow on the right hand side of the window and use the mouse to drag it to the top right corner of the box (this increases the resolution).\n",
      "Decrease the resolution by moving the arrow down if you find that the performance is decreasing.\n",
      "Adjust the resolution\n",
      "Step 3\n",
      "To change the way the light source is facing go to Options > Default Light.\n",
      "You can also add a light object to the scene if you are more comfortable working that way.\n",
      "Select default light\n",
      "Step 4\n",
      "Change the light source in the Default Light window. Click where you'd like the light source to come from on the sphere and it will sync with the view port. Experiment with different lighting positions to come up with a lighting situation that you like.\n",
      "This can be adjusted at anytime so you can change the lighting again if you changed your mind.\n",
      "Change the lighting direction\n",
      "Step 5\n",
      "Secondary-click on the arrow and select Alpha Mode in order to reveal the rest of the viewport. Some people may find working this way easier.\n",
      "Select Alpha Mode\n",
      "12. Other Lighting Solutions\n",
      "Step 1\n",
      "To set up the basic lighting, go to the Floor button located in the top menu bar. Primary-Click-Hold and then select Physical Sky from the menu.\n",
      "Select Physical Sky\n",
      "Step 2\n",
      "Make sure that Physical Sky is selected in the menu on the right, a new menu will appear on the bottom right of the screen. Select the Time and Location tab and choose a time using the left and right arrow keys.\n",
      "This will change the lighting of the scene (according to the time of the day). Choose a suitable time to light up the scene. You'll see how the lighting affects the scene in the viewport.\n",
      "Select a Time\n",
      "Step 3\n",
      "To add a light to the scene, select the Add Light button in the top menu bar at the top of the screen.\n",
      "This creates a Light Object which you can move around the scene. Move the light object using the Move Tool to a suitable position.\n",
      "Select the Add Light Button\n",
      "Step 4\n",
      "To customise the lighting further, experiment with the light object options in the bottom right of the screen. Here you can adjust the Intensity, Light Type and even Colour.\n",
      "Light Object adjustments\n",
      "13. How to Colour the iPhone Screen\n",
      "Step 1\n",
      "To create a new material we can duplicate the material by holding CTRL on the keyboard and then using the mouse to click and drag the material to the side.\n",
      "Duplicate material\n",
      "Step 2\n",
      "Double-click on the new material to open up the Material Editor and select Luminance. From there we can change the colour to the following:\n",
      "R: 56\n",
      "G: 47\n",
      "B: 66\n",
      "Choose a new colour\n",
      "Step 3\n",
      "Apply the new material to the screen by clicking and dragging it directly onto the object.\n",
      "Apply material to model\n",
      "14. How to Colour the iPhone Details\n",
      "Step 1\n",
      "Create a new material. You can also duplicate a previous material in order to keep the settings from before.\n",
      "Double-click on the new material to open up the Material Editor and select Luminance. From there we can change the colour to the following:\n",
      "R: 70\n",
      "G: 69\n",
      "B: 65\n",
      "Choose a new colour\n",
      "Step 2\n",
      "Apply the new material to the button objects inside the cutout group. You can also apply the material by clicking and dragging it to the object in the viewport.\n",
      "Apply material to objects in list view\n",
      "Step 3\n",
      "When the material is applied, the details will change colour to reflect the material.\n",
      "Apply new material to iPhone details\n",
      "Step 4\n",
      "Repeat the same steps for the side buttons. For the side buttons, use the same colour material which was used for the iPhone body.\n",
      "Apply new material to iPhone buttons\n",
      "Step 5\n",
      "For the back camera details, use the dark grey colour. Remember that you can change the colour of the material at a later date as well.\n",
      "Apply new material to iPhone camera\n",
      "15. How to Render the iPhone\n",
      "Step 1\n",
      "On the top menu bar, click on the Render Settings button. This brings up the render settings window.\n",
      "Click on the Render Settings button\n",
      "Step 2\n",
      "In the render settings menu, you can change the options to what you need. First, tick the Save Settings to select a file location, file format and alpha channel.\n",
      "Select Alpha Channel if you wish to keep the background see through.\n",
      "Save settings\n",
      "Step 3\n",
      "In the Output Settings choose the resolution, height and width of the image.\n",
      "Output settings\n",
      "Step 4\n",
      "To ensure that the render is nice and sharp go to the Anti-Aliasing settings. Select Cubic (Still Image) which can be found under Filter.\n",
      "Anti-Aliasing settings\n",
      "Step 5\n",
      "To create the final image, click on the Render button. Remember to select the right view in the viewport (front, right, left or perspective etc.) and that you're happy with the camera angle.\n",
      "Choose a suitable angle in the viewport by navigating around the scene.\n",
      "Click on the Render button\n",
      "Step 6\n",
      "If you want to have more control over how your final render looks, create a camera object to help. Find a suitable view using the viewport first and then click on the camera button.\n",
      "This will create a camera using the current view in the viewport. Check out the camera settings to see how they affect the final render.\n",
      "Click on the Camera button\n",
      "The End Result\n",
      "Wait for the final render to finish. Once the render is complete you can repeat the steps above and change the camera or the view port to create a new image from a different angle.\n",
      "Throughout the course of the project you have successfully learnt how to:\n",
      "Import Reference Images\n",
      "Prepare for Modelling\n",
      "Model an iPhone\n",
      "Create Materials\n",
      "Colour the Model\n",
      "Render the iPhone\n",
      "Feel free to share your own creations below. You can also export your image into Adobe Photoshop to enhance it further or to use it as part of a larger image.\n",
      "Final iPhone render\n",
      "Jonathan Lam\n",
      "Hi everyone! My name is Jonathan Lam and I'm a Digital Artist on a mission to empower, educate and inspire creative students just like you to gain the creative skills you desire! Currently I work for Ubisoft as a concept and game artist. My skills range from graphic design, illustration, animation, 3D modelling/sculpting, concept art and video editing. Some of the projects I've worked on include Hungry Shark World, Hungry Shark Evolution, Starbeard and the Kickstarter Funded Game called Eminence: Xander's Tales. I've also worked with many high profile clients including Riot Games, Sony Entertainment, Hasbro and Google as a graphic designer and illustrator.\n",
      "\n",
      "4.4. Collections\n",
      "Portfolio → Collections\n",
      "A collection is a set of pages that are linked to one another and have the same access permissions. You can create as many collections as you like, but a page cannot appear in more than one collection. You can create a collection from scratch or copy an existing one - either one of your own or one from another user that is copyable to you.\n",
      "4.4.1. Manage your collections\n",
      "When you are on the overview page of the collections, you can do several things.\n",
      "Collections overview page\n",
      "Create a new collection by clicking the New collection button.\n",
      "Copy an existing collection by clicking the Copy a collection button.\n",
      "Click on the collection title to go to the first page of the collection.\n",
      "Click on any title of a page within a collection to jump directly to it.\n",
      "Click the Manage button <画像> to move pages within a collection, add them to or delete them from a collection.\n",
      "Click the Edit button <画像> to change the title and description of a collection.\n",
      "Click the Delete button <画像> to delete the collection. The pages will still exist.\n",
      "When you submitted a collection to a group, you cannot edit or delete it until it has been released.\n",
      "Note\n",
      "You can see up to 10 collections on the collections overview page, and then use the pager to move to other collections.\n",
      "4.4.2. Add a collection\n",
      "Create a collection\n",
      "Click the New collection button under Portfolio → Collections.\n",
      "On the next screen…\n",
      "Collection name: Provide a title for your collection.\n",
      "Collection description: Optionally, you can write a short description about your collection.\n",
      "You do not have a visual editor, but just a plain text box.\n",
      "Tags: Enter tags to find your collection more easily at a later stage.\n",
      "Separate your tags with commas.\n",
      "If you already have tags, you can click on the link Show my tags and select the ones that you think will fit for this collection as well.\n",
      "They will be entered into the text field for you.\n",
      "Page navigation bar: Choose whether you wish to display a tabbed navigation or not.\n",
      "If you choose not to, you will have to include the navigation block for you to go from one page to the next on the individual pages that belong to this collection.\n",
      "Click the Next: Edit collection pages button or click the Cancel button if you want to abort adding your collection.\n",
      "4.4.3. Copy a collection\n",
      "4.4.3.1. Copy a collection by searching for it\n",
      "You can duplicate your own collections or collections of other users if they allowed you to do that. As every page can only be in one collection at a time, your own pages will be copied when you copy a collection.\n",
      "Copy a collection\n",
      "Click the Copy a collection button under Portfolio → Collections. On the next screen…\n",
      "Search: If there are many pages or collections from which you can choose, search here for a keyword in the page or collection title or for the name of the page owner.\n",
      "Collection title: Click on the title of a collection to preview it before copying it.\n",
      "Note\n",
      "The sort order on the screen is according to collection titles in alphabetical order.\n",
      "Page name: Click on the title of the page to see a preview of it before you copy it.\n",
      "Owner: Click on the name of the owner to view a larger profile picture and the self description if the owner provided one or to see information about a group it that is the owner.\n",
      "Click the Copy collection button to copy an entire collection with multiple pages into your portfolio. All pages within this collection are copied or\n",
      "Click the Copy page button to copy one page only into your own portfolio.\n",
      "Edit the collection and its pages as you would do any other collection and pages.\n",
      "Note\n",
      "The site administrator can decide to leave out “Copy of…” for copied pages or collections. This setting needs to be made in the config.php file. If $cfg->renamecopies = false;, copies of new pages and collections will not have “Copy of” prepended to their titles.\n",
      "See also\n",
      "You can watch a demo of this feature in action.\n",
      "4.4.3.2. <画像> Copy a collection directly from its location\n",
      "You can copy a page or collection directly when you view it by clicking the Copy button when you see it. The button is displayed on your own pages and collections as well as on pages and collections owned by others when you have the permission to copy them.\n",
      "Copy a page or collection\n",
      "Click the Copy button when you want to copy a page or collection that you can duplicate.\n",
      "If the page is part of a collection, you need to decide in the pop-up window whether you want to copy just the page that you can see currently by clicking the Page button.\n",
      "Or whether you want to copy the entire collection by clicking the Collection button.\n",
      "Edit the page or collection as you would to any other.\n",
      "4.4.4. Add collection pages\n",
      "In the next step after you have created your collection, you choose which portfolio pages you wish to include in this collection. You see all the potential pages that you can use. If you had already placed a page into another collection, it is not shown here.\n",
      "Add pages to a collection\n",
      "Click the Manage pages button <画像> under Portfolio → Collections. On the next screen…\n",
      "Put a check mark next to each page that you wish to include in your collection.\n",
      "Alternatively, you can click the All link to add all pages available to the collection or the None link to revert your selection.\n",
      "Click the Add pages button to add the pages to your collection.\n",
      "If you do not wish to click all pages, you can also drag and drop them into the collection by clicking their title and dragging them to the area Pages already in collection.\n",
      "A dotted line shows you where you can drag your page so you can already drag the pages into the collection in the order that you prefer.\n",
      "Click the Done button to finish this step.\n",
      "4.4.5. Manage collection pages\n",
      "Once you have added your pages to your collection. You can move them around or remove them.\n",
      "Manage the pages that are displayed within your collection\n",
      "If you are not already in the page management, click the Manage pages button <画像> under Portfolio → Collections. On the next screen…\n",
      "Use the Move up <画像> and Move down <画像> buttons to arrange your pages in a different order. Alternatively, you can drag and drop the pages within the list.\n",
      "Click the Remove button <画像> to take a page out of a collection. The page itself is not deleted.\n",
      "Put a check mark next to each page that you wish to include in your collection in addition to the ones already in it.\n",
      "Click the Add pages button to add the pages to your collection and then move them around with the Move up <画像> and Move down <画像> buttons. Alternatively, you can drag and drop the pages to the position where you would like to have them in the list.\n",
      "Click the Done button.\n",
      "When you add pages to your collection that have different access permissions than the collection has, the page's access permissions get added to the collection and the page is available under the same access permissions as the entire collection because it is part of the collection.\n",
      "Notice about changes in permissions\n",
      "If there is a change in access permissions, a warning will be displayed so that you are informed that changes have taken place.\n",
      "View the result of your collection by clicking on the collection title or any page that is part of your collection.\n",
      "A collection with the tabbed navigation\n",
      "4.4.6. Give others access to your collection\n",
      "See also\n",
      "Please refer to the section on sharing your pages and collections for further information.\n",
      "\n",
      "Over 20 Million Individuals Infected with Hepatitis E in Asia and Africa\n",
      "Posted March 27th, 2012 for NORC at the University of Chicago\n",
      "Over 20 Million Infected with Hepatitis E in Asia and Africa\n",
      "70,000 Deaths and 3,000 Stillbirths Caused by Infections\n",
      "New research funded by the World Health Organization (WHO) estimates that 20.1 million individuals were infected with hepatitis E virus (HEV) genotypes 1 and 2 across 9 world regions in 2005. According to findings available in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, there were 3.4 million symptomatic cases, 70,000 deaths, and 3,000 stillbirths from HEV that year in countries throughout Asia and Africa.\n",
      "Unlike hepatitis virus B and C strains that lead to chronic disease states, HEV causes acute illness. Previous studies show HEV genotypes 1 and 2 specifically infect humans, and are associated with large outbreaks in developing countries where sanitation conditions are poor. There is evidence that HEV increases mortality risk among pregnant women. While a safe and effective HEV vaccine has been developed, it has not been widely implemented.\n",
      "“Our study represents the first attempt to estimate the annual global impact of hepatitis E,” said lead author Dr. David Rein of the social science research organization NORC at the University of Chicago. Estimates were created by modeling the disease burden of HEV genotypes 1 and 2 in the 9 regions, representing 71% of the world's population. Based on published evidence the team—a collaboration between researchers from NORC, WHO and RTI International—also estimated annual incidence of infection to determine symptomatic, asymptomatic, and mortality cases.\n",
      "The team determined that the prevalence pattern of HEV was consistent across the regions, with the largest incident increase occurring in those between the ages of 5 and 20 years. The average age of infection was 17 years with the lowest age of infection in North Africa (8 years) and highest in East Asia (21 years).\n",
      "Of the more than 20 million people infected with HEV, 61% of the cases occurred in East and South Asia, two regions which also accounted for 65% of deaths from HEV. Researchers also noted that North Africa accounted for 14% of all global HEV infections, but only 8.3% of symptomatic cases and 8% of deaths, which the authors attribute to the younger average age of infection in that region.\n",
      "The authors caution there are limitation to the study which only estimated incidence of HEV genotypes 1 and 2, leaving out genotype 3 which is prevalently occurs in Europe and the U.S. and genotype 4. “Future HEV estimates should include genotypes 3 and 4 to provide a complete picture of the global burden of HEV,” concludes Rein.\n",
      "About Hepatology\n",
      "Hepatology is the premier publication in the field of liver disease, publishing original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished Editorial Board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism.\n",
      "About NORC\n",
      "NORC at the University of Chicago is an independent research organization headquartered in downtown Chicago with additional offices on the University of Chicago's campus and in the D.C. Metro area. NORC also supports a nationwide field staff as well as international research operations. With clients throughout the world, NORC collaborates with government agencies, foundations, educational institutions, nonprofit organizations, and businesses to provide data and analysis that support informed decision making in key areas including health, education, economics, crime, justice, energy, security, and the environment. NORC's 70 years of leadership and experience in data collection, analysis, and dissemination—coupled with deep subject matter expertise—provides the foundation for effective solutions.\n",
      "\n",
      "Gaming machines in clubs and pubs\n",
      "Introduction\n",
      "Who can apply for gaming machines\n",
      "Apply for a gaming machine licence\n",
      "Apply to transfer a gaming machine licence\n",
      "Apply to substitute premises: gaming machine licence\n",
      "Gaming machine licence forms\n",
      "Gaming machine application fees\n",
      "Prepare a community impact analysis\n",
      "Community benefit statement guidelines for licensed clubs\n",
      "Gaming machine finance providers\n",
      "Approved gaming equipment suppliers\n",
      "Servicing gaming machines\n",
      "Banknote acceptor devices\n",
      "Apply for a gaming machine licence\n",
      "To apply for a gaming machine licence you must complete the following steps:\n",
      "Step 1. To apply online, go to Licensing NT Online or fill in the gaming machine venue licence form. Get this and other gaming machine licence forms.\n",
      "Step 2. Supply all of the following documents:\n",
      "birth certificate\n",
      "current driver licence\n",
      "current passport - and visa, if applicable\n",
      "deed of release and indemnity DOCX <画像>(51.0 KB)\n",
      "marriage certificate, if applicable\n",
      "deed poll documents, if applicable\n",
      "financial statements\n",
      "tax returns or tax assessment notices for the previous three years.\n",
      "Step 3. Supply other supporting documentation:\n",
      "a community impact analysis\n",
      "a plan of the proposed premises, showing where gaming machines will be installed\n",
      "a criminal history check\n",
      "an affidavit disclosing anyone who influences or benefits from the proposed operation\n",
      "documents showing you lease, own or have a contract to buy the premises.\n",
      "Companies or other body corporate such as a clubs must include all of the following documents:\n",
      "certificate of incorporation\n",
      "a copy of the memorandum, rules, constitution or other incorporating documents, certified by the secretary or other authorised person and, in the case of a club, certified by the Registrar of Associations\n",
      "a certified copy of the resolution meeting minutes where the governing body decided to apply for the licence\n",
      "a statement showing how many members you have in each class of membership\n",
      "a copy of the club constitution\n",
      "a proposal consistent with the club's constitution.\n",
      "Step 4. Check the fee and the gaming machine levies.\n",
      "Step 5. Submit your application and pay the fees and levy to any Territory Business Centre.\n",
      "Advertising your application\n",
      "You must advertise your application in local media, or as directed by the Director-General of Licensing within 28 days of the the date you submitted it.\n",
      "Licensing NT will supply you with a suitable advertisement to put into the local paper.\n",
      "You must include all of the following information in the advertising:\n",
      "the location of the proposed premises\n",
      "the number of gaming machines applied for\n",
      "where people can find community impact information.\n",
      "Your advertising must also let people know that they can write to the Director-General about the application, within 30 days of the advertisement first being published.\n",
      "When you can't advertise\n",
      "You must not advertise an application between the second Friday in December and the second Monday in January. These are Christmas and new Year advertising restrictions.\n",
      "This means that your advertising can either:\n",
      "start and finish before the second Friday in December\n",
      "or start and finish after the second Monday in January.\n",
      "Advertising exemptions\n",
      "You do not have to advertise within 28 days of submitting your application this is during the Christmas and New Year advertising restrictions. If this does happen you should advertise as soon as possible after the restriction period.\n",
      "Print all pages in this section\n",
      "Last updated: 04 February 2020\n",
      "\n",
      "Legislation and compliance\n",
      "Home\n",
      "Environment\n",
      "Legislation and compliance\n",
      "The Department of Mines, Industry Regulation and Safety (DMIRS) assesses environmental proposals for prospecting, mining exploration and development activities in accordance with the Mining Act 1978 for onshore mining activities in Western Australia (WA) and the Offshore Minerals Act 2003 for mining activities within WA State waters.\n",
      "The Mining Rehabilitation Fund Act 2012 and the Mining Rehabilitation Fund Regulations 2013 provide a legislative framework for declaring abandoned mine sites and enables the Mining Rehabilitation Fund to receive levy contributions made by WA mining operators for the rehabilitation of abandoned mines.\n",
      "DMIRS also assesses environmental proposals for petroleum and geothermal activities in accordance with:\n",
      "The Petroleum and Geothermal Energy Resources (Environment) Regulations 2012 covers environmental approvals relating to petroleum activities located in onshore areas of the State, including islands and internal waters.\n",
      "The Petroleum (Submerged Lands) (Environment) Regulations 2012 covers environmental approvals relating to petroleum activities within WA State waters.\n",
      "The Petroleum Pipelines (Environment) Regulations 2012 covers environmental approvals relating to onshore petroleum pipelines.\n",
      "Native vegetation clearing permits are assessed by DMIRS under delegation from the Department of Water and Environmental Regulation in accordance with the provisions of the Environmental Protection Act 1986 and the Environmental Protection (Clearing of Native Vegetation) Regulations 2004. Permits may be required for mining or petroleum activities.\n",
      "DMIRS Resource and Environmental Compliance Division has an outcomes-focused regulatory system that requires robust compliance monitoring, reporting and data management to evaluate the performance of industry in achieving environmental outcomes. This is delivered through a risk-based, outcomes-focused assessment and compliance system with prioritisation of resources to manage compliance assurance, inspections and enforcement.\n",
      "State environmental approvals\n",
      "Mining, petroleum and geothermal activity proposals that may have a significant impact on the environment will be referred to the Environmental Protection Authority (EPA) for environmental impact assessment under the Environmental Protection Act 1986.\n",
      "Commonwealth environmental approvals\n",
      "Mining, petroleum and geothermal activity proposals likely to have significant impact to matters of national environmental significance should be referred by the company for environmental impact assessment under the Environment Protection and Biodiversity Conservation Act 1999 (Commonwealth). The Commonwealth and State have a bilateral agreement where environmental impact assessments may be undertaken by the EPA.\n",
      "Environmental risks and impacts associated with petroleum and greenhouse gas storage activities in Commonwealth waters are assessed by the National Offshore Petroleum Safety and Environmental Management Authority (NOPSEMA) in accordance with the Offshore Petroleum and Greenhouse Gas Storage (Environment) Regulations 2009.\n",
      "Guidance note on environmental non-compliance and incident reporting\n",
      "The Department of Mines, Industry Regulation and Safety's (DMIRS) compliance program for the minerals, petroleum, geothermal and greenhouse gas storage sectors includes a range of activities to achieve operator compliance with legislation and policies relevant to the relevant sector.\n",
      "At the core of the department's approach is the primary objective of fostering voluntary compliance with environmental obligations. This is in line with increased community expectations in relation to environmental performance, disclosure and transparency in the resources sector. To meet this expectation, the department has updated and improved the process by which industry can self-report environmental non-compliances and incidents.\n",
      "For information on how to report a non-compliance or incident, please refer to the Resource and Environmental Compliance Division's Guidance Note for Non-compliances and Incidents.\n",
      "Published Acts and Legislative Instruments\n",
      "The above Acts and Regulations are published in full on the State's Parliamentary Council's Office www.legislation.wa.gov.au and the Commonwealth Federal Register of Legislation www.legislation.gov.au websites.\n",
      "Contact\n",
      "Phone: +61 8 9222 3851\n",
      "\n",
      "Genentech Announces FDA Approval of Xofluza (Baloxavir Marboxil) for People at High Risk of Developing Influenza-Related Complications\n",
      "Posted October 17th, 2019 for Genentech\n",
      "Single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza (flu)\n",
      "The Centers for Disease Control and Prevention (CDC) defines people at high risk of serious flu complications as those who have conditions such as asthma, chronic lung disease, diabetes, heart disease, morbid obesity or adults 65 years of age or older\n",
      "South San Francisco, CA\n",
      "October 17, 2019\n",
      "Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older who have been symptomatic for no more than 48 hours and who are at high risk of developing flu-related complications. Xofluza is a first-in-class, one-dose oral medicine with a novel proposed mechanism of action that inhibits polymerase acidic endonuclease, an enzyme essential for viral replication.\n",
      "“With the flu season rapidly approaching, we can now offer Xofluza as the first and only FDA-approved treatment option indicated specifically for those at high risk of flu complications,” said Levi Garraway, M.D., Ph.D., chief medical officer and head of Global Product Development. “People with chronic conditions such as asthma, heart disease and diabetes are at higher risk of developing serious complications from the flu, so it is critical that these patients speak with their healthcare providers about possible treatment at the first signs and symptoms of the disease.”\n",
      "The flu has the potential to cause a variety of complications, ranging from sinus or ear infections to more serious complications such as pneumonia. This expanded indication for Xofluza was approved based on results from the Phase III CAPSTONE-2 study of a single dose of 40 mg or 80 mg of Xofluza compared to oseltamivir (75 mg twice daily for five days), or placebo in people 12 years of age or older who met CDC criteria for being at high risk of complications from the flu. Xofluza significantly reduced the time to improvement of flu symptoms compared to placebo, including in people infected with the flu type B virus. Adverse events reported in at least 1% of adult and adolescent subjects treated with Xofluza included diarrhea (3%), bronchitis (3%), nausea (2%), sinusitis (2%) and headache (1%).\n",
      "Xofluza is currently approved in several countries for the treatment of flu types A and B. In October 2018, Xofluza was first approved by the FDA for the treatment of acute, uncomplicated flu in otherwise healthy people 12 years of age and older who have been symptomatic for no more than 48 hours, representing the first new antiviral to treat the flu in the U.S. in 20 years.\n",
      "About CAPSTONE-2\n",
      "CAPSTONE-2 is a Phase III, multicenter, randomized, double-blind study that evaluated a single dose of Xofluza compared with placebo and oseltamivir in people 12 years of age or older who are at a high risk of complications from the flu. The Centers for Disease Control and Prevention (CDC) defines people at high risk of serious flu complications as those who have conditions such as asthma, chronic lung disease, diabetes, heart disease, morbid obesity or adults 65 years of age or older. The study was conducted globally by Shionogi & Co., Ltd.\n",
      "Participants enrolled in the study were randomly assigned to receive a single dose of 40 mg or 80 mg of Xofluza, placebo or 75 mg of oseltamivir twice a day for five days. The primary objective of the study was to evaluate the efficacy of a single dose of Xofluza compared with placebo by measuring the time to improvement of flu symptoms. Key findings from the study found that:\n",
      "Xofluza significantly reduced the time to improvement of flu symptoms versus placebo in people at high risk of complications from the flu (median time 73 hours versus 102 hours; p<0.001).\n",
      "Similar efficacy results were seen between Xofluza and oseltamivir in relation to duration of symptoms (median time 54 hours versus 54 hours).\n",
      "In subjects infected with type B virus, the median time to improvement of flu symptoms was shorter in the Xofluza group compared to the placebo group (75 hours versus 101 hours respectively).\n",
      "Adverse events reported in at least 1% of adult and adolescent subjects treated with Xofluza included diarrhea (3%), bronchitis (3%), nausea (2%), sinusitis (2%) and headache (1%). Xofluza was well-tolerated and no new safety signals were identified.\n",
      "About Xofluza ™(baloxavir marboxil)\n",
      "Xofluza is a first-in-class, one-dose oral medicine with a novel proposed mechanism of action that has demonstrated efficacy in a wide range of influenza viruses, including in vitro activity against oseltamivir-resistant strains and avian strains (H7N9, H5N1) in non-clinical studies. Unlike other currently available antiviral treatments, Xofluza is the first in a new class of antivirals designed to inhibit the cap-dependent endonuclease protein, which is essential for viral replication.\n",
      "Xofluza is being further studied in a Phase III development program, including children under the age of one (NCT03653364), severely ill, hospitalized people with the flu (NCT03684044), as well as to assess the potential to reduce transmission of the flu from an infected person to healthy people (NCT03969212).\n",
      "Xofluza was discovered by Shionogi & Co., Ltd. and is being further developed and commercialized globally in collaboration with the Roche Group (which includes Genentech in the U.S.) and Shionogi & Co., Ltd. Under the terms of this agreement, Roche holds worldwide rights to Xofluza excluding Japan and Taiwan, which will be retained exclusively by Shionogi & Co., Ltd.\n",
      "XOFLUZA U.S. Indication\n",
      "XOFLUZA is a prescription medicine used to treat the flu (influenza) in people 12 years of age and older who have had flu symptoms for no more than 48 hours and who are otherwise healthy or at high risk of developing flu-related complications.\n",
      "It is not known if XOFLUZA is safe and effective in children younger than 12 years of age or weighing less than 88 pounds (40 kg).\n",
      "Important Safety Information\n",
      "Do not take XOFLUZA if you are allergic to baloxavir marboxil or any of the ingredients in XOFLUZA.\n",
      "Before you take XOFLUZA, tell your healthcare provider about all of your medical conditions, including if you:\n",
      "Are pregnant or plan to become pregnant. It is not known if XOFLUZA can harm your unborn baby.\n",
      "Are breastfeeding or plan to breastfeed. It is not known if XOFLUZA passes into your breast milk.\n",
      "Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.\n",
      "Talk to your healthcare provider before you receive a live flu vaccine after taking XOFLUZA.\n",
      "Take XOFLUZA with or without food. Do not take XOFLUZA with dairy products, calcium-fortified beverages, laxatives, antacids, or oral supplements containing iron, zinc, selenium, calcium, or magnesium.\n",
      "If you take too much XOFLUZA, go to the nearest emergency room right away.\n",
      "XOFLUZA may cause serious side effects, including allergic reactions.\n",
      "Get emergency medical help right away if you develop any of these signs and symptoms of an allergic reaction:\n",
      "trouble breathing\n",
      "skin rash, hives or blisters\n",
      "swelling of your face, throat or mouth\n",
      "dizziness or lightheadedness\n",
      "The most common side effects are diarrhea, bronchitis, sinusitis, headache, and nausea.\n",
      "XOFLUZA is not effective in treating infections other than influenza. Other kinds of infections can have symptoms like those of the flu or occur along with flu and may need different kinds of treatment. Tell your healthcare provider if you feel worse or develop new symptoms during or after treatment with XOFLUZA or if your flu symptoms do not start to get better.\n",
      "Please see the XOFLUZA full Prescribing Information for complete safety information.\n",
      "You are encouraged to report side effects to Genentech by calling 1-888-835-2555 or to the FDA by visiting http://www.fda.gov/medwatch or calling 1-800-FDA-1088.\n",
      "About Genentech in Influenza\n",
      "Influenza, or flu, is one of the most common, yet serious, infectious diseases, representing a significant threat to public health. Since 2010, the Centers for Disease Control and Prevention (CDC) estimates that the flu has resulted annually in 9.3 to 49 million illnesses, 140,000 to 960,000 hospitalizations and 12,000 to 79,000 deaths. Although vaccines are an important first line of defense in preventing the flu, there is a need for new medical options for prophylaxis and treatment. Other antiviral medicines have limitations with respect to efficacy, convenience of dosing and resistance. Genentech is committed to addressing the unmet need in this area through its agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza.\n",
      "About Genentech\n",
      "Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com.\n",
      "\n",
      "Honeywell To Upgrade First Ice-Class Offshore Stationary Platform On Sakhalin Shelf\n",
      "Posted July 31st, 2014 for Honeywell International\n",
      "Safety and Production Process Upgrades for the Molikpaq Platform MOSCOW, July 31, 2014\n",
      "Honeywell (NYSE: HON) Process Solutions today announced it will upgrade process control and alarm management systems at the Molikpaq platform on the Sakhalin shelf, Russia, to improve safety, reliability and operational efficiency.\n",
      "The Molikpaq platform, owned by Sakhalin Energy Investment Co. Ltd., celebrated its 15-year anniversary in September 2013. The platform produces 48,000 barrels of crude oil per day.\n",
      "“Offshore production is associated with a number of risks to workers, the environment and efficient processes, and demands systems that meet the highest reliability, safety and durability standards,” said Frank Whitsura, vice president, Honeywell Process Solutions. “Our innovative solutions are designed to meet the requirements needed to operate in harsh environmental conditions and help our partners to improve their operational and cost efficiencies.”\n",
      "The Molikpaq platform was installed northeast of Sakhalin, 16 kilometers offshore, at a depth of 30 meters. In the winter, the temperature, including the wind chill, can be as cold as 70 degrees below zero Fahrenheit.\n",
      "To modernize the process control system and improve safety at the facility, Honeywell will implement the latest version of its Experion® Process Knowledge System (PKS), which will be extended by the new C300 controller including Foundation Fieldbus license. By enabling unified access to process control, production management and asset management, the distributed control system will help to improve efficiency and profitability, reduce total cost of ownership while helping the facility achieve optimum production of oil.\n",
      "In addition, Honeywell will install its DynAMo™ Alarm Suite, which leverages more than 20 years of alarm management experience in the process industries, and can help users reduce overall alarm count by as much as 80 percent, identify maintenance issues, and increase visibility of critical alarms that require urgent attention.\n",
      "Honeywell Process Solutions (www.honeywellprocess.com) is a pioneer in automation control, instrumentation and services for the oil and gas; refining; pulp and paper; industrial power generation; chemicals and petrochemicals; biofuels; life sciences; and metals, minerals and mining industries. Process Solutions is part of Honeywell's Performance Materials and Technologies strategic business group, which also includes UOP, a leading international supplier and licensor of process technology, catalysts, adsorbents, equipment, and consulting services to the petroleum refining, petrochemical, and gas processing industries.\n",
      "Honeywell (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; turbochargers; and performance materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit www.honeywellnow.com.\n",
      "This release contains certain statements that may be deemed \"forward-looking statements\" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.\n",
      "\n",
      "EESI Moves 100% of Stock Holdings to Socially Responsible Funds\n",
      "Posted May 25th, 2016 for Environmental and Energy Study Institute\n",
      "Investments to Focus on Clean Energy, Exclude Fossil Fuels\n",
      "May 25, 2016\n",
      "The Environmental and Energy Study Institute (EESI), a not-for-profit organization dedicated to promoting environmentally sustainable societies, will complete moving its stock holdings to socially responsible funds by December 2016. Half of EESI's holdings are already in such funds.\n",
      "\"Aligning our investments with our mission is essential to walk our talk,\" said EESI board member Claudine Schneider, a former Republican Member of Congress (RI, 1980-1990) who spearheaded EESI's move to socially responsible investing. \"Making investment decisions on the basis of environmental, social, and governance criteria helps EESI continue its work advancing clean energy and addressing climate change.\"\n",
      "EESI's commitment extends beyond mere avoidance of companies whose policies conflict with our mission statement: it emphasizes a positive search for companies that are in line with our organizational values and vision. In particular, EESI will preferentially invest in companies that have demonstrated a commitment to environmental stewardship, energy efficiency, and clean renewable energy; EESI will also divest from companies that extract energy from fossil fuels.\n",
      "The decision to divest from fossil fuels was driven by both mission-related and financial considerations. Because of EESI's longtime work on climate change, it understands that holding fossil fuel stocks carries significant risk, as many fossil fuels assets will likely remain in the ground, becoming stranded and worthless.\n",
      "To mark its fossil-free commitment, EESI signed the Divest Invest Pledge, joining more than 500 organizations with more than $3.4 trillion in assets. These organizations have all agreed to stop investing in the top 200 fossil fuel producers, and to instead direct at least 5 percent of their portfolios to renewable energy, energy efficiency, or clean energy access.\n",
      "EESI's Board of Directors made the unanimous decision to invest 100 percent of EESI's stock holdings in a socially responsible manner at its May meeting. The Board had previously decided to move a portion of EESI's stock holdings to socially responsible investing (SRI) in August 2013. This phased approach allowed EESI to explore its options and make sure socially responsible investments provided acceptable rates of return. In fact, EESI's initial SRI fund has outperformed its benchmark, the MSCI EAFE, by 2.6 percent on an annualized basis.\n",
      "\"The Board is concerned with our fiduciary responsibilities: EESI's investments contribute to our operating budget, enabling us to fulfill our mission,\" explained EESI Board Chair Jared Blum. \"Confirming our initial research, we found that investing in socially responsible funds was a sound investment. We are also thrilled to be investing in renewable energy and energy efficiency; moving to an economy based on clean energy is an important part of our mission.\"\n",
      "Several studies have confirmed that socially responsible investing does not mean foregoing returns and may in fact reduce investment risk. Divesting from fossil fuel companies, for instance, helps EESI avoid oil and gas sector volatility. It also helps avoid climate risk, which is the risk that companies face from climate change and policies to address climate change. Oil and coal companies are especially vulnerable: the upcoming implementation of the Paris Climate agreement means the international community is expected to clamp down on harmful carbon emissions; nations throughout the world are expected to promote energy efficiency and clean energy sources, making these a better investment.\n",
      "EESI's move has helped spur the ever-burgeoning market for socially responsible funds. \"In 2013, we expressed our commitment to socially responsible and fossil fuel-free investing to one of our long-time fund managers. In response, the firm established an environmental fund that not only meets our goals—an investment product that is socially responsible and fossil fuel-free—but that is also open to other institutional investors,\" said EESI Executive Director Carol Werner. \"It's exciting that we were able to drive change to help grow the market of investment options for sustainable, socially responsible, and fossil fuel free investing.\"\n",
      "Werner noted that \"EESI has offered SRI funds for the staff retirement plan for many years, and in July 2013, we began to provide employees with the option to invest in fossil-free funds. For so many of us, workplace retirement plans are the primary way we invest, so it was important for us to offer sustainable investment options to our staff, since we all are working for sustainability at EESI.\"\n",
      "Socially Responsible Investing has become a large market, accounting for more than one out of every six dollars under professional management in the United States, according to the Forum for Sustainable and Responsible Investment. Not all SRI funds are fossil-free, however. Several organizations can help investors identify fossil-free, socially responsible funds, including Fossil Free Funds and the US SIF - the Forum for Sustainable and Responsible Investment.\n",
      "EESI developed a Policy for Socially Responsible Investment to guide its investments when it began shifting them in 2013. In addition to traditional financial analysis, EESI considers environmental criteria, employment and workplace practices, workforce diversity, community relations, human rights, and corporate governance. One of EESI's goals is to invest in companies that have demonstrated a commitment to sustainability by either minimizing their environmental and carbon footprint or by producing products and services that have a direct environmental benefit (such as renewable energy). EESI's policy excludes companies that extract or generate energy from fossil fuels. EESI also emphasizes investments in companies with exceptional workplace safety records; innovative programs promoting diversity in the workplace; positive relations with their communities; strong policies protecting human rights; and transparent corporate governance structures—among many other criteria.\n",
      "EESI is proud to further its mission through its investments, as part of a broader trend toward socially responsible and sustainable investing.\n",
      "\n",
      "Electronic Health Records (EHRS) and Patient Work Information\n",
      "Standards and Data\n",
      "NIOSH has been working to establish standards and tools to support the collection and use of self-reported ODH in the medical records of EHRs. The benefits of collecting ODH include:\n",
      "Informing practitioners about their patient's work and how it could impact their patient's health\n",
      "Supporting Research-to-Practice (R2P) dissemination through clinical decision support (real-time, automated assistance with clinical decision-making tasks at the point of patient care)\n",
      "Encouraging consideration of work and health in patient care through health system quality measures that utilize ODH\n",
      "Supporting population health management tools used by health systems to improve the health outcomes of a group of patients\n",
      "Improving structured ODH data available to support occupational public health activities, including surveillance and research\n",
      "Structured ODH enables health system data analytics, supporting surveillance\n",
      "Occupational Data for Health and Interoperability Standards\n",
      "NIOSH has worked to include Occupational Data for Health (ODH) in the key data-formatting interoperability standards for health information systems. These standards include the three product lines of Health Level Seven, International (HL7®) and the technical frameworks of Integrating the Healthcare Enterprise International (IHE). EHRs and other health information systems use these standards to share information within and across healthcare organizations. Including ODH in all of these standards ensures and supports opportunities to collect the data once, then have it shared with other care providers.\n",
      "The HL7 CDA® R2 Implementation Guide: Consolidated CDA (C-CDA) R2.1 Supplemental Template for Occupational Data for Health, Release 1 – US Realm, Standard for Trial Use (STU) can be used to include ODH in the social history section of any CDA ‘document' that is electronically transmitted by an EHR or other health information system, e.g., a patient summary.\n",
      "The Normative HL7® Version 2.9 Messaging Standard (V2.9) includes segments (OH1-OH4) and vocabulary for ODH. Older Version 2 message standards (e.g., V2.5.1) are often used to share information within organizations, to report laboratory results, and to share information with public health agencies. The V2.9 ODH segments may be retrofitted into these older versions for specific purposes or included when the newer version is adopted for specific purposes.\n",
      "The HL7 FHIR Profile: Occupational Data for Health (ODH), Release 1.0 (Standard for Trial Use) is now available. FHIR, or Fast Healthcare Interoperability Resources, is the newest HL7 data-sharing standard. It can be used to make health information accessible to healthcare providers, business associates, patients, and public health. The ODH Implementation Guide is a composition of profiles on the observation resource.\n",
      "The optional ODH Section in the IHE Quality, Research and Public Health (QRPH) Technical Framework Healthy Weight (HW) Supplement for Trial Implementation has recently been updated and is being tested for use in clinical data sharing. This section is aligned with the ODH HL7® C-CDA Supplemental Template.\n",
      "More information:\n",
      "HL7 ODH CDA® templateexternal icon\n",
      "HL7® V2.9 Messaging Standardexternal icon\n",
      "HL7® ODH FHIR templateexternal icon\n",
      "Quality, Research and Public Health Technical Frameworkexternal icon\n",
      "Collaboration with HL7® to Provide Technical Guidance for Including Work Information in Electronic Health Records\n",
      "NIOSH has led an effort to develop the HL7® EHR System-Functional Model Release 2: Functional Profile; Work and Health, Release 1 – US Realm, which informs EHR system software developers about useful features for the collection, management, and use of ODH.\n",
      "The functional profile is:\n",
      "A set of technical instructions for EHR software developers. These instructions are organized by discrete sections to describe the behavior of an EHR system in user-oriented language.\n",
      "Grouped by functions a system performs. It also includes an introduction and glossary of ODH terms.\n",
      "A hierarchical framework of criteria that describe valuable system features for each function and to which an EHR system conforms in order to achieve the function. Criteria must use specified, defined action-verbs, e.g., The system SHALL provide the ability to link all data pertaining to a single job (so industries and occupations must be paired by job and separate lists of industries and occupations that do not reflect individual jobs is not acceptable).\n",
      "A way to express optionality of features. The criteria have three levels of conformance (SHALL, SHOULD, MAY) that guide developers to include at least the basic attributes in order to conform (SHALL) and also criteria that add extra value (SHOULD, MAY).\n",
      "The functional profile is NOT:\n",
      "An instructional document for health information messaging from one provider to another. Instead, NIOSH is also leading efforts to incorporate ODH in HL7 and IHE interoperability standards (see above).\n",
      "A set of definitions for the information collected as ODH data. Instead, the ODH information model outlines the definitions and value sets that developers should consider using when developing an EHR system (see vocabulary project below).\n",
      "More information:\n",
      "Work and Health Functional Profileexternal icon\n",
      "A Prototype to Demonstrate Collection of Self-Reported Occupational Data for Health (ODH) in a Standardized Way\n",
      "NIOSH is working to develop a prototype that will demonstrate the features and the necessary ODH value sets to collect self-reported ODH to be included in EHRs and other health information systems. It aligns with the instructions found in the HL7® Work and Health, EHR Functional Profile. The goal is to encourage healthcare providers and software vendors to build the functionality and include ODH vocabulary into their solutions.\n",
      "Electronic Case Reporting of Occupational Illnesses and Injuries\n",
      "NIOSH is working with CSTE and state partners to define specifications, value sets and rules logic for the electronic reporting of occupational conditions using EHRs. These have been defined for silicosis and are under development for acute pesticide poisoning, lead exposure, and work-related asthma.\n",
      "More information:\n",
      "Health Level Seven Internationalexternal icon\n",
      "Occupational Data for Health (ODH) Vocabulary\n",
      "NIOSH has prepared value sets for several data elements that are part of ODH by looking at national and international terms used to describe work. The value sets are the entry-choices (values) for ODH data elements: Employment Status, Work Schedule, Work Classification, Job Supervisory Level, Job Employment Type, Industry, and Occupation. These data elements have not previously been standardized in medical records and in EHRs. The value sets are available in the Public Health Information Network Vocabulary Distribution System (PHIN VADS) and there is an ODH “Hot Topic” on the PHIN VADS home page.\n",
      "More information:\n",
      "PHIN VADS Home Page\n",
      "\n",
      "JLT Mobile Computers expands partnership and becomes exclusive reseller of Winmate products on the US market\n",
      "Posted March 5th, 2020 for MHI\n",
      "Agreement deepens existing relationship between the companies with the aim to provide complete rugged computing solutions for enhanced operational efficiency in the warehouse, ports and other demanding application environments\n",
      "Friday, March 06, 2020\n",
      "Växjö, Sweden, 5 March 2020\n",
      "JLT Mobile Computers, a leading supplier of reliable computers for demanding environments, announces that it has signed a distribution agreement with rugged computing and embedded solutions provider Winmate Inc. Under the terms of the new agreement, JLT will exclusively distribute Winmate's portfolio of rugged mobile computers, rugged tablets, and vehicle-mount computers in the United States. Strengthening the existing relationship between the two companies, the agreement marks another step in JLT's growth strategy centering on expanded product, service, and solution offerings and strategic partnerships to address customers' business needs.\n",
      "Recognizing the increasing complexity of customers' planning, acquisition, implementation and management processes as a result of digitization, IoT, Cloud and Industry 4.0 trends, JLT's vision is to ensure trouble-free business operations for its customers. To realize this vision, JLT is gradually transforming itself into a provider of end-to-end rugged IT solutions, with a strengthened commitment to customers through the sale of complementary products, services and consultancy besides the leverage of a growing number of strategic partnerships.\n",
      "“JLT has been a pioneer and leader in the rugged computing industry for more than 25 years and today owns a long-standing presence in the U.S., especially within the warehousing, transportation and ports segments”, said Allan Lin, COO of Winmate. “By combining the JLT offering with Winmate products and expertise, we will together provide the best possible enterprise mobility solutions and services in the U.S. market.”\n",
      "“Our strategy to become a provider of end-to-end rugged IT solutions is an ongoing transformation that has been underway for a while”, explained Per Holmberg, CEO at JLT Mobile Computers Group. “JLT is transforming from predominantly being a traditional hardware vendor to becoming a business partner and trusted advisor to our customers, providing the best combination of rugged hardware, software, services and solutions.”\n",
      "“Leveraging the strength of JLT's products, deep expertise in system integration and proactive customer support, in combination with Winmate's rugged enterprise mobility offering, we will bring outstanding products and solutions to the growing industrial-grade enterprise mobility industry in the United States,” says Eric Miller, CEO at JLT Mobile Computers USA.\n",
      "To learn more about JLT Mobile Computers, and the company's products, services and solutions, visit www.jltmobile.com.\n",
      "About JLT Mobile Computers\n",
      "Reliable performance, less hassle. JLT Mobile Computers is a leading supplier of rugged mobile computing devices and solutions for demanding environments. 25 years of development and manufacturing experience have enabled us to set the standard in rugged computing, combining outstanding product quality with expert service, support and solutions to ensure trouble-free business operations for customers in warehousing, transportation, manufacturing, mining, ports and agriculture. JLT operates globally from offices in Sweden and the US, complemented by an extensive network of sales partners in local markets. The company was founded in 1994, and the share has been listed on the Nasdaq First North Growth Market stock exchange since 2002 under the symbol JLT. Eminova Fondkommission AB acts as Certified Advisor. Learn more at www.jltmobile.com.\n",
      "About Winmate Inc.\n",
      "Winmate Inc. is a rugged computing and embedded solutions provider for industries operating in some of the most challenging environments. Founded in 1996 in Taipei, Taiwan where its headquarters, research and development facility, and production lines are located, today the company has offices and service centers worldwide. Winmate develops rugged industrial-grade computing solutions that advance the Industrial Internet-of-Things (IoT). Industrial display and panel PC, HMI, embedded systems, IoT gateways to rugged tablets and handheld devices for industries ranging from transportation and logistics to marine and military, railway, oil and gas, smart grid, healthcare, and field services. Winmate also provides professional services in customizing products and project management create a unique solution for specific customer's needs. For more information, visit www.winmate.com.\n",
      "\n",
      "Building contractor renewal\n",
      "This page is for:\n",
      "Builder\n",
      "Check your inbox, not your post box: Courtesy renewal notices are now sent by email. Further information at dmirs.wa.gov.au/LSupdate.\n",
      "Financial capacity\n",
      "The Building Services (Registration) Act 2011 requires the board to be satisfied that a building service contractor in their class of registration meets the prescribed financial requirements.\n",
      "The prescribed requirements for each class of building service are set out in the renewal form.\n",
      "All contractors must answer questions about their financial capacity. Building and building surveying contractors must also provide supporting documents as detailed on the application forms as evidence of financial capacity.\n",
      "Fees and payments\n",
      "Payment of the fee must accompany the renewal form. Fees can be paid by post or in person. Acceptable payment methods are cheque, money order, credit card, cash or EFTPOS. Please note that online payment is NOT available for renewal fees. Details of the current fees can be found here.\n",
      "Forms\n",
      "Contractor only\n",
      "Individual – Form 52\n",
      "Company – Form 53\n",
      "Partnership – Form 54\n",
      "Practitioner and contractor\n",
      "Use the following two forms:\n",
      "Practitioner – Form 51\n",
      "Contractor – Form 52\n",
      "Lodging your application\n",
      "In person\n",
      "Monday to Friday, 8.30am–5.00pm\n",
      "Building and Energy\n",
      "Level 1, Mason Bird Building\n",
      "303 Sevenoaks Street Cannington\n",
      "By post\n",
      "Registration renewal\n",
      "Locked Bag 100\n",
      "East Perth WA 6892\n",
      "Late applications\n",
      "Late applications may be lodged within six months after the expiry date of a registration but you must first write a letter giving reasons for the delay. You can use the late application form for this purpose. If the board accepts your reasons, you are then required to complete a renewal application form and pay the required fee.\n",
      "If the board does not accept your reasons, you may not apply to renew your registration, but you may apply for a new registration. The board has particular forms to assist applicants applying for a new registration within three years of a former registration expiry date.\n",
      "It is recommended that you lodge your renewal application before your registration expires to avoid the inconvenience of a late application or a new registration. If you have difficulty submitting your complete renewal application on time, please submit an incomplete renewal application before the expiry date. Contact the department for further assistance on 1300 489 099.\n",
      "For more information, please refer to the board's policy on late applications (renewals).\n",
      "Share this page:\n",
      "Last modified: Wednesday, March 11, 2020 - 09:44\n",
      "\n",
      "Evaluation and Acceptance of Emergency Breathing Support Systems (EBSS) Incorporated into SCBA Approvals\n",
      "Letter to All Interested Parties\n",
      "Issue Date: February 18, 2014\n",
      "From: Jonathan Szalajda, Acting Chief, Technical Evaluation Branch, National Personal Protective Technology Laboratory\n",
      "Subject: Evaluation and Acceptance of Emergency Breathing Support Systems (EBSS) Incorporated into SCBA Approvals\n",
      "NIOSH is revising its policy on the use of Emergency Breathing Support Systems (EBSS), also known as “Buddy Breathers”. This policy change is being made coincident with the addition of requirements related to the use and operation of these devices in the NFPA 1981, 2013 edition. This policy change will be applicable only to SCBAs meeting the requirements of NFPA 1981, 2013, or subsequent editions. NIOSH will recognize NFPA 1981, 2013-compliant EBSS systems as a part of the NIOSH SCBA approval for users who have received the appropriate level of training. Users will be able to identify approvals for SCBA which incorporate the required hardware by the explicit listing of an additional EBSS statement to the standard cautions and limitations on the approval label. The statement will signify the EBSS components have been evaluated by NIOSH and accepted as meeting the requirements for EBSS under the requirements of NFPA 1981, Revision 2013.\n",
      "Based upon a review of submissions made to the NIOSH Docket 147, as well as the applicable OSHA standards, NIOSH is modifying the existing “Buddy Breather” policy to further support and encourage best practices in the fire service for the deployment of EBSS. Accessories available on some manufacturers' products enable users to have the option to provide buddy breathing; however, effective training programs are not in place across the nation. It has been reported that departments are reluctant to document success stories; however, anecdotal evidence submitted to the docket indicates that lives have been saved when Buddy Breathers have been used.\n",
      "Recognition of these practices and use of EBSS conforming to the newly developed NFPA 1981:2013 standard provides a framework for the Fire Service to formally incorporate best practices in the fire service for the maintenance and use of EBSS and development of “Buddy Breathing” training programs conforming to National Fire Protection Association Standards 1404, Fire Service Respiratory Protection Training and 1500, Fire Department Occupational Safety and Health Program, which will further address cautions and limitations associated with the use of EBSS in future editions. Until such time that the personnel training requirements of NFPA 1404 and the Occupational Safety and Health Program requirements of NFPA 1500 are revised to address EBSS maintenance and use, NIOSH will require the manufacturer User Instructions to provide training information.\n",
      "Those making application for approval are advised of the following minimum requirements.\n",
      "Additional standards:\n",
      "In order to be evaluated for incorporation into SCBA approval, EBSS systems must be incorporated into SCBA configurations found to be conforming to NFPA 1981:2013, by a certification organization accredited for personal protective equipment in accordance with ISO/IEC Guide 65, General requirements for bodies operating product certification systems, currently Safety Equipment Institute (SEI).\n",
      "Additional testing:\n",
      "All components of the EBSS must be able to operate at the specified low temperature limit without adversely affecting the operation of the SCBA, as determined by testing conducted in accordance with the current revision of Standard Test Procedure TEB-CBRN-ASR-STP-0219.\n",
      "At the minimum activation pressure with the EBSS receiver line held open to atmosphere, the donor unit must be able to meet Pressure-Demand performance requirements through the remainder of the air supply as determined by testing in accordance with the current revision of Standard Testing Procedure TEB-CBRN-ASR-STP-0220.\n",
      "Starting from a full cylinder and prior to the minimum End-of-Service-Time-Indicator (EOSTI) activation pressure the EBSS donor/receiver line will be opened to atmosphere and held open. The duration for which the host unit performance meets Pressure-Demand performance requirements as determined by testing in accordance with the current revision of Standard Testing Procedure TEB-CBRN-ASR-STP-0220, will be measured and recorded.\n",
      "Additional cautions and limitations:\n",
      "The approval label must include these additional cautions and limitations:\n",
      "EBSS Activation or engagement of EBSS in either the donor or receiver mode changes the SCBA use to Escape-Only, approved service time for either the donor, or the receiver is no longer applicable. Additional critical cautions and limitations apply. Refer to section EBSS in the users' manual.\n",
      "At a minimum, these additional caution and limitation statements must appear in section EBSS.\n",
      "EBSS may not be engaged or activated in donor mode after the donor End-of-Service-Time-Indicator (EOSTI) has activated.a\n",
      "Users must be fully trained in the operation of EBSS in accordance with a training program conforming to the requirements of NFPA Standards 1404, Fire Service Respiratory Protection Training and 1500, Fire Department Occupational Safety and Health Program.\n",
      "Simultaneous connection of more than two users, one donor, and one receiver, is not permitted.\n",
      "General application information:\n",
      "All certification application(s) shall 1) be submitted concurrently to NIOSH (Records Room) and SEI and 2) include a completed application package for each SCBA respirator model for which approval is requested. NIOSH submittals must conform to the requirements outlined in the Standard Application Procedures (SAP). Standard SCBA approval fees are applicable to each new approval sought. Consultations with NIOSH are available and encouraged prior to submitting an application to enable an accurate determination of required test hardware to be made. Your effort in following these procedures will assist NIOSH and SEI in ensuring an orderly certification process.\n",
      "We hope this information is helpful to you. Please feel free to contact Robert Stein at 412-386-6889 or by email at rstein@cdc.gov if you have any questions.\n",
      "Evaluation and Acceptance of Emergency Breathing Support Systems (EBSS) Incorporated into SCBA Approvals\n",
      "[PDF – 33 KB]\n",
      "a Consistent with the requirements of NFPA 1981:2013, EOSTI settings of less than 33% of service pressure will not be permitted; however, higher minimum EBSS activation pressures will be considered contingent upon acceptable notification to the user.\n",
      "Page last reviewed: December 10, 2014 (archived document)\n",
      "Content source: National Institute for Occupational Safety and Health\n",
      "\n",
      "Agriculture, forestry and fishing\n",
      "Businesses that grow crops, raise animals, grow and harvest timber, and harvest fish and other animals from farms or their natural habitats, fall within the agriculture industry.\n",
      "There are two basic activities captured in this category:\n",
      "production, eg raising beef cattle, off shore prawn fishing, felling of plantation trees\n",
      "support services to production, eg fruit picking, wool classing.\n",
      "Farming\n",
      "Looking after yourself, your family, workers and visitors.\n",
      "Find out more\n",
      "Plant nurseries\n",
      "Overcome specific health and safety challenges.\n",
      "Find out more\n",
      "Top causes of injury\n",
      "There are a vast range of activities and workplaces within this industry. Each workplace presents its own safety challenges.\n",
      "But, across the industry, common causes of injuries are:\n",
      "unsafe use of quad bikes\n",
      "manual tasks and repetitive motion\n",
      "hearing loss due to noise\n",
      "incorrect and unsafe use of hazardous chemicals\n",
      "injuries from farm animals.\n",
      "Common hazards\n",
      "Working in the agriculture, forestry and fishing industry is physically demanding and workers face challenges of working outdoors, working in all types of weather and conditions, and often working in regionally isolated areas. These aspects of the work complicate the safety risks.\n",
      "Each workplace is different though. You need to know what the hazards are in your business so you can assess the risk they pose.\n",
      "To help you get started, we've prepared information on how to identify hazards and manage the risks common to the agriculture sector, including:\n",
      "quad bikes\n",
      "noise\n",
      "manual handling\n",
      "animal handling\n",
      "electrical work and working near overhead powerlines\n",
      "biosecurity hazards\n",
      "tree work (arboriculture)\n",
      "Resources to help you\n",
      "As the work health and safety regulator in NSW, we have a wide range of technical, business, management and support services to help you make our business safe.\n",
      "You can find specific information on:\n",
      "Our 'resource' and 'hazard' libraries\n",
      "Our resource library and hazard library is where you will find up-to-date information on managing hazards and risks as well as codes of practice.\n",
      "We also have extensive information that will help you improve and review your risk management processes. This includes videos, checklists, training and supervisory information, and safety alerts.\n",
      "SafeWork Australia also has a fact sheet on developing a hazardous chemicals register.\n",
      "Our safety management resources\n",
      "Our Safety starts here section has a range of essential resources including:\n",
      "business must haves like emergency plans and first aid\n",
      "the basics for physical safety at work\n",
      "the basics for mental health at work\n",
      "Our business resources\n",
      "Safety support\n",
      "Small business rebate\n",
      "Building a health and safety culture\n",
      "Consultation @ work\n",
      "Our safety support services\n",
      "If you employ fewer than 50 workers, you can book request a workplace advisory visit by one of our SafeWork inspectors who will help you identify hazards and develop risk management procedures.\n",
      "Our mentor program, where other businesses work with you to improve safety in your workplace, is also a valuable addition to your risk management program.\n",
      "You can call us on 13 10 50 at any time for assistance in finding the services you need quickly.\n",
      "Farm Safety Advisory Program\n",
      "The NSW Farm Safety Advisory Pilot Program aims to reduce farm-related death, injury and disease and improve health and safety of workers in the farming industry by:\n",
      "working with the agricultural industry to provide advice and education of farm safety issues\n",
      "raising awareness on farm safety issues.\n",
      "SafeWork NSW has partnered with NSW Farmers Association to deliver the program.\n",
      "Keeping up to date\n",
      "Get into the habit of checking our website twice a week for updates on your legislative obligations, on current incidents and prosecutions, for new safety tips and general health and safety information.\n",
      "Link your business to our social media channels including Twitter, Facebook and LinkedIn and never miss any of our news.\n",
      "Subscribe to the SafeWork Wrap, our monthly newsletter, which contains safety tips, general information, industry updates, and news about our prosecutions and enforceable undertakings.\n",
      "Visit the Alive and Well website and hear stories about staying safe on the farm from agriculture workers just like you.\n",
      "Subscribe to industry publications and join your industry groups. Some of the relevant industry groups include:\n",
      "For farmers:\n",
      "National Farmers Federation (NFF)\n",
      "For commercial fish operations owners:\n",
      "Commonwealth Fisheries Association (CFA)\n",
      "For forest products growers and support:\n",
      "Australian Forest Products Association (AFPA)\n",
      "For agriculture and fisheries workers:\n",
      "Australian Workers’ Union (AWU)\n",
      "For forestry workers:\n",
      "The Construction, Forestry, Mining and Energy Union (CFMEU).\n",
      "Legislation\n",
      "The NSW Work Health and Safety Act 2011 (WHS Act) and the NSW Work Health and Safety Regulation 2017 (WHS Regulation) define the obligations both employers and workers have to health and safety in the workplace.\n",
      "The WHS legislation is supported by our Compliance policy and prosecution guidelines, which supplements the National compliance and enforcement policy.\n",
      "You can find a complete breakdown of business operations that fall within the administrative and support services industry from the Australian Bureau of Statistics (ABS).\n",
      "\n",
      "Chapter 1\n",
      "Introduction\n",
      "Chapter 1 - Travel Epidemiology\n",
      "Chapter 2 - The Pretravel Consultation\n",
      "Perspectives: Why Guidelines Differ\n",
      "David R. Shlim\n",
      "INTRODUCTION\n",
      "Numerous international, national, and professional organizations publish guidelines and recommendations for travelers, including the CDC Yellow Book. Travel health providers should be aware of these recommendations, even though they may not follow them in every instance. This way they can explain to their patients how their recommendations, and their patients' choices, may be at odds with what others recommend. It can be unsettling for patients to receive travel medicine advice, vaccines, or an antimalarial drug prescription from a provider, only to find that what has been advised or prescribed is contradicted by what other professionals, friends, or destination-country nationals have to say. The skillful travel health provider will be able to help the traveler reconcile seemingly conflicting advice.\n",
      "HOW GUIDELINES ARE CREATED\n",
      "In the United States, the Food and Drug Administration (FDA) approves standards for how to use a vaccine or medication, including dosages, ages for which the product is approved, and booster recommendations. Recommendations about when to use a product may come from a separate body, such as the Advisory Committee on Immunization Practices (ACIP). To give ACIP the best possible information on which to base their recommendations, working groups of experts may hold meetings to review the literature and new studies. CDC Yellow Book travel advice will always be compatible with ACIP recommendations but may, on occasion, offer country- and situation-specific guidelines for vaccine use.\n",
      "International organizations such as the World Health Organization (WHO) and national committees of other countries, as well as medical organizations such as the International Society of Travel Medicine (ISTM) or the Infectious Diseases Society of America, may each promote their own sets of guidance. Other professional organizations may create consensus clinical practice guidelines based on published medical literature and expert opinion. Travel medicine–specific paid subscription services employ travel medicine experts to organize and present guidelines for health care providers who see international travelers in their practice but who may lack expertise in the subject. Guidance provided about vaccines and malaria prophylaxis can differ from CDC advice.\n",
      "Guidelines put forward by different countries and organizations may differ in substantial ways. Reasons for this include differing licensure and availability of products, cultural perceptions of risk, lack of definitive evidence, and differences of opinion among experts.\n",
      "Availability of Products\n",
      "Travel health providers can only use the products available to them. Availability is determined by the regulatory approval status of the product and, to a lesser extent, the marketing and distribution plan of the manufacturer. Regulatory approval processes vary greatly by country. For example, registering a new vaccine or antimalarial drug in the United States is a costly and rigorous process. If the market in a particular country is insufficient to justify the expense of registration, a commercial company may not seek it.\n",
      "Standards for licensure also vary. What may be sufficient for one regulatory authority may not suffice for another. For example, primaquine, an option for malaria prophylaxis in the United States, is not registered or commercially available in Switzerland. Atovaquone-proguanil was available for malaria prophylaxis in the United States before many other countries. Four Japanese encephalitis vaccines are available in the world, but only 1 is licensed in the United States.\n",
      "Even when the same products are available, recommendations for use may not be the same in all countries. The injectable capsular polysaccharide typhoid vaccine and the oral typhoid vaccine are examples. In the United States, a booster of the polysaccharide vaccine is recommended after 2 years, but in most European countries, a booster is recommended after 3 years. In the United States, a packet of 4 oral typhoid vaccine capsules is dispensed, whereas in Europe, 3 doses are considered adequate. The regulatory agencies may have reviewed the same data and drawn different conclusions, or they may have reviewed different data at separate times. Regulatory submissions to various agencies rarely occur at the same time; therefore, the data available for review by each agency may not be the same, for legitimate reasons.\n",
      "Perception of Risk\n",
      "People from varying backgrounds can view the same risk data and come to very different conclusions as to the cost and benefit of minimizing that risk to what they consider to be an acceptable level. For example, recommendations to prevent malaria during travel to India vary widely. Germany does not recommend using standard prophylaxis for any travel to an Indian destination; standby emergency treatment (SBET) or self-treatment only is the recommendation for identified risk destinations. Guidelines from the United Kingdom recommend only awareness and mosquito bite prevention for more than half the Indian subcontinent, including large cities and popular tourist destinations in the north and south, while suggesting prophylaxis consideration for some travelers or for those visiting higher-risk areas. By contrast, CDC recommends malaria prophylaxis for any Indian destination (except for some mountainous areas of northern states) for all travelers.\n",
      "Lack of Evidence\n",
      "In many cases, limited or no data are available to inform an evidence-based assessment. Travel health providers must then defer to expert opinion or extrapolate from limited data in conjunction with expert opinion. In travel medicine, it is rare to have numerator and denominator data on the risk of any disease. For example, any new data on the risk of hepatitis A in travelers would have to account for the high immunization rate with hepatitis A vaccine. Because such data are rarely available, travel health providers often rely on historical data that captured few actual cases.\n",
      "CAN WE HARMONIZE GUIDELINES?\n",
      "The complex nature of how health organizations obtain, evaluate, and verify data, combined with fundamental differences in risk perception, makes it likely that multiple, overlapping, and at times conflicting guidelines will continue to exist. However, conflicting guidelines have decreased in the past decade due to the efforts of several organizations. A recent example has been the collaboration among the WHO, US CDC, and the European Centre for Disease Prevention and Control (ECDC) to develop consistency and clarity in defining the risk of Zika infection for travelers so that providers can more clearly relay traveler risk, particularly to those who are pregnant or planning pregnancy.\n",
      "In summary, the role of the travel health provider is to understand the various differences in guidelines, interpret this information, and convey tailored and informed advice in an assured and comforting manner to travelers.\n",
      "BIBLIOGRAPHY\n",
      "CDC. Malaria surveillance—United States, 2015. MMWR Surveill Summ. 2018 May 4;67(7):1–28.\n",
      "CDC. Advisory Committee on Immunization Practices (ACIP). Atlanta: CDC; 2018 [cited 2018 Sep 12]. Available from: www.cdc.gov/vaccines/acip/.\n",
      "Chiodini PL, Field VK, Whitty CJM, Lalloo DG. Guidelines for malaria prevention in travellers from the UK: 2017. London: Public Health England; 2017 [cited 2018 Sep 12]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/660051/Guidelines_for_malaria_prevention_in_travellers_from_the_UK_2017.pdf.\n",
      "Committee to Advise on Tropical Medicine and Travel (CATMAT). Canadian recommendations for the prevention and treatment of malaria. Ottawa: Public Health Agency of Canada; 2014 [cited 2018 Sep 12]. Available from: http://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-102-2014-eng.pdf.\n",
      "German Society for Tropical Medicine and International Health Association (DTG). [Recommendations for the prophylaxis and treatment of malaria of DTG 2018]. 2018 [cited 2018 Sep 12]. Available from: www.dtg.org/empfehlungen-und-leitlinien/empfehlungen/malaria.html.\n",
      "Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO, Kozarsky PE, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Dec 15;43(12):1499–539.\n",
      "World Health Organization. International Health Regulations (2005). Geneva: World Health Organization; 2016 [cited 2018 Sep 12]. Available from: www.who.int/ihr/publications/9789241580496/en.\n",
      "World Health Organization. International Travel and Health. Geneva: World Health Organization; 2012 (with 2016 updates) [cited 2016 June 14]. Available from: www.who.int/ith/en/.\n",
      "Perspectives sections are editorial discussions written to add depth and clinical perspective to the official recommendations contained in the book. The views and opinions expressed in this section are those of the authors and do not necessarily represent the official position of CDC.\n",
      "Chapter 1 - Travel Epidemiology\n",
      "Chapter 2 - The Pretravel Consultation\n",
      "Page last reviewed: June 21, 2019\n",
      "Content source: National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)\n",
      "Division of Global Migration and Quarantine (DGMQ)\n",
      "\n",
      "Advanced ovarian cancer treatment approved for Cancer Drugs Fund\n",
      "Posted October 11th, 2019 for Cancer Research UK\n",
      "In collaboration with the Press Association\n",
      "cross_section_fallopiantube_edutham.jpg\n",
      "A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.\n",
      "The drug, rucaparib (Rubraca), is designed to help maintain the effects of chemotherapy and will be available for women with ovarian, fallopian tube or peritoneal cancer that has come back and responded to chemotherapy.\n",
      "The National Institute of Health and Care Excellence (NICE) said the decision could benefit around 1,350 people in England living with ovarian cancer.\n",
      "Dr Yvette Drew, a consultant medical oncologist from Newcastle University, was a Cancer Research UK-funded scientist on the first clinical trial that tested rucaparib against ovarian cancer. She said it was “fantastic news” that the drug will be more widely available.\n",
      "“Rucaparib is a very well-tolerated oral treatment giving women quality of life for longer and helps them to avoid the sometimes-debilitating side effects of chemotherapy,” said Drew.\n",
      "She said trials have shown that the drug significantly delays the progression of a person's cancer after they have responded to chemotherapy and delays the need for them to have subsequent chemotherapy treatments.\n",
      "Slowing progression\n",
      "Rucaparib is a type of cancer drug called a PARP inhibitor.\n",
      "It slows the progression of the disease by preventing cancer cells from repairing.\n",
      "Rucaparib kills cancer cells by blocking the activity of a molecule called PARP, which helps repair damage to DNA.\n",
      "Clinical trial results suggest that rucaparib extends the time before cancer progresses to 10.8 months, compared with 5.4 months with routine care.\n",
      "However, there is uncertainty over exactly how much longer people may live after taking the drug, because those taking part in the trial have not been studied for long enough.\n",
      "NICE added the treatment to the Cancer Drugs Fund so eligible patients could benefit from rucaparib while long-term data is collected from an ongoing clinical trial.\n",
      "NICE change their initial decision\n",
      "Rucaparib was initially rejected for routine use on the NHS due to uncertainties surrounding the trial evidence and the cost of the drug.\n",
      "Following the initial decision, NICE and the drug manufacturer negotiated a lower treatment price. NICE concluded that the drug could offer value for money at this lower price, if long-term data from the clinical trial show the drug is effective at extending patients' lives.\n",
      "Meindert Boysen, director of the NICE Centre for Health Technology Evaluation, said the health watchdog was pleased with the positive response from the company that has led to rucaparib being approved for use in the Cancer Drugs Fund.\n",
      "“This will allow patients to access the treatment immediately, while more evidence can be collected on its overall survival benefit.”\n",
      "Medicines on the Cancer Drugs Fund in England are also usually made available to patients in Wales and Northern Ireland.\n",
      "Decisions over which drugs should be funded by the NHS in Scotland are made separately by the Scottish Medicines Consortium.\n",
      "Michelle Mitchell, Cancer Research UK's chief executive, added that this approval is the result of many years of hard work by Cancer Research UK scientists based at Newcastle University, who developed this drug in the 1990s in collaboration with industry partners.\n",
      "“Rucaparib could bring new hope for those affected by this type of ovarian cancer, giving them a better quality of life for longer and with fewer side-effects than other types of treatment.”\n",
      "Mitchell said more trials are underway to discover whether this drug could also benefit people with other types of cancer and that “we await those results with interest.”\n",
      "\n",
      "BioTime to Present New Data From OpRegen and Vision Restoration Programs at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2019)\n",
      "Posted February 25th, 2019 for BIOTIME, Inc.\n",
      "ALAMEDA, Calif., Feb. 26, 2019\n",
      "BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced today that updated results from a Phase I/IIa study of its lead product candidate, OpRegen®, a retinal pigment epithelium (RPE) cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (Dry-AMD), will be presented at the 2019 Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2019), to be held April 28 through May 2, 2019 at the Vancouver Convention Centre in Vancouver, BC, Canada. OpRegen® is currently being evaluated in a Phase I/IIa clinical trial for the treatment of dry-age related macular degeneration.\n",
      "The abstract presentation, entitled, “Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, OpRegen) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results,” will be presented as part of the Advances in Retinal Gene Therapy and Stem Cells Session on May 2, 2019 between 10:15 AM to 12:00 PM EDT in Session Number 530 by Eyal Banin, MD, PhD, Professor of Ophthalmology, Director, Center for Retinal and Macular Degenerations, Department of Ophthalmology at Hadassah-Hebrew University Medical Center (presentation number 6402). The abstract will provide updated data from patient cohorts 1 through 3 of the study and new data from the ongoing patient cohort 4 in better vision patients.\n",
      "In addition, BioTime will present preclinical results from its Vision Restoration Program, the Company's proprietary program based on the ability to generate 3-dimensional human retinal tissue derived from pluripotent cells. BioTime's 3-dimensional retinal tissue technology may address the unmet need of implementing a retinal tissue restoration strategy to address a wide range of severe retinal degenerative conditions including retinitis pigmentosa and advanced forms of AMD. In 2017, the Small Business Innovation Research program of the National Institutes of Health awarded BioTime a grant of up to $1.56 million to further develop this innovative, next generation vision restoration program.\n",
      "The poster presentation, entitled, “Transplantation of human embryonic stem cell derived retinal tissue in the subretinal space of immunodeficient rats with retinal degeneration (RD),” will be presented as part of the Animal Models for Visual Disease and Restoration Session on April 30, 2019 between 8:45am to 10:30am EDT in Session Number 332 by Igor Nasonkin, PhD, Principal Investigator, Director of Research & Development at BioTime, Inc. (Posterboard Number: 3109 - A0500).\n",
      "The poster presentation, entitled, “Evaluation of selected Human Embryonic Stem Cell Lines for differentiation to three-dimensional retinal tissue (organoids) for cell therapies of retinal degenerative conditions,” will be presented as part of the Stem Cells and Retinal Organoids: Disease modeling Session on April 30, 2019 between 8:45am to 10:30am EDT in Session Number 323 by Ratnesh Singh, PhD, Senior Scientist at BioTime, Inc. (Posterboard Number: 2873 - A0044).\n",
      "About OpRegen®\n",
      "OpRegen® is a retinal pigment epithelium transplant therapy in Phase I/IIa development for the treatment of dry age-related macular degeneration, the leading cause of adult blindness in the developed world. OpRegen® consists of a suspension of retinal pigment epithelial (RPE) cells delivered subretinally as an intraocular injection. RPE cells are essential components of the back lining of the retina and function to help nourish the retina including photoreceptors. OpRegen® has been granted Fast Track designation from the U.S. Food and Drug Administration. OpRegen® is a registered trademark of Cell Cure Neurosciences Ltd., a majority-owned subsidiary of BioTime, Inc.\n",
      "About BioTime, Inc.\n",
      "BioTime is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime's pipeline is based on two platform technologies which encompass cell replacement and cell/drug delivery. BioTime's lead cell replacement product candidate is OpRegen®, a retinal pigment epithelium transplant therapy in Phase 2 development for the treatment of dry age-related macular degeneration, the leading cause of blindness in the developed world. BioTime's lead cell delivery clinical program is Renevia®, an investigational medical device being developed as an alternative for whole adipose tissue transfer procedures. BioTime common stock is traded on the NYSE American and TASE under the symbol BTX. For more information, please visit www.biotimeinc.com or connect with the company on Twitter, LinkedIn, Facebook, YouTube, and Google+. To receive ongoing BioTime corporate communications, please click on the following link to join the Company's email alert list: http://news.biotime.com.\n",
      "\n",
      "Bioo Scientific Releases MaxSignal® Colistin ELISA Test Kit for the Rapid Quantitation of Colistin in Meat\n",
      "Posted January 19th, 2015 for Bioo Scientific\n",
      "Bioo Scientific's MaxSignal Colistin ELISA Test Kit helps prevent the abuse of colistin, a last-line antibiotic, as an agricultural drug. The MaxSignal Colistin ELISA Test Kit is the only commercially available ELISA optimized for the screening of Colistin in meat samples including poultry, beef and pork.\n",
      "Austin, TX, USA., January 19, 2015\n",
      "(PressReleasePoint)\n",
      "Bioo Scientific's MaxSignal® Colistin ELISA Test Kit is the only commercially available ELISA optimized for the screening of Colistin in meat samples including poultry, beef and pork. This kit combines a unique and proprietary colistin extraction method along with stable standards to deliver dependable, accurate, rapid, cost effective and easy colistin analysis.\n",
      "Colistin is used by physicians as a drug of last resort to treat Gram-negative superbug infections. It is also used in agriculture against infectious diseases in rabbits, pigs, cattle, sheep and goats, contributing to the development of antibiotic-resistant bacterial strains. Recently the European Center for Disease Prevention and Control (ECDC) observed that resistance to colistin was found in 5 percent of Klebsiella pneumoniae isolates for the EU, making the use of tests such as the MaxSignal Colistin ELISA Test Kit critical to ensure that colistin does not enter the food stream, helping prevent the development of additional colistin-resistant strains of bacteria.\n",
      "The MaxSignal Colistin ELISA Test Kit is the latest addition to Bioo Scientific's line of ELISA and strip tests for the detection of antibiotics, hormones and other veterinary drugs in food and feed samples. This kit is manufactured to the international quality standard ISO 9001:2008 (ISO CI#: SARA-2009-CA-0114-A).\n",
      "About Bioo Scientific\n",
      "As a world leader in food safety testing, Bioo Scientific is dedicated to improving the safety of the world's food and feed supply by developing accurate, affordable tools which allow companies to readily screen for microbial and industrial contaminants, natural toxins, hormones, antibiotics and other residues.\n",
      "Bioo Scientific has been awarded numerous Small Business Innovation Research (SBIR) grants that support innovative product development activities from agencies such as the National Institutes of Health (NIH), the United States Department of Agriculture (USDA), Food and Drug Administration (FDA), the National Science Foundation (NSF), and Department of Defense (DOD). The company has also been awarded the Tech Innovation Award and the Greater Austin Business Export Award highlighting its international business activities. Bioo Scientific food safety test kits are being used around the globe in agricultural settings, as well as by governmental testing agencies, to provide the high level of assurance that consumers need for their raw and processed food products.\n",
      "Press Contact:\n",
      "Dawn Obermoeller\n",
      "7050 Burleson Rd Austin, TX 78744\n",
      "512-707-8993\n",
      "*****@**o**c**n**f**.com\n",
      "www.biooscientific.com\n",
      "Contact Dawn Obermoeller\n",
      "\n",
      "License borrowing\n",
      "Share\n",
      "License borrowing is an optional feature of network licensing.\n",
      "What is License Borrowing?\n",
      "How Does Borrowing Work?\n",
      "How Long Can a License be Borrowed?\n",
      "What is License Borrowing?\n",
      "If you are using a network-licensed version of your Autodesk product and your network supports the license borrowing feature, you can borrow a product license from your network license server to use the Autodesk product for a specified time when your computer is not connected to the network. Borrowing may also be beneficial in situations where the connection to your license server may not be consistent or the license server needs to be taken down for maintenance during work hours.\n",
      "Your borrowed license is automatically returned to the license server at the end of the day on the return date you set when you borrow the license. You can also return a license early.\n",
      "Note: Borrowing only applies to Network licenses. For stand-alone licenses, you may be able to use the License Transfer Utility to transfer a license from one machine to another.\n",
      "Return to Top\n",
      "How Does Borrowing Work?\n",
      "When a license is borrowed, it reduces the count of available licenses in the network license pool. If you have a pool of 10licenses and someone borrows one, you then have a remaining pool of nine licenses available for others to use. As long as that license is borrowed, it is not available on the license server.\n",
      "Borrowing is handled on a per-user and per-computer basis and requires being on the network to do the borrowing. Only machines that can make a connection to your license server are able to borrow a license. Once a license has been borrowed, the Network License Manager will keep track of that license, for the machine that borrowed it, and for the specified period of time.\n",
      "Note: A limited number of licenses are available for borrowing. If you try to borrow a license and are notified that no licenses are available, see your network administrator for help.\n",
      "Unless returned early, borrowed licenses are automatically returned when the borrow period expires. If the defined borrow period was seven days, the borrowed license will automatically be returned to the license pool when seven days have passed. Borrowed licenses can be returned early but requires being connected to the network license server. Just as you connected to borrow a license in the first place, you have to connect to the same license server to return it early.\n",
      "Return to Top\n",
      "How Long Can a License be Borrowed?\n",
      "When borrowing a license you must specify the period of time you want to borrow the license. The maximum period of time a license can be borrowed is six months however the allowable borrow period may be much shorter if restricted by an options file. Borrowed licenses are automatically returned when the borrow period expires or upon expiration of your subscription with multi-user access, whichever is sooner. Restricting the maximum borrow period to a much shorter duration than six months helps avoid the risk of a license being out of circulation for an extended period. For example, if the license is on a laptop computer, and the computer is stolen or damaged, the license cannot be returned early.\n",
      "By using an options file, you can configure license borrowing behavior to specify the maximum amount of time a license can be borrowed, restrict the number of licenses that can be borrowed, and set up a list of specific users who are allowed to borrow licenses. See the article, Control Network License Access Using an Options File, for detailed information.\n",
      "Return to Top\n",
      "\n",
      "OWASP Cornucopia\n",
      "OWASP Cornucopia is a mechanism in the form of a card game to assist software development teams identify security requirements in Agile, conventional and formal development processes. It is language, platform and technology agnostic.\n",
      "Introduction\n",
      "The idea behind Cornucopia is to help development teams, especially those using Agile methodologies, to identify application security requirements and develop security-based user stories. Although the idea had been waiting for enough time to progress it, the final motivation came when SAFECode published its Practical Security Stories and Security Tasks for Agile Development Environments in July 2012.\n",
      "The Microsoft SDL team had already published its super Elevation of Privilege: The Threat Modeling Game (EoP) but that did not seem to address the most appropriate kind of issues that web application development teams mostly have to address. EoP is a great concept and game strategy, and was published under a Creative Commons Attribution License. Cornucopia Ecommerce Website Edition is based the concepts and game ideas in EoP, but those have been modified to be more relevant to the types of issues ecommerce website developers encounter. It attempts to introduce threat-modelling ideas into development teams that use Agile methodologies, or are more focused on web application weaknesses than other types of software vulnerabilities or are not familiar with STRIDE and DREAD.\n",
      "To start using Cornucopia:\n",
      "Download the document\n",
      "Print the cards onto plain paper or pre-scored card\n",
      "Cut/separate the individual cards\n",
      "Identify an application, module or component to assess\n",
      "Invite business owners, architects, developers, testers along for a card game\n",
      "Get those infosec folk to provide chocolate, pizza, beer, flowers or all four as prizes\n",
      "Select a portion of the deck to start with\n",
      "Play the game to discuss & document security requirements (and to win rounds)\n",
      "Remember, points make prizes!\n",
      "The Card Decks\n",
      "Ecommerce Website Edition\n",
      "Instead of EoP's STRIDE suits, Cornucopia suits were selected based on the structure of the OWASP Secure Coding Practices - Quick Reference Guide (SCP), but with additional consideration of sections in the OWASP Application Security Verification Standard, the OWASP Web Security Testing Guide and David Rook's Principles of Secure Development. These provided five suits, and a sixth called “Cornucopia” was created for everything else:\n",
      "Data validation and encoding\n",
      "Authentication\n",
      "Session management\n",
      "Authorization\n",
      "Cryptography\n",
      "Cornucopia\n",
      "Each suit contains 13 cards (Ace, 2-10, Jack, Queen and King) but, unlike EoP, there are also two Joker cards. The content was mainly drawn from the SCP. Full Wiki Deck.\n",
      "Other Decks\n",
      "Future editions such as for mobile app development will use different sources of information and suits.\n",
      "Mappings\n",
      "The other driver for Cornucopia is to link the attacks with requirements and verification techniques. An initial aim had been to reference CWE weakness IDs, but these proved too numerous, and instead it was decided to map each card to CAPEC software attack pattern IDs which themselves are mapped to CWEs, so the desired result is achieved.\n",
      "Each card is also mapped to the 36 primary security stories in the SAFECode document, as well as to the OWASP SCP v2, ASVS v3.0.1 and AppSensor (application attack detection and response) to help teams create their own security-related stories for use in Agile processes.\n",
      "Licensing\n",
      "OWASP Snakes and Ladders is free to use. It is licensed under the Creative Commons Attribution-ShareAlike 3.0 license, so you can copy, distribute and transmit the work, and you can adapt it, and use it commercially, but all provided that you attribute the work and if you alter, transform, or build upon this work, you may distribute the resulting work only under the same or similar license to this one.\n",
      "© OWASP Foundation\n",
      "Other Security Gamification\n",
      "If you are interested in using gaming for security, also see Elevation of Privilege: The Threat Modeling Game, Security Cards from the University of Washington, the commercial card game Control-Alt-Hack (presentation), OWASP Snakes and Ladders, and web application security training tools incorporating gamification such as OWASP Hackademic Challenges Project, OWASP Security Shepherd and ITSEC Games.\n",
      "Additionally, Adam Shostack maintains a list of tabletop security games and related resources at security games.\n",
      "Get the Cards\n",
      "The primary source document is a Word document. However, pre-printed card decks may be more useful, or there are links to the source design files for the cards themselves.\n",
      "Printed\n",
      "Professionally printed decks are available by two methods:\n",
      "Single decks or in bulk from OWASP (v1.20)\n",
      "As promotion items by OWASP Leaders from their own chapter budgets using the Chapter and Project Merchandise Request form\n",
      "For other individuals, organisations and companies, please email lisa.jones@owasp.com with purchase inquiries.\n",
      "Request a free deck of cards gifted by Blackfoot UK Limited:\n",
      "Request a free pack of cards (v1.10) (gifted by Blackfoot UK)\n",
      "Source files\n",
      "Cornucopia - Ecommerce Website Edition:\n",
      "v1.20 (current version)\n",
      "EN DOC, FR DOC, PT-BR DOC\n",
      "EN PDF\n",
      "Print-Ready design files 24Mb zip\n",
      "v1.1 EN\n",
      "DOC - see current version link above for previous versions of DOC including with track changes\n",
      "Wiki\n",
      "Print-Ready design files 24Mb zip\n",
      "v1.04 EN\n",
      "DOC - see current version link above for previous versions of DOC including with track changes\n",
      "Print-Ready design files (gifted by Blackfoot UK) 47Mb Zip\n",
      "The current version of Cornucopia Ecommerce Website Edition cards (v1.20 with updated mapping to ASVS v3.0.1 and CAPEC v2.8, and has some minor text changes on the cards) can be printed using the following methods:\n",
      "Download the free Adobe Illustrator files (EN) and get them professionally printed\n",
      "Download and self-print the free document word-processing (EN, FR) or PDF (EN)\n",
      "Print the document onto business card blank cards; or\n",
      "Print the document onto normal card and cut the cards out individually using the guide; or\n",
      "Generate your own cards from the free source XML data file\n",
      "There are also other ways to obtain particular versions:\n",
      "Download the free PDF (v1.03) (gifted by Travelex)\n",
      "Have the cards commercially printed; or\n",
      "Import into your own files (such as this way suggested by Cam Morris via the mailing list)\n",
      "OWASP does not endorse or recommend commercial products or services.\n",
      "Twitter\n",
      "Collect/share/use the pseudo-random cards tweeted twice daily @OWASPCornucopia\n",
      "How to Play\n",
      "It is possible to play Cornucopia in many different ways. Here is one way, and explained in a YouTube video.\n",
      "Primary method\n",
      "A - Preparations\n",
      "A1. Obtain a deck, or print your own Cornucopia deck and separate/cut out the cards\n",
      "A2. Identify an application or application process to review; this might be a concept, design or an actual implementation\n",
      "A3. Create a data flow diagram\n",
      "A4. Identify and invite a group of 3-6 architects, developers, testers and other business stakeholders together and sit around a table (try to include someone fairly familiar with application security)\n",
      "A5. Have some prizes to hand (gold stars, chocolate, pizza, beer or flowers depending upon your office culture)\n",
      "B - Play\n",
      "One suit - Cornucopia - acts as trumps. Aces are high (i.e. they beat Kings). It helps if there is someone dedicated to documenting the results who is not playing.\n",
      "B1. Remove the Jokers and a few low-score (2, 3, 4) cards from Cornucopia suit to ensure each player will have the same number of cards\n",
      "B2. Shuffle the pack and deal all the cards\n",
      "B3. To begin, choose a player randomly who will play the first card - they can play any card from their hand except from the trump suit - Cornucopia\n",
      "B4. To play a card, each player must read it out aloud, and explain how (or not) the threat could apply (the player gets a point for attacks that work, and the group thinks it is an actionable bug) - don't try to think of mitigations at this stage, and don't exclude a threat just because it is believed it is already mitigated - someone record the card on the score sheet\n",
      "B5. Play clockwise, each person must play a card in the same way; if you have any card of the matching lead suit you must play one of those, otherwise they can play a card from any other suit. Only a higher card of the same suit, or the highest card in the trump suit Cornucopia, wins the hand.\n",
      "B6. The person who wins the round, leads the next round (i.e. they play first), and thus defines the next lead suit\n",
      "B7. Repeat until all the cards are played\n",
      "C - Scoring\n",
      "The objective is to identify applicable threats, and win hands (rounds):\n",
      "C1. Score +1 for each card you can identify as a valid threat to the application under consideration\n",
      "C2. Score +1 if you win a round\n",
      "C3. Once all cards have been played, whoever has the most points wins\n",
      "D - Closure\n",
      "D1. Review all the applicable threats and the matching security requirements\n",
      "D2. Create user stories, specifications and test cases as required for your development methodology\n",
      "See Márk Vinkovits leading a threat modelling talk and group session playing Cornucopia in the OWASP track @hacktivityconf 1510.\n",
      "Alternative game rules\n",
      "If you are new to the game, remove the two Joker cards to begin with. Add the Joker cards back in once people become more familiar with the process. Apart from the “trumps card game” rules described above which are very similar to the EoP, the deck can also be played as the “twenty-one card game” (also known as “pontoon” or “blackjack”) which normally reduces the number of cards played in each round.\n",
      "Practice on an imaginary application, or even a future planned application, rather than trying to find fault with existing applications until the participants are happy with the usefulness of the game.\n",
      "Consider just playing with one suit to make a shorter session – but try to cover all the suits for every project. Or even better just play one hand with some pre-selected cards, and score only on the ability to identify security requirements. Perhaps have one game of each suit each day for a week or so, if the participants cannot spare long enough for a full deck.\n",
      "Some teams have preferred to play a full hand of cards, and then discuss what is on the cards after each round (instead of after each person plays a card).\n",
      "Another suggestion is that if a player fails to identify the card is relevant, allow other players to suggest ideas, and potentially let them gain the point for the card. Consider allowing extra points for especially good contributions.\n",
      "You can even play by yourself. Just use the cards to act as thought-provokers. Involving more people will be beneficial though.\n",
      "In Microsoft's EoP guidance, they recommend cheating as a good game strategy.\n",
      "Frequently Asked Questions\n",
      "Can I copy or edit the game?\n",
      "Yes of course. All OWASP materials are free to do with as you like provided you comply with the Creative Commons Attribution-ShareAlike 3.0 license. Perhaps if you create a new version, you might donate it to the OWASP Cornucopia Project?\n",
      "How can I get involved?\n",
      "Please send ideas or offers of help to the project's mailing list.\n",
      "How were the attackers' names chosen?\n",
      "EoP begins every description with words like “An attacker can…”. These have to be phrased as an attack but I was not keen on the anonymous terminology, wanting something more engaging, and therefore used personal names. These can be thought of as external or internal people or aliases for computer systems. But instead of just random names, I thought how they might reflect the OWASP community aspect. Therefore, apart from “Alice and Bob”, I use the given (first) names of current and recent OWASP employees and Board members (assigned in no order), and then randomly selected the remaining 50 or so names from the current list of paying individual OWASP members. No name was used more than once, and where people had provided two personal names, I dropped one part to try to ensure no-one can be easily identified. Names were not deliberately allocated to any particular attack, defence or requirement. The cultural and gender mix simply reflects theses sources of names, and is not meant to be world-representative.\n",
      "Why aren't there any images on the card faces?\n",
      "There is quite a lot of text on the cards, and the cross-referencing takes up space too. But it would be great to have additional design elements included. Any volunteers?\n",
      "Are the attacks ranked by the number on the card?\n",
      "Only approximately. The risk will be application and organisation dependent, due to varying security and compliance requirements, so your own severity rating may place the cards in some other order than the numbers on the cards.\n",
      "How long does it take to play a round of cards using the full deck?\n",
      "This depends upon the amount of discussion and how familiar the players are with application security concepts. But perhaps allow 1.5 to 2.0 hours for 4-6 people.\n",
      "What sort of people should play the game?\n",
      "Always try to have a mix of roles who can contribute alternative perspectives. But include someone who has a reasonable knowledge of application vulnerability terminology. Otherwise try to include a mix of architects, developers, testers and a relevant project manager or business owner.\n",
      "Who should take notes and record scores?\n",
      "It is better if that someone else, not playing the game, takes notes about the requirements identified and issues discussed. This could be used as training for a more junior developer, or performed by the project manager. Some organisations have made a recording to review afterwards when the requirements are written up more formally.\n",
      "Should we always use the full deck of cards?\n",
      "No. A smaller deck is quicker to play. Start your first game with only enough cards for two or three rounds. Always consider removing cards that are not appropriate at all of the target application or function being reviewed. For the first few times people play the game it is also usually better to remove the Aces and the two Jokers. It is also usual to play the game without any trumps suit until people are more familiar with the idea.\n",
      "What should players do when they have an Ace card that says “invented a new X attack”?\n",
      "The player can make up any attack they think is valid, but must match the suit of the card e.g. data validation and encoding). With players new to the game, it can be better to remove these to begin with.\n",
      "I don't understand what the attack means on each card - is there more detailed information?\n",
      "Yes, the Wiki Deck at was created to help players understand the attacks. See Wiki Deck.\n",
      "My company wants to print its own version of OWASP Cornucopia - what license do we need to refer to?\n",
      "What is required/reasonable might depend upon how you propose to use the source Cornucopia material. See fuller answer immediately below.Some examples of re-using or reproducing Cornucopia are:\n",
      "Print some decks and give them away to customers\n",
      "Reproduce the game exactly but with a corporate-branded package\n",
      "Use the idea and/or source files to produce a similar game but with different attacks/mappings\n",
      "Distribute modified design files\n",
      "If option 1 above, you can order these in bulk from OWASP and attach your own details below the “compliments of” section on the boxes. There are three aspects to consider for options 2, 3 or 4, or combinations of those - see below. The existing printed decks (and their boxes and leaflets include such text).\n",
      "A - Cornucopia License\n",
      "The precise wording will depend how the material is being used or reproduced. Under Creative Commons Attribution-ShareAlike 3.0 license it is necessary to attribute all previous contributions (in this case, Microsoft, Boeing, Mitre, etc). The easiest place to put the wording is on the leaflet (folded inside, or separate booklet). The current required long-form wording is:\n",
      "OWASP Cornucopia is licensed under the Creative Commons Attribution-ShareAlike 3.0 license http://creativecommons.org/licenses/by-sa/3.0/\n",
      "The files used to create these materials were created from the OWASP project and are also open source, and are licensed under the same conditions.\n",
      "OWASP Cornucopia can be downloaded for free from the OWASP website and printed yourself.\n",
      "The OWASP Cornucopia project source in vendor neutral and unbranded.\n",
      "OWASP does not endorse or recommend commercial products or services.\n",
      "© 2012-2018 OWASP Foundation\n",
      "This document is licensed under the Creative Commons Attribution-ShareAlike 3.0 license.\n",
      "Acknowledgments:\n",
      "Microsoft SDL Team for the Elevation of Privilege Threat Modelling Game, published under a Creative Commons Attribution license, as the inspiration for Cornucopia and from which many ideas, especially the game theory, were copied.\n",
      "Keith Turpin and contributors to the “OWASP Secure Coding Practices - Quick Reference Guide”, originally donated to OWASP by Boeing, which is used as the primary source of security requirements information to formulate the content of the cards.\n",
      "Contributors, supporters, sponsors and volunteers to the OWASP ASVS, AppSensor and Web Framework Security Matrix projects, Mitre's Common Attack Pattern Enumeration and Classification (CAPEC), and SAFECode's “Practical Security Stories and Security Tasks for Agile Development Environments” which are all used in the cross-references provided.\n",
      "Playgen for providing an illuminating afternoon seminar on task gamification, and tartanmaker.com for the online tool to help create the card back pattern.\n",
      "Blackfoot UK Limited for creating and donating print-ready design files, Tom Brennan and the OWASP Foundation for instigating the creation of an OWASP-branded box and leaflet, and OWASP employees, especially Kate Hartmann, for managing the ordering, stocking and despatch of printed card decks.\n",
      "Oana Cornea and other participants at the AppSec EU 2015 project summit for their help in creating the demonstration video.\n",
      "Colin Watson as author and co-project leader with Darío De Filippis, along with other OWASP volunteers who have helped in many ways.\n",
      "The box/container for the cards must have the wording:\n",
      "Created by Colin Watson.\n",
      "Contains: One pack of Cornucopia Ecommerce Website playing cards. OWASP Cornucopia is open source and can be downloaded free of charge from the OWASP website.\n",
      "OWASP Cornucopia is free to use. It is licensed under the Creative Commons Attribution-ShareAlike 3.0 license, so you can copy, distribute and transmit the work, and you can adapt it, and use it commercially, but all provided that you attribute the work and if you alter, transform, or build upon this work, you may distribute the resulting work only under the same or similar license to this one.\n",
      "The following short-form wording must also appear on any materials referencing the outputs (e.g. press releases, leaflets, reports, blog posts):\n",
      "OWASP does not endorse or recommend commercial products or services.\n",
      "OWASP Cornucopia is licensed under the Creative Commons Attribution-ShareAlike 3.0 license and is © 2012-2016 OWASP Foundation.\n",
      "If any files are distributed electronically, the long-form wording should also be aded in a license.txt file within the distribution.\n",
      "If the intention is to use the idea only (option 3 above), the long-form, box and short-form wording might be different, and probably simpler. And it might make more sense to start with the Microsoft-provided Elevation of Privilege files (and open source license).\n",
      "B - Upcoming update to Cornucopia\n",
      "Note that the current print design files are v1.04, and the current Word document is v1.10, but we are in the process of updating all of these to v1.20.\n",
      "Whatever is used as a starting point, please state the source version, for example:\n",
      "Based on OWASP Cornucopia Ecommerce Website Edition v1.04\n",
      "C - OWASP brand usage\n",
      "Additionally individuals, companies and other organisations must not breach OWASP's brand usage guidelines.\n",
      "https://www.owasp.org/www-policy/operational/branding.html\n",
      "In the case of Cornucopia, in 2014 Blackfoot Limited produced some printed decks of cards.\n",
      "Blackfoot's name and logo did not appear anywhere on the OWASP-branded cards, and the OWASP logo did not appear on the Blackfoot-branded box and leaflet. In fact there is no OWASP logo on any part of the Blackfoot branded decks.\n",
      "Acknowledgements\n",
      "Volunteers\n",
      "Cornucopia is developed, maintained, updated and promoted by a worldwide team of volunteers. The contributors to date have been:\n",
      "Simon Bennetts\n",
      "Thomas Berson\n",
      "Tom Brennan\n",
      "Fabio Cerullo\n",
      "Oana Cornea\n",
      "Johanna Curiel\n",
      "Todd Dahl\n",
      "Luis Enriquez\n",
      "Ken Ferris\n",
      "Darío De Filippis\n",
      "Sebastien Gioria\n",
      "Tobias Gondrom\n",
      "Timo Goosen\n",
      "Anthony Harrison\n",
      "Martin Haslinger\n",
      "John Herrlin\n",
      "Jerry Hoff\n",
      "Marios Kourtesis\n",
      "Franck Lacosta\n",
      "Mathias Lemaire\n",
      "Antonis Manaras\n",
      "Jim Manico\n",
      "Mark Miller\n",
      "Cam Morris\n",
      "Susana Romaniz\n",
      "Ravishankar Sahadevan\n",
      "Tao Sauvage\n",
      "Wagner Voltz\n",
      "Stephen de Vries\n",
      "Colin Watson\n",
      "Also:\n",
      "Attendees at OWASP London, OWASP Manchester and OWASP Netherlands chapter meetings, the London Gamification meetup, and the training at AppSec USA 2015 in san Francisco who made helpful suggestions and asked challenging questions\n",
      "Others\n",
      "Microsoft SDL Team for the Elevation of Privilege Threat Modelling Game, published under a Creative Commons Attribution license, as the inspiration for Cornucopia and from which many ideas, especially the game theory, were copied.\n",
      "Keith Turpin and contributors to the “OWASP Secure Coding Practices - Quick Reference Guide”, originally donated to OWASP by Boeing, which is used as the primary source of security requirements information to formulate the content of the cards.\n",
      "Contributors, supporters, sponsors and volunteers to the OWASP ASVS, AppSensor and Web Framework Security Matrix projects, Mitre's Common Attack Pattern Enumeration and Classification (CAPEC), and SAFECode's “Practical Security Stories and Security Tasks for Agile Development Environments” which are all used in the cross-references provided.\n",
      "Playgen for providing an illuminating afternoon seminar on task gamification, and tartanmaker.com for the online tool to help create the card back pattern.\n",
      "Blackfoot UK Limited for creating and donating print-ready design files, Tom Brennan and the OWASP Foundation for instigating the creation of an OWASP-branded box and leaflet, and OWASP employees, especially Kate Hartmann, for managing the ordering, stocking and despatch of printed card decks.\n",
      "Oana Cornea and other participants at the AppSec EU 2015 project summit for their help in creating the demonstration video.\n",
      "Colin Watson as author and co-project leader with Darío De Filippis, along with other OWASP volunteers who have helped in many ways.\n",
      "Road Map and Getting Involved\n",
      "Involvement in the development and promotion of Cornucopia is actively encouraged! You do not have to be a security expert in order to contribute. Some of the ways you can help are listed below.\n",
      "Localization\n",
      "Are you fluent in another language?\n",
      "Can you help translate Cornucopia into that language? Niote tthis is a very large task due to the number of documents involved.\n",
      "Use and Promote the Cornucopia Card Decks\n",
      "Please help raise awareness of Cornucopia by printing cards:\n",
      "Use Cornucopia with specifiers, architects, designers, developers, testers and others, in part to train them, but also to solicit feedback on their usability, practicality and appropriateness for their work\n",
      "Create video about how to play the game\n",
      "Develop a mobile app to play the game\n",
      "Feedback\n",
      "Please use the friendly project Google Group for feedback:\n",
      "What do like?\n",
      "What don't you like?\n",
      "What cards don't make sense?\n",
      "How could the guidance be improved?\n",
      "What other decks would you like to see?\n",
      "Keep the Cards Updated\n",
      "As the source referenced documents change, we have to update the decks. You may also find errors and omissions. In the first instance, please send a message to the project's Google Group if you have identified errors & omissions, have some time to maintain the source documents, or can help in other ways.\n",
      "Create a New Deck\n",
      "The only version currently available is the Cornucopia Ecommerce Website Edition in English. We would like to create a new mobile app specific deck, probably using the wonderful OWASP Mobile Security Project as inspiration for the card source materials. Do you have an idea for your own application security requirements card deck? Perhaps for mobile apps or something else?\n",
      "\n",
      "TIP! Drawing Template Construction\n",
      "Products and versions covered AutoCAD, & AutoCAD Electrical\n",
      "Mark Behrens, CAD administrator / contols de...\n",
      "The subject of this article is a core component of AutoCAD, the drawing template, and the best practices to follow when setting one up. When this file, specified in the QNEW setting of a user's AutoCAD configuration (see options 1) has been formatted properly, any new drawing created will match company specified standards.\n",
      "As the base of a drawing package, the drawing template is the enforcer of drawing standards. My experience on the CAD admin side of this, has shown that often as new users are added, they are set up under the radar. These unknown users, left unchecked, will cause issues for everyone who has to deal with their drawings throughout the design and build of entire projects.\n",
      "The template must be incisive of all relevant settings necessary to conform to company standards, and should be configured carefully. This template should also be located in a networked location, which will need to be added to user's pathing options in AutoCAD (see options 2).\n",
      "The failure to start a drawing with the proper protocol can lead to many issues, some of which are not obvious to those who are untrained in, or new to, CAD. Additional editing time due to data errors and drawing quality is something that is hard to explain to non CAD users (read: management). This is usually caused by files generated by cowboy CAD operators or new CAD operators. These categories of user will both fail to follow a company defined standard. When they create or edit files which will be used or modified at some time in the future by other CAD users, the problems they cause often go undetected and get multiplied unknowingly.\n",
      "The company standard template and drawing properties should address several areas:\n",
      "Title block layout (see options 3 & options 4)\n",
      "Default layers (this becomes especially important in AutoCAD electrical) (see options 5)\n",
      "Default font type (style, height & width) (see options 6)\n",
      "Default OSNAP, snap and grid setup (see options 7)\n",
      "Default dimension style setup (see options 8 & options 9)\n",
      "Default table style (see options 10)\n",
      "By predefining the above settings, users have less of a chance to create drawings that will not be consistent with company standards. Users will always have the chance to modify the above parameters in a drawing should they decide to. The only way to reduce the frequency of this happening is the establishment of an organized checking process and actively enforcing it. I will discuss briefly the benefits to each of the points noted above separately on their own in this article.\n",
      "The company approved title block layout needs to be established as a foundation for the drawing template. When setting up the layout, it is important to take all potential uses of the template into account. As I create controls documentation, I incorporate multiple types of layouts into a drawing set.\n",
      "The cover sheet for a drawing set will often require different information and different style than the working drawings. The layout for both the cover sheet and the working drawings should both be in the same file, on separate layers. See (options 3) for an example of how our cover sheet is set up. This layout is independent of the working drawing layout. See (options 4) for an example of our working drawings. The format takes into account the multiple types of drawings in a complete package.\n",
      "The company's standard default layers to be used when producing drawings needs to be native to the template. As I use AutoCAD electrical, (options 5) shows that I have a block created that contains all of my standard wire layers and their proper names. Using AutoCAD electrical, these default layers and their naming format are especially important. They are in a block for ease of manipulation. This block, when included in a drawing, captures all the layers that I use in my schematic packages. A bonus to this is that I can insert this block into any drawing and it will import all my standard wire layers at one time. When through editing a drawing, this block, selectable as one entity, can easily be deleted and purging will remove the extra layers associated with it. I have chosen only to include wire layers, as other layers should be set independently.\n",
      "TIP! When done editing a drawing package, just before final documents are printed, it is important to zoom extents and purge each drawing. I have created a command to zoom extents and execute 3 consecutive purges for this function. Multiple purges are often needed when dealing with nested blocks!\n",
      "One of the most obvious ways poor quality is evident in a drawing is the use of mixed font styles. This issue becomes worse as the number of people editing a drawing increases. If a user's AutoCAD settings are not set to match company standards, the default style is (txt.shx). This is often accepted as standard just by default. Our company prefers a different style and width, as we generate our signage and device tags from data within the drawings. Many users are given computers when they start, yet not informed that AutoCAD should be configured to support company networks or drawing standards. The result is potentially as many styles and formats to drawings as there are users. The preferred company settings should be applied to the (standard) font definitions as shown in (options 6), as this is the default style in AutoCAD. Remember to select “set current” after defining the text style!\n",
      "TIP! Always keep your font height set to 0. Setting this value to anything else will override changes to font height in other commands using this style!\n",
      "Grid settings and snap settings are very important to consistent drawings. Grid and snap settings must be set with to work together efficiently, and also provide a benefit to the software user. Whether you use Metric or Imperial units, your grid and snap settings must match your unit choice (this may seem obvious, however is not for many new CAD users). We set our major line spacing at 1”, with the snap value set to 1/8” (options 7). When a user has their drawing zoomed to extents with a “D” size title block border, this is still a good visual delineation between snap points as the cursor is moved, while being helpful in object placement in a drawing. Setting snap spacing too close will cause the user to erroneously snap to a point they do not realize if they are using a full zoom display. I have come across drawings with snap set to 1/32”. This is not discernable as snap when zoomed out in a drawing! As some users prefer not to have their cursor width set very high, they never realize that the incorrect snap point has been used until they are well into editing a drawing.\n",
      "Mechanical layouts with different dimension styles are another area in a drawing package where inconsistencies are very obvious. Having a standard as a company is a requirement. Making that standard practical and clean is important to the quality of the drawings. Poor mechanical layouts lead to errors and miscommunication that can be expensive.\n",
      "The mechanical drawings that I work with are mainly enclosure and subpanel layouts. The primary user for these drawings in our in-house production department. I have set up my dimension style with them in mind, having tried to follow their preferences, yet follow accepted industry protocol. Dimension style settings should have a clean look. By that I mean, the layout details should be uniform. Arrowheads and text need to be consistent in size for legible drawings. The settings that AutoCAD defaults to as installed by our IT department, I have found to be a good start. It helps if someone with CAD experience has an input into the installation process IT allows this. I recommend that all the dimension style options being considered by an organization be put in an example drawing so they can be compared easily. Make your choice and apply the settings to your template. Our default settings are shown (Options 8) as an example.\n",
      "TIP! When necessary to edit dimension size in a drawing (differently scaled title block layouts to match mechanical drawings) only the overall scale setting should be changed! This will keep a clean format regardless of sheet size (options 9)! Try to match the scale factor to the drawing sheet if possible.\n",
      "Table style should be set up with consideration given to font style, as text is the basic component in both. Setting up the company specific settings in the standard table style will preset this for all users (options 10). I have not included how to details here, as each company standard may vary. At a minimum, a predetermined maximum number of rows in a table should be defined based on sheet layout size.\n",
      "The company drawing template should be stored on a revision controlled network drive and locked down to all except the CAD manger.\n",
      "\n",
      "Restrictive interventions and compulsory treatment: information for authorised program officers\n",
      "Senior Practitioner-Disability (Disability Act 2006)\n",
      "Contents\n",
      "Key responsibilities of authorised program officers\n",
      "1\n",
      "PART 7 restrictive interventions\n",
      "1\n",
      "PART 8 compulsory treatment\n",
      "2\n",
      "More information about restrictive interventions\n",
      "3\n",
      "Key responsibilities of authorised program officers\n",
      "This document outlines the key responsibilities of authorised program officers as defined by the Disability Act 2006 (the Act), in relation to the use of restrictive interventions and compulsory treatment. An authorised program officer must ensure that the authorised program officer responsibilities under the Act are administered. The supervised treatment order must state that the authorised program officer is responsible for the implementation of the supervised treatment order section193 (3) (a).\n",
      "As such the responsibilities of the role as defined in Parts 7 (restrictive interventions) and 8 (compulsory treatment) of the Act must be clearly understood and undertaken by the authorised program officer. This document only provides a checklist and it is recommended that all authorised program officers understand Part 7 and if a person within their service is subject to compulsory treatment they should understand Part 8 of the Act.\n",
      "New authorised program officers and any interested existing authorised program officers are encouraged to contact the Senior Practitioner Disability on 03 9096 8427 to discuss meeting members from the integrated health care team (who work within Part 7 of the Act), the compulsory treatment team (who work within Part 8 of the Act) and the research and service development team who can go through the Restrictive Intervention Data System (RIDS) responsibilities.\n",
      "The authorised program officers must:\n",
      "have been appointed by the disability service provider\n",
      "once appointed, advise the Senior Practitioner Disability of their name and qualifications within 5 working days from the appointment via RIDS.\n",
      "PART 7 restrictive interventions\n",
      "1.\n",
      "Ensure a behaviour support plan is developed or reviewed if restraint or seclusion is proposed and only approve restraint or seclusion if all requirements of the Act are met.\n",
      "2.\n",
      "Apply for approval to use restrictive interventions via RIDS.\n",
      "3.\n",
      "Ensure the behaviour support plan is authorised at least two working days before using restraint or seclusion.\n",
      "4.\n",
      "Notify the person with a disability in writing 48 hrs before using the restraint or seclusion.\n",
      "5.\n",
      "Ensure an independent person is available to explain the behaviour support plan to the person with a disability.\n",
      "6.\n",
      "Report the use of all restraint and seclusion through RIDS as follows:\n",
      "Routine (for example, every day by the end of the month before the 7th day of the next month);\n",
      "pro re nata (PRN) (when used before the 7th day of the next month);\n",
      "Emergency (when used before the 7th day of the next month);\n",
      "When the person leaves the service, cancel access via RIDS.\n",
      "7.\n",
      "Maintain behaviour support plans in RIDS by lodging a new behaviour support plan every 12 months or earlier if specified.\n",
      "If a person no longer requires restraint and seclusion, the Office of Professional Practice should be notified via email <officeofprofessionalpractice@dhhs.vic.gov.au>.\n",
      "PART 8 compulsory treatment\n",
      "The authorised program officers is responsible for the implementation of the supervised treatment order section 193 (3)(a).\n",
      "1.\n",
      "The authorised program officer makes an application to the Victorian Civil and Administrative Tribunal (VCAT) for a supervised treatment order or for review of the treatment plan if the person is subject to a Residential Treatment Order at the Disability Forensic Assessment and Treatment Service (DFATS).\n",
      "2.\n",
      "An authorised program officer may apply to VCAT for a supervised treatment order for a person:\n",
      "who has an intellectual disability;\n",
      "who is receiving residential services;\n",
      "in respect of whom the disability service provider has prepared a treatment plan approved by the Senior Practitioner;\n",
      "who meets the criteria specified in subsection 191(6).\n",
      "3.\n",
      "Prior to the VCAT hearing, the Senior Practitioner Disability will review and approve the treatment plan and provide a treatment plan certificate. The authorised program officer should review the directions in the certificate and update the treatment plan, if required.\n",
      "4.\n",
      "Notify the Public Advocate when an application for a supervised treatment order is made, as well as the person with a disability for whom the application is made.\n",
      "5.\n",
      "Lodge an e-treatment plan to RIDS at least 28 days prior to the expiration of the order or the next scheduled VCAT hearing, attaching all assessments used to inform the plan, including a recent risk assessment. A Treatment plan guide is available from the compulsory treatment team.\n",
      "6.\n",
      "A VCAT hearing will be scheduled. Support the person to access legal representation and provide copies of all supporting documentation to the legal representative as soon as possible.\n",
      "7.\n",
      "The authorised program officer should attend and be prepared to go through the content of the proposed treatment plan and the criteria below (Appendix A of the treatment plan) to evidence how the person meets the criteria.\n",
      "8.\n",
      "Section 191 (6) VCAT can only make a supervised treatment order if it is satisfied that:\n",
      "(a)\n",
      "The person has previously exhibited a pattern of violent or dangerous behaviour causing serious harm to another person or exposing another person to a significant risk of serious harm;\n",
      "(b)\n",
      "There is a significant risk of serious harm to another person which cannot be substantially reduced by using less restrictive means;\n",
      "(c)\n",
      "The services to be provided to the person in accordance with the treatment plan will be of benefit to the person and substantially reduce the significant risk of serious harm to another person;\n",
      "(d)\n",
      "The person is unable or unwilling to consent to voluntarily complying with a treatment plan to substantially reduce the significant risk of serious harm to another person;\n",
      "(e)\n",
      "It is necessary to detain the person to ensure compliance with the treatment plan and prevent a significant risk of serious harm to another person.\n",
      "9.\n",
      "Once an order is made at VCAT, an Implementation Report is required to be provided to the Senior Practitioner Disability via RIDS at least every six months. The exact dates will be specified in the treatment plan certificate provided by the Senior Practitioner Disability. An Implementation report practice guide is available from the compulsory treatment team.\n",
      "10.\n",
      "Once an order has been made by VCAT, any changes to the plan will require approval. For a decrease in restrictions, a material change application via email to the Senior Practitioner Disability is required detailing the context and circumstances of how restraint is being used:\n",
      "(a)\n",
      "For an increase in restriction outside of that specified in the treatment plan, a material change application needs to be made to VCAT;\n",
      "(b)\n",
      "In the event that restraint or seclusion has been used in an emergency, the authorised program officer must email the Senior Practitioner Disability within 2 working days detailing the circumstances relating to the use of emergency restraint or seclusion. The Senior Practitioner Disability will review the information and if an increase in restriction has been used outside of that specified in the treatment plan, the Senior Practitioner Disability will apply to VCAT for a review of the treatment plan. If the authorised program officer delays reporting to the Senior Practitioner Disability in applying for emergency approval of restraint or seclusion beyond two working days, the Senior Practitioner Disability will not be able to approve this and will request the authorised program officer to apply to VCAT for a review.\n",
      "For further information regarding compulsory treatment, contact the Senior Practitioner Disability on 03 9096 8427.\n",
      "More information about restrictive interventions\n",
      "For definitions of chemical restraint, mechanical restraint, seclusion and physical restraint see the Restrictive Intervention Self Evaluation Tool RISET <http://www.surveygizmo.com/s3/2741253/Has-a-Restrictive-Intervention-Occurred>.\n",
      "It is important to note that The Physical restraint direction paper – May, 2011 states that the use of physical restraint is considered as an ‘other restrictive intervention’ under s.150 of the Act. Disability service providers are prohibited from using physical restraint in the course of providing a disability service, except as permitted under the Physical restraint direction paper.\n",
      "To receive this publication in an accessible format phone 9096 8427, using the National Relay Service 13 36 77 if required, or email Office of Professional Practice <officeofprofessionalpractice@dhhs.vic.gov.au>\n",
      "Authorised and published by the Victorian Government, 1 Treasury Place, Melbourne.\n",
      "© State of Victoria, Department of Health and Human Services, January 2019.\n",
      "Available at Authorised program officer practice advice <https://dhhs.vic.gov.au/publications/authorised-program-officer-practice-advice>\n",
      "Use of restrictive interventions and compulsory treatment: important information for Authorised Program Officers\n",
      "\n",
      "GE Healthcare Announces FDA Approval of SenoClaire, New Breast Imaging with 3D Tomosynthesis Solution\n",
      "Posted September 3rd, 2014 for General Electric\n",
      "September 3, 2014\n",
      "Wauwatosa, WI, September 3, 2014\n",
      "GE Healthcare (NYSE: GE) today announced the FDA approval of SenoClaire*, GE's new breast tomosynthesis solution designed with a three-dimensional imaging technology. In collaboration with Massachusetts General Hospital, GE developed SenoClaire technology that uses a low-dose short X-ray sweep around the positioned breast with nine exposures acquired with a “step-and-shoot” method, removing the potential motion from the tube helping to reduce blur and increase image sharpness.\n",
      "“Today's announcement marks a key milestone in our mission of providing women with cutting edge screening technology to detect early breast cancer,” said Dr. Daniel Kopans, Senior Radiologist, Breast Imaging Division Department of Radiology, Massachusetts General Hospital. “When cancer is identified and treated earlier, we know women have a better rate of survival.”\n",
      "A key challenge when performing screening mammography is keeping the radiation levels as low as possible. With GE's SenoClaire, there is no increase in dose from a 2D standard mammogram to a 3D view, which means there is no increased radiation to patients during a SenoClaire breast exam. “3D breast screening technology helps clinicians uncover small cancers which can be a limiting factor in standard 2D mammography. As a radiologist, it's important to offer technology like this for patients that produces higher image quality without increasing dose,” said Dr. Murray Rebner MD, FACR, Professor of Diagnostic Radiology and Molecular Imaging at Oakland University William Beaumont School Of Medicine and Director of the Division of Breast Imaging and Intervention at Beaumont Hospital, Royal Oak.¹ “We believe this technology can have a significant impact on helping clinicians to identify breast cancer.”\n",
      "In addition to offering more clarity, confidence and low dose, SenoClaire offers a complete solution by helping to improve overall workflow. SenoClaire is compatible with CentricityTM PACS with Universal Viewer and supports the DICOM standard that can be read by capable PACS vendors. When SenoClaire is combined with GE Healthcare's Centricity PACS and Centricity Clinical Archive solution², clinicians have access to the patient's longitudinal record, providing data that helps to enable better patient care.\n",
      "“With the FDA's approval of SenoClaire, we build on our breast care continuum which offers physicians and patients a complete suite of solutions – from screening and diagnosis through treatment and monitoring,” said Catherine Tabaka, Chief Marketing Officer, GE Healthcare, Detection and Guidance Solutions. “SenoClaire not only offers patients a new solution to help clinicians better detect breast cancer, but does so with low dose radiation and high image quality. This new generation technology, breast tomosynthesis, together with innovative solutions like contrast enhanced spectral mammography, automated whole breast ultrasound, and molecular breast imaging will equip healthcare providers with a comprehensive set of tools that will help their patients across the entire breast care continuum.”\n",
      "Currently, GE Healthcare has 180 units installed in Europe, Australia, Latin America, Southeast Asia and the Middle East.\n",
      "About GE Healthcare\n",
      "GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.\n",
      "Tackling Cancer\n",
      "At GE, we envision a day when cancer is no longer a deadly disease. In September 2011, GE Healthcare launched an ambitious global campaign against cancer, committing $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its advanced technologies for the manufacture of biopharmaceuticals and for cancer research. By the end of 2012, $335M had been invested, setting GE on track to meet its five-year commitment. To accelerate progress, and to help clinicians deliver better care to 10 million patients by 2020, the campaign against cancer combines the strength of GE's portfolio of cancer technologies with the innovations born from collaborations with key partners. To learn more on how GE is tackling cancer, see: http://www.getacklingcancer.com/.\n",
      "Media Contact\n",
      "GE Healthcare\n",
      "Jennifer Fox\n",
      "Manager, PR & Global Communications, DGS\n",
      "jennifer.r.fox@ge.com\n",
      "+1 414-721-3813\n",
      "* Trademark of General Electric Company\n",
      "¹ Dr. Murray Rebner has performed research affiliated with GE Healthcare's SenoClaire.\n",
      "² Centricity Clinical Archive solution includes the following product components: Centricity Enterprise Archive, Universal Viewer ZFP, Caradigm™ eHIE, Centricity Clinical Gateway, NextGate MatchMetrix EMPI, and PACSGEAR PacsSCAN™.\n",
      "\n",
      "NOTES ON THE USE OF THIS FORM\n",
      "This form is used to supply information on contracts as required by the Premier and Cabinet Circular: ‘PC027 Disclosure of Government Contracts’\n",
      "For more information on the disclosure requirements which apply to contracts please refer to Premier and Cabinet Circular: ‘PC027 Disclosure of Government Contracts’\n",
      "a copy of which is posted at : https://dpc.sa.gov.au/documents/rendition/B17980\n",
      "Please complete this form and email it to satendersandcontracts@sa.gov.au when ready to have details of the contract published on www.tenders.sa.gov.au\n",
      "To ensure that the contract information is displayed on the website in a timely fashion, agencies are asked to provide all the documentation to the SA Tenders and Contracts Systems Administrator five working days before it is to be displayed. In addition, agencies are required to obtain all the appropriate approvals from within their agencies to display the contract information before the documentation is released to SA Tenders and Contracts.\n",
      "If you have any queries on this process, please contact:\n",
      "Tenders Help Desk\n",
      "Ph: +61 (08) 8462 1401\n",
      "Email: satendersandcontracts@sa.gov.au\n",
      "\n",
      "Carrier powers and immunities\n",
      "Telecommunications companies have some powers to enter land and install and maintain some types of telecommunications facilities, and some immunities from some state and territory legislation.\n",
      "The laws are set out under Schedule 3 to the Telecommunications Act 1997 and are critical to the efficient construction and maintenance of telecommunications networks.\n",
      "In using their powers and immunities, carriers need to meet the requirements in the Telecommunications Act 1997 and the Telecommunications Code of Practice 2018.\n",
      "The laws are designed to strike the right balance between the community's need to access reliable, affordable telecommunications services and ensuring that property owners, local governments and communities have a say in the deployment of infrastructure that affects them.\n",
      "The laws can mean that telecommunications companies deploying infrastructure (known as carriers) are exempt from some state and territory laws, including planning laws, for:\n",
      "facilities that are determined to be low-impact facilities,\n",
      "temporary facilities for use by a defence organisation, or\n",
      "facilities for which the Australian Communications and Media Authority (ACMA) has granted a Facility Installation Permit.\n",
      "If a facility is not in one of these three groups, then carriers must comply with state and territory laws and planning regulations.\n",
      "It's in everyone's interests for carriers to provide services to the people who need them quickly and cost effectively. Carriers can rollout low-impact facilities infrastructure under one, national process, rather than multiple state, territory and local government requirements. This reduces the administrative burden on governments and carriers. There are strong safeguards and objection rights to protect the rights of the community and property owners.\n",
      "What are low-impact facilities?\n",
      "Low-impact facilities include some radiocommunications facilities, underground and above-ground housing, underground and some aerial cables, public payphones, emergency and co-located facilities.\n",
      "This list of the different type of facilities has been specified in the Telecommunications (Low-impact Facilities) Determination 2018.\n",
      "These low-impact facilities are needed for telecommunications networks to provide wider coverage and services. The strict type, size, colour and location limitations of low-impact facilities means that carriers can rollout networks with as little disruption to the community as possible during installation or operation.\n",
      "Some facilities installed during the rollout of the National Broadband Network, such as node cabinets, are low-impact facilities.\n",
      "Facilities can't be low-impact facilities if they're to be installed in areas of environmental significance, which includes places listed on a Commonwealth, state or territory heritage register. These facilities must meet the requirements of the usual Commonwealth, state or territory approval processes, such as the Environment Protection and Biodiversity Conservation Act 1999 or the broader telecommunications regime, including the Radiocommunications Act 1992.\n",
      "Carriers installing low-impact facilities for mobile phone networks must also comply with the additional requirements in the Industry Code for Mobile Phone Base Station Deployment C564:2011.\n",
      "What obligations do carriers have?\n",
      "There are limits on what carriers can do under the Telecommunications Act 1997 . These give land owners and occupiers the right to:\n",
      "Notification—Carriers must give 10 days' written notice before they start any work, other than in emergencies or if the owner or occupier has already waived the right to be notified. There are alternative arrangements if the carrier can't find the land owner.\n",
      "Objection—The owner or occupier can object to the carrier, but it has to be at least five business days before the carrier plans to start work. The matter can then be resolved with the carrier, or through the Telecommunications Industry Ombudsman. Parties can also settle the matter through the courts.\n",
      "More information on the objection process can be found on the Telecommunications Industry Ombudsman's website.\n",
      "The Telecommunications Code of Practice 2018 sets out further obligations on carriers. For example, carriers, and their contractors, must comply with good engineering practice and consider noise limits, the environment, and obstruction of essential services when installing or maintaining facilities.\n",
      "Compliance with the Telecommunications Act and the Telecommunications Code of Practice is a licence condition. As the regulator, the ACMA can enforce licence conditions by, for example, issuing directions to carriers, or by initiating court action in serious cases.\n",
      "Obligations on landholders and occupiers\n",
      "Carriers own any infrastructure they install, including cables.\n",
      "Property owners have certain responsibilities and a duty of care to carriers under common law. If a carrier is able to demonstrate that a property owner had deliberately or negligently caused damage to a cable, the carrier may be able to seek damages from the property owner in a court of law. Criminal offences may also apply for intentional damage to a carrier's property.\n",
      "Providing services to multi-dwelling units\n",
      "Carriers supplying telecommunications services to multi-dwelling units often need to install termination boxes and other equipment in the building. Some of these in-building facilities are low-impact facilities. This equipment is generally unobtrusive and it lets occupants of multi-dwelling units access telecommunications services.\n",
      "The Communications Alliance (formerly the Australian Communications Industry Forum) worked with carriers to find technical solutions to access issues relating to in-building subscriber equipment. These are set out in the industry guideline on building access operations and installation:\n",
      "ACIF Code G571:2002 Building access operations and installation (PDF 890KB)\n",
      "Communications Alliance website.\n",
      "Getting help to resolve a complaint\n",
      "In the first instance, concerns about a carrier's use of powers and immunities should be raised with the carrier itself.\n",
      "The Telecommunications Industry Ombudsman provides a free dispute resolution service for people who've raised a complaint with a carrier but can't reach a resolution.\n",
      "The ACMA is the Australian regulator of telecommunications carriers. The ACMA can look into carrier non-compliance with regulatory obligations.\n",
      "Contacts\n",
      "Email: powersandimmunities [at] communications.gov.au\n",
      "Post:\n",
      "Competition Branch\n",
      "Department of Communications and the Arts\n",
      "GPO Box 2154 Canberra ACT 2601\n",
      "\n",
      "Building practitioner registration\n",
      "This page is for:\n",
      "Builder\n",
      "New registration (first time)\n",
      "To work as a building practitioner in Western Australia, registration with the Building Services Board is required. If you intend to be the 'nominated supervisor' of a building contractor, you must be registered as a building practitioner.\n",
      "If you are a builder and you neither intend to seek building permits from local government permit authorities, nor intend to contract directly with others to provide building work valued at over $20,000, you do not need to be registered.\n",
      "When considering an application for registration as a building practitioner, the Board considers, among other factors, the applicant's qualifications, experience and fitness to be registered.\n",
      "Registration as a building practitioner does not authorise a person to provide services as a building contractor.\n",
      "How do I apply?\n",
      "To apply for registration as a building practitioner you must complete the application form for the set that you wish to apply under. There are five sets, each with different requirements. Select the set most suited to your qualifications and experience. Submit your completed application form to Licensing Services along with your supporting documentation and applicable fees.\n",
      "Each application is thoroughly reviewed by the Licensing staff and may be individually considered by the Building Services Board.\n",
      "Time frame for application processing\n",
      "Most building practitioner applications are determined within 14 weeks. You can assist by submitting all of the information required in your application and allow sufficient time for it to be fully assessed.\n",
      "Sets and application forms\n",
      "Set 1\n",
      "To apply under set 1, you need to have: completed the Diploma of Building and Construction; and seven years experience in carrying out or supervising building work.\n",
      "Set 1 – Building practitioner initial application (Form 05)\n",
      "Set 2\n",
      "To apply under set 2, you need to: have five years full time experience in supervising building construction; and be registered under the Architects Act 2004, or be a member of the: Royal Australian Institute of Architects; Institution of Engineers Australia; or Australian Institute of Mining and Metallurgy.\n",
      "Set 2 – Building practitioner initial application (Form 06)\n",
      "Set 3\n",
      "To apply under set 3, you need to have: five years of full time experience in carrying out, supervising or managing building construction; and hold membership with the Australian Institute of Building as a Member or Fellow.\n",
      "Set 3 – Building practitioner initial application (Form 07)\n",
      "Set 4\n",
      "To apply under set 4, you need to have: gained sufficient knowledge and skills equivalent to a person who completed the Diploma of Building and Construction (as referred to in set 1); and five years of full time experience in supervising or managing building construction.\n",
      "Set 4 – Building practitioner initial application (Form 08)\n",
      "Set 5\n",
      "To apply under set 5, you need to have: sufficient experience to gain the equivalent knowledge and skills as a person who has successfully completed the Diploma of Building and Construction (as referred to in set 1); and seven years full time experience outside the area of the Board's jurisdiction in carrying out building work.\n",
      "Set 5 – Building practitioner initial application (Form 09)\n",
      "Qualifications and experience\n",
      "To apply for registration as a building practitioner you must document that you have particular qualifications and experience. For more information go to the web page 'Documenting your experience and qualifications'.\n",
      "Still unsure which set to use?\n",
      "If you are unsure which set to apply under or any of the above information, contact Building and Energy on 1300 489 099 or email be.info@dmirs.wa.gov.au.\n",
      "Mutual recognition\n",
      "If you are registered or licensed as a building practitioner elsewhere in Australia or New Zealand, and want to be registered as a building practitioner with the Building Services Board in Western Australia, you can find out more information about having your qualifications recognised in WA.\n",
      "Share this page:\n",
      "Last modified: Tuesday, October 8, 2019 - 10:58\n",
      "\n",
      "Online Technical Writing: Complaint Letter made available by David McMurrey\n",
      "1313 Horse Trail Rd. Buda, Texas 78610\n",
      "6 June, 1996\n",
      "Customer Relations/Claims Company\n",
      "John Duke Manufacturing Company\n",
      "1104 Sutton Drive Suite #112 Cairo, MI 45006\n",
      "Dear Representative:\n",
      "I am writing in regards to a Digital Multimeter (DMM) that I recentlypurchased by mail-order from your company. Because the DMM only functions partially, I am requesting repairs, another DMM with comparable features, or a refund equal to the purchase price + C.O.D. charges, and shipping and handling.\n",
      "I purchased the meter for $250.00 by calling the 1-800 number listed in an advertisement. My phone order occurred on August 20th. The meter was delivered on August 23rd via UPX C.O.D. The total purchase price was $282.50. The following items were included with the DMM: one set of meter leads, one power supplycord, and one black nylon-fiber carrying case.\n",
      "The DMM (Duke Model 8012A) will not register an accurate voltage or current reading. The other features function exactly as intended, and the fuse that protects the AC circuitry is in good operating condition. However, when a regulated AC voltage or current is applied to the meter leads, the only reading displayed is a low negative value. This is true whether the function switch is set to measure either AC voltage or current.\n",
      "When I received the DMM, I inspected the packaging in which the meter was shipped, and there was no evidence of damage. Styrofoam inserts were used to protect the meter from any shock during the shipping process. Because I saw no loose componentsupon inspection of the primary fuse, I am led to believe the problem somehow occurred during manufacture. No doubt, there is a temporary malfunction that can easily be fixed.\n",
      "Your prompt attention and response would be greatly appreciated as I intend to use the meter in conjunction with my job.\n",
      "Sincerely, Terry Ward\n",
      "Enclosed:\n",
      "1 Duke 8012A DMM, Lot #3308-WIC4\n",
      "1 Set of Meter Leads\n",
      "1 Power Supply Cord\n",
      "1 Black Nylon-fiber carrying case\n",
      "1 Purchase Receipt\n",
      "Original Packaging\n",
      "\n",
      "DIB Guide: Detecting Agile BS\n",
      "Agile is a buzzword of software development, and so all DoD software development projects are, almost by default, now declared to be “agile.” The purpose of this document is to provide guidance to DoD program executives and acquisition professionals on how to detect software projects that are really using agile development versus those that are simply waterfall or spiral development in agile clothing (“agile-scrum-fall”).\n",
      "Principles, Values, and Tools\n",
      "Experts and devotees profess certain key “values” to characterize the culture and approach of agile development. In its work, the DIB has developed its own guiding maxims that roughly map to these true agile values:\n",
      "Agile value\n",
      "Individuals and interactions over processes and tools\n",
      "Working software over comprehensive documentation\n",
      "Customer collaboration over contract negotiation\n",
      "Responding to change over following a plan\n",
      "DIB maxim\n",
      "“Competence trumps process”\n",
      "“Minimize time from program launch to deployment of simplest useful functionality”\n",
      "“Adopt a DevSecOps culture for software systems”\n",
      "“Software programs should start small, be iterative, and build on success ‒ or be terminated quickly”\n",
      "Key flags that a project is not really agile:\n",
      "Nobody on the software development team is talking with and observing the users of the software in action; we mean the actual users of the actual code.14 (The PEO does not count as an actual user, nor does the commanding officer, unless she uses the code.)\n",
      "Continuous feedback from users to the development team (bug reports, users assessments) is not available. Talking once at the beginning of a program to verify requirements doesn't count!\n",
      "Meeting requirements is treated as more important than getting something useful into the field as quickly as possible.\n",
      "Stakeholders (dev, test, ops, security, contracting, contractors, end-users, etc.)15 are acting more-or-less autonomously (e.g., ‘it's not my job.')\n",
      "End users of the software are missing-in-action throughout development; at a minimum they should be present during Release Planning and User Acceptance Testing.\n",
      "14 Acceptable substitutes for talking to users: Observing users working, putting prototypes in front of them for feedback, and other aspects of user research that involve less talking.\n",
      "15 Dev is short for development, ops is short for operations\n",
      "DevSecOps culture is lacking if manual processes are tolerated when such processes can and should be automated (e.g., automated testing, continuous integration, continuous delivery).\n",
      "Some current, common tools in use by teams using agile development (these will change as better tools become available):16\n",
      "Git, ClearCase, or Subversion - version control system for tracking changes to source code. Git is the de facto open source standard for modern software development.\n",
      "BitBucket or GitHub - Repository hosting sites. Also provide issues tracking, continuous integration “apps” and other productivity tools. Widely used by the open source community.\n",
      "Jenkins, Circle CI or Travis CI - continuous integration service used to build and test BitBucket and GitHub software projects\n",
      "Chef, Ansible, or Puppet - software for writing system configuration “recipes” and streamlining the task of configuring and maintaining a collection of servers\n",
      "Docker - computer program that performs operating-system-level virtualization, also known as “containerization”\n",
      "Kubernetes or Docker Swarm for Container orchestration\n",
      "Jira or Pivotal Tracker - issues reporting, tracking, and management\n",
      "Graphical version:\n",
      "Questions to Ask Programming Teams\n",
      "16 Tools listed/shown here are for illustration only: no endorsement implied.\n",
      "How do you test your code? (Wrong answers: “we have a testing organization,” “OT&E is responsible for testing”)\n",
      "Advanced version: what tool suite are you using for unit tests, regression testing, functional tests, security scans, and deployment certification?\n",
      "How automated are your development, testing, security, and deployment pipelines?\n",
      "Advanced version: what tool suite are you using for continuous integration (CI), continuous deployment (CD), regression testing, program documentation; is your infrastructure defined by code?\n",
      "Who are your users and how are you interacting with them?\n",
      "Advanced version: what mechanisms are you using to get direct feedback from your users? What tool suite are you using for issue reporting and tracking? How do you allocate issues to programming teams? How to you inform users that their issues are being addressed and/or have been resolved?\n",
      "What is your (current and future) cycle time for releases to your users?\n",
      "Advanced version: what software platforms to you support? Are you using containers? What configuration management tools do you use?\n",
      "Questions for Program Management\n",
      "How many programmers are part of the organizations that owns the budget and milestones for the program? (Wrong answers: “we don't know,” “zero,” “it depends on how you define a programmer”)\n",
      "What are your management metrics for development and operations; how are they used to inform priorities, detect problems; how often are they accessed and used by leadership?\n",
      "What have you learned in your past three sprint cycles and what did you do about it? (Wrong answers: “what's a sprint cycle?,” “we are waiting to get approval from management”)\n",
      "Who are the users that you deliver value to each sprint cycle? Can we talk to them? (Wrong answers: “we don't directly deploy our code to users”)\n",
      "Questions for Customers and Users\n",
      "How do you communicate with the developers? Did they observe your relevant teams working and ask questions that indicated a deep understanding of your needs? When is the last time they sat with you and talked about features you would like to see implemented?\n",
      "How do you send in suggestions for new features or report issues or bugs in the code? What type of feedback do you get to your requests/reports? Are you ever asked to try prototypes of new software features and observed using them?\n",
      "What is the time it takes for a requested feature to show up in the application?\n",
      "Questions for Program Leadership\n",
      "Are teams delivering working software to at least some subset of real users every iteration (including the first) and gathering feedback? (alt: every two weeks)\n",
      "Is there a product charter that lays out the mission and strategic goals? Do all members of the team understand both, and are they able to see how their work contributes to both?\n",
      "Is feedback from users turned into concrete work items for sprint teams on timelines shorter than one month?\n",
      "Are teams empowered to change the requirements based on user feedback?\n",
      "Are teams empowered to change their process based on what they learn?\n",
      "Is the full ecosystem of your project agile? (Agile programming teams followed by linear, bureaucratic deployment is a failure.)\n",
      "For a team working on agile, the answer to all of these questions should be “yes.”\n",
      "Graphical version:\n",
      "More information on some of the features of DoD software programs are included in the DIB's “Ten Commandments of Software,” the DIB's “Metrics for Software Development,” and the DIB's “Do's and Don'ts of Software.”\n",
      "\n",
      "MEPs call for country of origin labelling of meat in processed foods\n",
      "Posted February 11th, 2015 for European Parliament\n",
      "Press release\n",
      "Recent food fraud cases have made consumers suspicious. A growing number want to know from which country meat in processed food comes. © BELGAIMAGE/EASYFOTOSTOCK/Zoonar_V.Gudovskiy\n",
      "Meat used as an ingredient in processed foods, such as lasagne, should be labelled by country of origin as is already the case with bovine fresh meat, said MEPs on Wednesday. They call on the European Commission, which published a report on the issue in late 2013, to come up with legislative proposals in order to rebuild consumer confidence in the wake of the horsemeat scandal and other food fraud cases.\n",
      "The resolution, passed by 460 votes to 204 with 33 abstentions, urges the Commission to follow up its 2013 report with legislative proposals to make it mandatory to state the country of origin of meat used in processed foods, in order to ensure more transparency throughout the food chain, better inform European consumers and thus help rebuild their confidence.\n",
      "\"After the horse meat scandal, it is now up to us to regain consumers' trust. We are asking the Commission to come up with a legislative proposal with a mandatory country of origin labelling, because this will help to enhance transparency and to provide clear and complete information to the consumers”, said Environment Committee chair Giovanni La Via (EPP, IT).\n",
      "“We must nonetheless ensure that this does not lead to additional burdens on small and medium-sized enterprises, of which there are many in this sector\", he added.\n",
      "MEPs reiterate their concern over the potential impact of food fraud on food safety, consumer confidence and health, the functioning of the food chain and farm produce prices.\n",
      "Let the consumer choose\n",
      "MEPs point out that the European Commission's report (17.12.2013) itself acknowledges that more than 90% of consumer respondents consider it important that meat origin should be labelled on processed food products. This is one of the several factors influencing consumer behaviour, MEPs say.\n",
      "Impact on prices needs further check\n",
      "MEPs also point out that estimates of the impact on prices, based on the findings of a French consumer organisation, diverge widely from those in the Commission's report, and ask for a clearer picture. The evaluation should be carried out in conjunction with consumer organisations and would not delay legislative proposals, they add.\n",
      "Background\n",
      "Depending on the member state concerned, 30 to 50% of slaughtered meat is processed into meat ingredients for foodstuffs, mostly minced meat, meat preparations and meat products.\n",
      "\n",
      "Equipment Authorization – RF Device\n",
      "What is an RF Device?\n",
      "The FCC regulates radio frequency (RF) devices contained in electronic-electrical products that are capable of emitting radio frequency energy by radiation, conduction, or other means. These products have the potential to cause interference to radio services operating in the radio frequency range of 9 kHz to 3000 GHz.\n",
      "Almost all electronic-electrical products (devices) are capable of emitting radio frequency energy. Most, but not all, of these products must be tested to demonstrate compliance to the FCC rules for each type of electrical function that is contained in the product. As a general rule, products that, by design, contain circuitry that operates in the radio frequency spectrum need to demonstrate compliance using the applicable FCC equipment authorization procedure (i.e., Supplier's Declaration of Conformity (SDoC) or Certification) as specified in the FCC rules depending on the type of device. A product may contain one device or multiple devices with the possibility that one or both of the equipment authorization procedures apply. An RF device must be approved using the appropriate equipment authorization procedure before it can be marketed, imported, or used in the United States.\n",
      "The following discussions and descriptions are provided to help identify whether a product is regulated by the FCC and whether it requires approval. The more difficult issue, but not covered in this document, is how to categorize an individual RF device (or multiple components or devices within an end product) to determine the specific FCC rule part(s) that apply, and the specific equipment authorization procedure or procedures that need to be used for FCC compliance purposes. This determination requires technical understanding of the product, as well as knowledge of the FCC rules.\n",
      "Some basic guidance on how to obtain an equipment authorization is provided at the Equipment Authorization Page.\n",
      "Radio Frequency Devices are grouped under the Following Categories:\n",
      "INCIDENTAL RADIATORS (Part 15, Subpart A)\n",
      "An incidental radiator (defined in Section 15.3 (n)) is an electrical device that is not designed to intentionally use, intentionally generate or intentionally emit radio frequency energy over 9 kHz. However, an incidental radiator may produce byproducts of radio emissions above 9 kHz and cause radio interference. A product that is classified as an incidental radiator device is not required to obtain an equipment authorization. Nonetheless, incidental radiator are regulated under the general operating conditions of Section 15.5 and if there is harmful interference the user must stop operation and remedy the interference. Manufacturers and importers should use good engineering judgment before they market and sell these products, to minimize possible interference (Section 15.13).\n",
      "Examples of products that are classified as incidental radiators include: AC and DC motors, mechanical light switches, basic electrical power tools (that do not contain digital logic).\n",
      "UNINTENTIONAL RADIATORS (Part 15, Subparts B and G)\n",
      "An unintentional radiator (defined in Section 15.3 (z)) is a device that by design uses digital logic, or electrical signals operating at radio frequencies for use within the product, or sends radio frequency signals by conduction to associated equipment via connecting wiring, but is not intended to emit RF energy wirelessly by radiation or induction.\n",
      "Today the majority of electronic-electrical products use digital logic, operating between 9 kHz to 3000 GHz and are regulated under 47 CFR Part 15 Subpart B.\n",
      "Examples include: coffee pots, wrist watches, cash registers, personal computers, printers, telephones, garage door receivers, wireless temperature probe receiver, RF universal remote control and thousands of other types of common electronic-electrical equipment that rely on digital technology. This also includes many traditional products that were once classified as incidental radiators – like motors and basic electrical power tools that now use digital logic.\n",
      "Products that only contain digital logic may also be specifically exempted from an equipment authorization under Section 15.103.\n",
      "INTENTIONAL RADIATORS (Part 15, Subparts C through F and H)\n",
      "An intentional radiator (defined in Section 15.3 (o)) is a device that intentionally generates and emits radio frequency energy by radiation or induction that may be operated without an individual license.\n",
      "Examples include: wireless garage door openers, wireless microphones, RF universal remote control devices, cordless telephones, wireless alarm systems, Wi-Fi transmitters, and Bluetooth radio devices.\n",
      "INDUSTRIAL, SCIENTIFIC, AND MEDICAL EQUIPMENT (Part 18)\n",
      "When electronic-electrical products are used for providing RF energy for other than telecommunications applications, such as for the production of physical, biological, or chemical effects, such as heating, ionization of gases, mechanical vibrations, and acceleration of charged particles, these devices fall under the FCC rules 47 CFR Part 18.\n",
      "Examples include: fluorescent lighting, halogen ballasts, arc welders, microwave ovens, and medical diathermy machines.\n",
      "Note:\n",
      "A general consumer medical device does not typically come under this classification; rather Part 18 applies for medical equipment only when it is designed to generate and use RF energy locally for medical or therapeutic purposes.\n",
      "EQUIPMENT OPERATING IN LICENSED RADIO SERVICES\n",
      "Products that use licensed radio spectrum, from fixed microwave links to cellular telephones to mobile broadband services, are considered RF devices and are subject to equipment authorization.\n",
      "Examples of licensed radio equipment subject to Certification include: low power TV transmitters, cell phones/smart phones, base stations, licensed point-to-point microwave radios, private land mobile transmitters, aviation and marine radios.\n",
      "For more information on licensed radio services:\n",
      "List of Wireless Services\n",
      "Wireless Telecommunications Bureau\n",
      "Public Safety and Homeland Security Bureau\n",
      "International Bureau\n",
      "Radio spectrum allocation, regulatory responsibility for the radio spectrum is divided between the Federal Communications Commission (FCC) (non-Government uses) and the National Telecommunications and Information Administration (NTIA) (Government agencies usage). At present only frequency bands between 9 kHz and 275 GHz have been allocated (i.e., designated for use by one or more terrestrial or space radiocommunication services, or for the radio astronomy service under specified conditions). OET maintains the FCC's Table of Frequency Allocations, which is a compilation of allocations. The FCC's Table of Frequency Allocations is codified at Section 2.106 of the Commission's Rules. For a more detailed description go to the Table of Frequency Allocations Chart.\n",
      "Bureau/Office:\n",
      "Engineering & Technology\n",
      "Tags:\n",
      "Devices - Devices, Engineering & Technology\n",
      "\n",
      "Posted January 27th, 2020 for DAT Solutions\n",
      "Peggy Dorf on January 27, 2020 3:26 pm\n",
      "It's officially the slow season for truckload freight. January is coming to an end, and it already feels like the February slump has kicked in. Luckily, things should start to pick up again in mid-March, so it will be a short winter for truckers.\n",
      "The weather is not expected to be quite as bad this week as it was last week, but that's not saying much. The forecast calls for snow in the Mountain States, plus Kansas and parts of Missouri. Later in the week, expect big rainstorms stretching from Texas up to Tulsa, and east from there to the Carolinas and Florida. At least the driving conditions might be okay in the Upper Midwest, for once. The Southwest also looks good.\n",
      "Find loads and trucks in any season, on DAT load boards. DAT hosts the biggest and best truckload freight marketplace, where you can network with other transportation pros and grow your business.\n",
      "Hot Market Maps depict the outbound load-to-truck ratios from 135 market areas and thousands of 3-digit zip code zones, by the hour, day, week, or month. Load-to-truck ratio trends are a leading indicator of changes in rate trends, so look for Hot Market Maps in DAT RateView and the DAT Power load board.\n",
      "Van rates declined last week, but volumes held steady. Truckers should be able to find loads, but it may be a bit tougher to get paid as much as last month on the same lanes.\n",
      "Rates rise on a handful of high-traffic lanes\n",
      "Last week there were only a few lanes with rising rates, and most of those lanes didn't pay all that well to begin with. Plus, rates declined for most of the return legs, so there was no improvement in the roundtrip.\n",
      "Denver to Houston jumped 10¢ to $1.34 last week, but it already lost traction by Monday, and there aren't a lot of loads. Houston to Denver lost 9¢ to $1.92.\n",
      "Salt Lake City to Stockton, CA was up 6¢ to $1.63 per mile, and Stockton to Salt Lake held steady at $2.40.\n",
      "Buffalo to Columbus gained 3¢ to $2.00 even, while Columbus to Buffalo dropped 4¢ to $3.15.\n",
      "Memphis to Charlotte added 2¢ to $2.03, and Charlotte to Memphis lost 3¢ to $1.51. Not great, but not awful.\n",
      "Seattle to Spokane added another 3¢ to reach $3.32 and Spokane to Seattle held at $2.87 per loaded mile.\n",
      "Van rates slip lower everywhere else\n",
      "Pretty much all the other lane rates declined in our Top 100. Here are a few of the highlights – or rather, the lowlights.\n",
      "Phoenix to Los Angeles dropped 10¢ to $1.23 and L.A. to Phoenix fell 8¢ to $2.61.\n",
      "Columbus to Atlanta rates plummeted 17¢ to $2.11, and the return trip from Atlanta to Columbus paid $1.44, down 2¢.\n",
      "Dallas to Houston lost 9¢ to $2.12, and Houston to Dallas fell 3¢ to $1.97 per loaded mile.\n",
      "Chicago to Allentown, PA plunged 16¢ to $2.52 per mile, and Allentown to Chicago paid $1.31, which hasn't changed much recently.\n",
      "\n",
      "Morrison Property Dismissed From Lawsuit\n",
      "Posted June 13th, 2007 for Pacific Booker Minerals\n",
      "Vancouver, BC, June 13, 2007:\n",
      "The company wishes to announce that the application by the optionors of the Hearne Hill property to include the company's Morrison property as part of their claim has been dismissed by the Supreme Court of British Columbia.\n",
      "The company is vigorously defending the lawsuit respecting the Hearne Hill property and is proceeding to have the matter set for trial at the earliest opportunity.\n",
      "The company continues to proceed with development of the Morrison property including the completion of a feasibility study.\n",
      "The Hearne Hill property was previously explored by the company from May of 1993 until October of 1997 and 142 holes were drilled totaling 33,493 meters, however, it was determined that the Hearne Hill deposit was uneconomic.\n",
      "On behalf of the Board of Directors\n",
      "Greg Anderson\n",
      "Director and President\n",
      "No regulatory authority has approved or disapproved the information contained in this news release. This release includes certain statements that may be deemed \"forward-looking statements\". All statements in this release, other than statements of historical facts, that address future production, reserve potential, exploration drilling, exploitation activities and events or developments that the Company expects are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, statements are not guarantees of future performance and actual results or developments may differ materially from the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploration successes, continued availability of capital and financing, general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and that actual results or developments may differ materially from those projected in the forward-looking statements.\n",
      "Cautionary Note to U.S. Investors\n",
      "The United States Securities and Exchange Commission permits U.S. mining companies, in their filings with the SEC, to disclose only those mineral deposits that a company can economically and legally extract or produce. We use certain terms on this website (or press release), such as \"measured,'' \"indicated,\" and \"inferred\" \"resources,\" that the SEC guidelines strictly prohibit U.S. registered companies from including in their filings with the SEC. U.S. Investors are urged to consider closely the disclosure in our Form 20- F, File No. 0-51453, which may be secured from us, or from the SEC's website at http://www.sec.gov/edgar.shtml\n",
      "\n",
      "GE Software Solutions Makes It Easier to Manage Europe's Grid\n",
      "Posted August 21st, 2014 for General Electric\n",
      "August 21, 2014\n",
      "GE's PowerOn(TM) Advantage ADMS Helps Utilities Deliver a More Productive, Efficient and Reliable Electrical Grid\n",
      "Proven GE Technology Provides Immediate Access to Information Across the Network\n",
      "GE Will Address Grid Congestion, Asset Optimization and Grid Resiliency at CIGRE 2014—Booth #246\n",
      "ATLANTA\n",
      "August 21, 2014\n",
      "As Europe drives towards greater energy efficiency and increased grid complexity, GE (NYSE: GE) continues its mission to help utilities build a modern grid to meet electricity demands. Similarly, empowered consumers are driving the integration of solar, wind and electric vehicles—driving grid operators to seek new solutions to upgrade their situation's awareness.\n",
      "Designed from the utilities' perspective, the latest release of GE's PowerOn(TM) Advantage Advanced Distribution Management System (ADMS) offers the region an upgrade in grid technology, providing grid operators a centralized view of the network in a modular system built on a single platform.\n",
      "PowerOn Advantage ADMS is a powerful tool for utilities to manage the complexity of an active network. GE's PowerOn Advantage ADMS can provide the visualization of work processes across the grid to help optimize the network's performance. In addition, PowerOn Advantage ADMS supports the need for increased stakeholder engagement—delivering productivity, reliability and efficiency improvements to a utility's electrical grid.\n",
      "“Utilities need upgraded technologies to meet higher performance targets as demanded by the growing pressure to optimize operations,” said Keith Grassi, product line leader—software solutions, GE's Digital Energy business. “Our PowerOn Advantage ADMS provides the industry with our best-in-class outage management system (OMS) and distribution management system (DMS) capabilities to meet the ongoing commitment to manage a more active network due to grid complexity.”\n",
      "As situational awareness and visibility become more critical, PowerOn Advantage ADMS specifically supports grid operators through a unique and easy-to-use user interface, where data finds the user via a predefined dashboard with user-configurable widgets. PowerOn Advantage ADMS provides immediate access to information and a centralized view of the entire distribution network in real time. Through guided work pages and streamlined and robust workflows, GE's intuitive PowerOn Advantage ADMS provides the advanced situational awareness utility professionals require, helping to guide decision making during critical situations.\n",
      "PowerOn Advantage's modular design enables it to be offered as a standalone OMS or DMS as well as an integrated ADMS. The upgraded technology joins GE's PowerOn platform of grid management solutions, which includes products such as its PowerOn Reliance energy management system and PowerOn Precision demand response management system. PowerOn Advantage ADMS is a part of GE's portfolio of Industrial Internet solutions, which establish a constant flow of communication between a business operation and its machines. The Industrial Internet enables big data to be converted into real-time analytical insight, improving grid reliability and efficiency. Click here to view GE's PowerOn solutions in action.\n",
      "GE's Digital Energy business is a global leader in transmission and distribution solutions that manage and move power from the power plant to the consumer. Its products and services increase the reliability of electrical power networks and critical equipment for utility, industrial and large commercial customers. From protecting and optimizing assets such as generators, transmission lines and motors, to delivering analytic tools to help manage the power grid, GE's Digital Energy business delivers industry-leading technologies to solve the unique challenges of each customer. For more information, visit http://www.gedigitalenergy.com/.\n",
      "About GE\n",
      "GE (NYSE: GE) works on things that matter. The best people and the best technologies taking on the toughest challenges. Finding solutions in energy, health and home, transportation and finance. Building, powering, moving and curing the world. Not just imagining. Doing. GE works. For more information, visit the company's website at www.ge.com.\n",
      "\n",
      "The9 Limited Announces Unaudited Financial Information As Of and For the Six Months Ended\n",
      "Posted January 1st, 2015 for The9\n",
      "Shanghai,China\n",
      "March 26,2015.\n",
      "The9 Limited (NASDAQ: NCTY) (“The9”), an online game developer and operator, announced its unaudited financial results for the six months ended December 31, 2014 today.\n",
      "Financial Highlights:\n",
      "Net revenues in the second half of 2014 amounted to RMB36.9 million (US$5.9 million), representing an increase of 34.4% from RMB27.4 million (US$4.4 million) in the first half of 2014 and a decrease of 37.2% from RMB58.7 million (US$9.5 million) in the second half of 2013.\n",
      "In the second half of 2014, net profit attributable to holders of ordinary shares was RMB34.2 million (US$5.5 million). In the first half of 2014 and the second half of 2013, net loss attributable to holders of ordinary shares was RMB141.9 million (US$22.9 million) and RMB244.4 million (US$39.4 million), respectively.\n",
      "Management Comments:\n",
      "Jun Zhu, Chairman and Chief Executive Officer of The9, said, \"Red 5 launched Firefall in July 2014 in North America and Europe. We have high expectations for Firefall in the China market. In August 2014, Shanghai Oriental Pearl Culture Development Co. Ltd., a wholly-owned subsidiary of Shanghai Oriental Pearl (Group) Co., Ltd. (SH: 600832), closed its investment in Red 5 and became a minority shareholder of Red 5. Also in August 2014, Qihoo 360 Technology Co., Ltd. (QIHU) and us established a 50-50 joint venture System Link Corporation Limited to publish and operate Firefall in China for a five-year term. Under this license agreement, System Link is expected to pay to us no less than an aggregate of US$160 million including license fee and royalties during the term of the agreement. All these show the great potential of Firefall in China. We are dedicating our best resources to prepare for the launch of Firefall in China and we target to launch Firefall in China in the second half of 2015. In addition, we are also planning to launch several mobile games in 2015. In August 2014, we sold Huopu Cloud, a subsidiary which developed and held a proprietary web game, for a total consideration of RMB200 million. This sale has proven our in-house game development capability has been recognized by the market.\"\n",
      "Discussion of The9's Unaudited 2014 Second Half Results\n",
      "Net Revenues\n",
      "Our net revenues in the second half of 2014 amounted to RMB36.9 million (US$5.9 million), representing an increase of 34.4% from RMB27.4 million (US$4.4 million) in the first half of 2014 and a decrease of 37.2% from RMB58.7 million (US$9.5 million) in the second half of 2013. The increase over the first half of 2014 was mainly due to increase of revenue from Firefall in North America and Europe, and partly offset by decrease of revenue from various MMO, web and social games in China. The decrease from the second half of 2013 was mainly due to the decrease of revenue from Planetside 2.\n",
      "Gross Loss\n",
      "Our gross loss in the second half of 2014 amounted to RMB7.2 million (US$1.2 million), compared with RMB14.3 million (US$2.3 million) and RMB5.2 million (US$0.8 million) in the first half of 2014 and in the second half of 2013, respectively. The gross loss in the second half of 2014 reflected lower level of revenue generated coupled with the continued incurrence of a relatively fixed portion of our costs, such as overhead, depreciation and rental charges.\n",
      "Operating Expenses\n",
      "In the second half of 2014, our operating expenses, excluding gain from disposal of subsidiaries, were RMB151.8 million (US$24.5 million), which decrease by 0.8% from RMB153.0 million (US$24.7 million) in the first half of 2014 and decrease by 39.9% from RMB252.6 million (US$40.7 million) in the second half of 2013. The decrease compared to the first half of 2014 was primarily due to the net effect of the increase in marketing expenses in the second half relating to the launch of Firefall in the North America and Europe, and reversal of an allowance provided on a long-term receivable from a supplier recognized in the second half of 2013. The decrease compared to the second half of 2013 was primarily due to the cost cutting on product development, marketing expenses and general and administrative expenses, and the reversal of an allowance provided on a long-term receivable from a supplier recognized in the second half of 2013. In addition, in the first half of 2014, we also recorded a gain on disposal of subsidiaries of RMB165.4 million (US$26.7 million) in the second half of 2014 in connection with the disposal of Huopu Cloud Computing Terminal Technology Co., Ltd., a wholly-owned subsidiary, as well as certain other subsidiary, which was recorded as a deduction to operating expense.\n",
      "Interest Income\n",
      "Interest income in the second half of 2014 was RMB1.9 million (US$0.3 million), compared to RMB1.5 million (US$0.2 million) in the first half of 2014 and RMB2.6 million (US$0.4 million) in the second half of 2013. The fluctuation of interest income was typically in line with our cash balances.\n",
      "Other Income (Expenses), Net\n",
      "Other expenses in the second half of 2014 was RMB5.4 million (US$0.9 million), compared to other income of RMB3.3 million (US$0.5 million) in the first half of 2014 and other income of RMB7.0 million (US$1.1 million) in the second half of 2013. Other expenses in the second half of 2014 mainly represented foreign exchange losses. Other income in the first half of 2014 mainly represented foreign exchange gains. Other income in the second half of 2013 mainly represented a refund of game license fee.\n",
      "Net Profit (Loss) attributable to holders of ordinary shares\n",
      "In the second half of 2014, net profit attributable to holders of ordinary shares was RMB34.2 million (US$5.5 million). In the first half of 2014 and the second half of 2013, net loss attributable to holders of ordinary shares was RMB141.9 million (US$22.9 million) and RMB244.4 million (US$39.4 million), respectively.\n",
      "Basic net profit per share and per ADS in the second half of 2014 was RMB1.48 (US$0.25), compared to basic net loss per share of RMB6.13 (US$0.99) in the first half of 2014 and basic net loss per share of RMB10.64 (US$1.71) in the second half of 2013.\n",
      "Currency Convenience Translation\n",
      "The translation of Renminbi (RMB) into US dollars (US$) in this press release are presented solely for the convenience of the readers at the noon buying rate in the City of New York for cable transfers in Renminbi per U.S. dollar as certified for customs purposes by the H.10 weekly statistical release of the Federal Reserve Board as of December 31, 2014, which was RMB 6.2046 to US$1.00. Such translations should not be construed as representations that the RMB amounts represents, or have been or could be converted into, US$ at that or any other rate. The percentages stated in this press release are calculated based on the RMB amounts.\n",
      "About The9 Limited\n",
      "The9 Limited is an online game developer and operator in China. The9 develops and operates, directly or through its affiliates, its proprietary MMO, web and mobile games including Firefall, TianTianWanDiaoChan and Dao Feng. In 2010, The9 established its wireless business unit to focus on mobile internet business. In 2013, The9 formed a joint venture with Shanghai ZTE to develop and operate home entertainment set top box business.\n",
      "Safe Harbor Statement\n",
      "This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. The9 may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission on Forms 20-F and 6-K, etc., in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about The9's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, political and economic policies of the Chinese government, the laws and regulations governing the online game industry, information disseminated over the Internet and Internet content providers in China, intensified government regulation of Internet cafes, The9's ability to retain existing players and attract new players, license, develop or acquire additional online games that are appealing to users, anticipate and adapt to changing consumer preferences and respond to competitive market conditions, and other risks and uncertainties outlined in The9's filings with the U.S. Securities and Exchange Commission, including its annual reports on Form 20-F. The9 does not undertake any obligation to update any forward-looking statement, except as required under applicable law.\n",
      "\n",
      "How To Apply Online For Just Medicare\n",
      "You can apply online for Medicare even if you are not ready to retire. You can use our online application to sign up. It takes less than 10 minutes. There are no forms to sign and usually no documentation is required. Social Security will process your application and contact you if we need more information.\n",
      "Apply for Medicare Only\n",
      "Return to Saved Application\n",
      "Check Application Status\n",
      "Replace Medicare Card\n",
      "Medicare is managed by the Centers for Medicare and Medicaid Services (CMS). Social Security works with CMS by enrolling people in Medicare.\n",
      "For more information about applying for Medicare only and delaying retirement benefits, visit Applying for Medicare Only – Before You Decide.\n",
      "If you have a Health Savings Account (HSA) and/or health insurance based on employment, you may want to ask your personnel office or insurance company how signing up for Medicare will affect you.\n",
      "To find out what documents and information you need to apply, go to the Checklist For The Online Medicare, Retirement, And Spouses Application.\n",
      "Medicare Cards\n",
      "To help protect your identity, your Medicare card has a Medicare Number that's unique to you. If you did not receive your red, white, and blue Medicare card, there may be something that needs to be corrected, like your mailing address. You can update your mailing address by logging in to or creating your personal my Social Security account. Learn more about your Medicare card.\n",
      "Learn about Medicare\n",
      "Medicare is our country's health insurance program for people age 65 or older. Certain people younger than age 65 can qualify for Medicare, too, including those with disabilities and those who have permanent kidney failure. To learn more, read our Medicare publication.\n",
      "Already Enrolled in Medicare\n",
      "If you already have Medicare, you can get information and services online. Find out how to manage your benefits.\n",
      "If you already have Medicare Part A and wish to sign up for Medicare Part B, please complete form CMS 40-B, Application for Enrollment in Medicare - Part B (Medical Insurance), and take or mail it to your local Social Security office.\n",
      "You'll have Original Medicare unless you make another choice. You can decide to add a drug plan (Part D) or buy a Medigap policy to help pay for costs that Original Medicare doesn't cover. You can choose to join a Medicare Advantage Plan (Part C) and get all your Medicare coverage (including drugs and extra benefits like vision, hearing, dental, and more) bundled together in one plan.\n",
      "Some people with limited resources and income may also be able to get Extra Help to pay for Part D drug costs.\n",
      "Applying for Medicare\n",
      "When you apply for Medicare, you can sign up for Part A (Hospital Insurance) and Part B (Medical Insurance). Because you must pay a premium for Part B coverage, you can turn it down. However, if you decide to enroll in Part B later on, you may have to pay a late enrollment penalty for as long as you have Part B coverage. Your monthly premium will go up 10 percent for each 12-month period you were eligible for Part B, but didn't sign up for it, unless you qualify for a \"Special Enrollment Period\".\n",
      "If you're eligible at age 65, your initial enrollment period begins three months before your 65th birthday, includes the month you turn age 65, and ends three months after that birthday. However, if you don't enroll in Medicare Part B during your initial enrollment period, you have another chance each year to sign up during a “general enrollment period” from January 1 through March 31. Your coverage begins on July 1 of the year you enroll. Read our Medicare publication for more information.\n",
      "If you live in Puerto Rico you will not receive Medicare Part B ( Medical Insurance automatically. You will need to sign up for it during your initial enrollment period, or you will pay a penalty. To sign up, please call our toll-free number at 1-800-772-1213 (TTY 1-800-325-0778). You also may contact your local Social Security office. You can find your local Social Security office by using our Office Locator.\n",
      "Questions about our online application\n",
      "Who can apply for Medicare online?\n",
      "You can use our online Medicare application if you:\n",
      "Are at least 64 years and 9 months old;\n",
      "Want to sign up for Medicare but do not currently have ANY Medicare coverage;\n",
      "Do not want to start receiving Social Security benefits at this time; and\n",
      "Are not currently receiving Social Security retirement, disability or survivors benefits.\n",
      "When should I apply?\n",
      "You should sign up for Medicare three months before reaching age 65, even if you are not ready to start receiving retirement benefits. You can opt out of receiving cash retirement benefits now once you are in the online application. Then you can apply online for retirement benefits later.\n",
      "With our online application, you can sign up for Medicare Part A (Hospital Insurance) and Part B (Medical Insurance). Because you must pay a premium for Part B coverage, you can turn it down.\n",
      "If you choose not to enroll in Medicare Part B and then decide to do so later, your coverage may be delayed and you may have to pay a higher monthly premium for as long as you have Part B. Your monthly premium will go up 10 percent for each 12-month period you were eligible for Part B, but didn't sign up for it, unless you qualify for a \"Special Enrollment Period.\"\n",
      "Special Enrollment Period (SEP)\n",
      "If you have medical insurance coverage under a group health plan based on your or your spouse's current employment, you may not need to apply for Medicare Part B at age 65. You may qualify for a \"Special Enrollment Period\" (SEP) that will let you sign up for Part B during:\n",
      "Any month you remain covered under the group health plan and your, or your spouse's, employment continues; or\n",
      "The 8-month period that begins with the month after your group health plan coverage or the employment it is based on ends, whichever comes first.\n",
      "Why apply for Medicare online?\n",
      "Using the online Medicare application has a number of benefits. You can:\n",
      "Avoid trips to your Social Security Office, saving you time and money.\n",
      "Answer questions at your convenience by starting and stopping the application without fear of losing any information you entered.\n",
      "Make corrections to the application prior to submission.\n",
      "Submit your application electronically. There is no need to mail in your application. When you are finished, just select “Submit Now” to send your application to Social Security.\n",
      "Receive a receipt online for your application that you can print and keep for your records.\n",
      "Check the status of your application online. You will receive a confirmation number once you submit your application.\n",
      "What happens after I apply?\n",
      "Once we receive your application, we will\n",
      "Review your application and contact you if we need more information or if we need to see your documents;\n",
      "Process your application once we have all of the necessary information and documents; and\n",
      "Mail you a decision letter.\n",
      "If your application is approved, the Centers for Medicare & Medicaid Services will send you a Welcome to Medicare packet in the mail with your Medicare card. You will also receive the most current version of the Medicare & You handbook, with important information about your Medicare coverage choices.\n",
      "Other Medicare registration/enrollment options\n",
      "You can also apply:\n",
      "By phone - Call us at 1-800-772-1213 from 7 a.m. to 7 p.m. Monday through Friday. If you are deaf or hard of hearing, you can call us at TTY 1-800-325-0778.\n",
      "In person - Visit your local Social Security office. (Call first to make an appointment.)\n",
      "If you do not live in the U.S. or one of its territories you can also contact the Federal Benefits Unit that provides service to your country of residence.\n",
      "\n",
      "GUIDANCE DOCUMENT\n",
      "Guidance for Industry: Necessity of the Use of Food Product Categories in Food Facility Registrations and Updates to Food Product Categories (2016 Edition)\n",
      "September 2016\n",
      "Docket Number:\n",
      "FDA-2012-D-0585\n",
      "Issued by:\n",
      "Guidance Issuing Office\n",
      "Office of Foods and Veterinary Medicine, Center for Food Safety and Applied Nutrition\n",
      "Because of Congress's explicit statutory authorization to effectuate certain binding requirements related to food product categories in food facility registrations based on findings in guidance, this document is not subject to the usual restrictions in FDA's good guidance practice (GGP) regulations, such as the requirements that guidances not establish legally enforceable responsibilities and that they prominently display a statement of the document's nonbinding effect. See 21 CFR 10.115(d) and (i). This guidance contains findings that serve as the predicates for binding requirements on industry.\n",
      "This guidance represents the Food and Drug Administration's (FDA's) conclusion on the necessity of food product categories in food facility registrations submitted to FDA under section 415 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 350d), as added by section 305 of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act) and amended by section 102 of the FDA Food Safety Modernization Act (FSMA) (Public Law 111-353). This guidance also updates the food product categories in food facility registrations.\n",
      "Section 415(a)(2) of the FD&C Act provides, in relevant part, that a food facility must submit to FDA a registration containing information about the general food category (as identified in 21 CFR 170.3 or any other food categories as determined appropriate by FDA, including “by guidance”) of a food manufactured/processed, packed or held at such facility, if the Agency determines “through guidance” that such information is necessary.\n",
      "To comply with the GGP regulations and make sure that regulated entities and the public understand that guidance documents are nonbinding, FDA guidances ordinarily contain standard language explaining that guidances should be viewed only as recommendations unless specific regulatory or statutory requirements are cited, and FDA's guidances also ordinarily include the following standard paragraph:\n",
      "This guidance represents the current thinking of the Food and Drug Administration (FDA or we) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. To discuss an alternative approach, contact the FDA staff responsible for this guidance as listed on the title page.\n",
      "FDA is not including this standard language in this guidance because it is not an accurate description of the effect of this guidance. This guidance contains findings that serve as the predicates for binding requirements on industry. As provided in section 305 of the Bioterrorism Act, this guidance contains FDA's finding that inclusion of food product categories in food facility registrations is necessary for a quick, accurate, and focused response to an actual or potential bioterrorist incident or other food-related emergency. Based in part on this finding, FDA's regulations for the registration of food facilities in 21 CFR Part 1, Subpart H require that a food facility submit a registration to FDA containing information on applicable food product categories manufactured/processed, packed, or held at such facility. As provided in section 102 of FSMA, this guidance contains FDA's finding that inclusion of food product categories other than just those identified in 21 CFR 170.3 is also necessary to facilitate such rapid communications. In addition, this guidance sets forth the other food product categories to be included in food facility registrations as determined to be appropriate by FDA, as provided by section 102 of FSMA.\n",
      "To the extent that this guidance modifies food product categories for food facility registration pursuant to section 415 of the FD&C Act, it has a binding effect. For these reasons, FDA is not including the standard guidance paragraph in this guidance.\n",
      "Download the Guidance\n",
      "Submit Comments\n",
      "Submit Comments Online\n",
      "You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))\n",
      "If unable to submit comments online, please mail written comments to:\n",
      "Dockets Management\n",
      "Food and Drug Administration\n",
      "5630 Fishers Lane, Rm 1061 Rockville, MD 20852\n",
      "All written comments should be identified with this document's docket number: FDA-2012-D-0585.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "\"\\nmt_ids = {}\\nfor mt_file in os.listdir(mt_folder):\\n    mt_path = os.path.join(mt_folder, mt_file)\\n    mt_id, _ = os.path.splitext(mt_file)\\n    #if mt_path.endswith('.txt'):\\n        #with open(mt_path, 'r') as f:\\n        #    print(f.read())\\n\""
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import os\n",
    "sd_folder = './MultiEnJa/source-document'\n",
    "mt_folder = './MultiEnJa/MT-PE/en-ja.mt'\n",
    "ht_folder = './MultiEnJa/human-translation/en-ja.final'\n",
    "\n",
    "#print(len(os.listdir(mt_folder))) # 46\n",
    "#print(len(os.listdir(ht_folder))) # 46\n",
    "#print(os.listdir(ht_folder))\n",
    "#print(os.listdir(mt_folder) == os.listdir(ht_folder)) # True\n",
    "\n",
    "for file in os.listdir(mt_folder):\n",
    "    sd_file = sd_folder + '/' + file\n",
    "    with open(sd_file, 'r') as f:\n",
    "        print(f.read())\n",
    "\n",
    "\"\"\"\n",
    "mt_ids = {}\n",
    "for mt_file in os.listdir(mt_folder):\n",
    "    mt_path = os.path.join(mt_folder, mt_file)\n",
    "    mt_id, _ = os.path.splitext(mt_file)\n",
    "    #if mt_path.endswith('.txt'):\n",
    "        #with open(mt_path, 'r') as f:\n",
    "        #    print(f.read())\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'0': {'sent_id': '0', 'sent': '電子コモン・テクニカル・ドキュメント(eCTD)', 電子: {'token_id': '0', 'token': 電子, 'lemma': '電子', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ドキュメント, 'head.id': 5}, コモン: {'token_id': '1', 'token': コモン, 'lemma': 'コモン', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ドキュメント, 'head.id': 5}, ・: {'token_id': '2', 'token': ・, 'lemma': '・', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': ドキュメント, 'head.id': 5}, テクニカル: {'token_id': '3', 'token': テクニカル, 'lemma': 'テクニカル', 'pos': 'PROPN', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': ドキュメント, 'head.id': 5}, ・: {'token_id': '4', 'token': ・, 'lemma': '・', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': ドキュメント, 'head.id': 5}, ドキュメント: {'token_id': '5', 'token': ドキュメント, 'lemma': 'ドキュメント', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': ドキュメント, 'head.id': 5}, (: {'token_id': '6', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': ドキュメント, 'head.id': 5}, eCTD: {'token_id': '7', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ドキュメント, 'head.id': 5}, ): {'token_id': '8', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': ドキュメント, 'head.id': 5}}, '1': {'sent_id': '1', 'sent': 'eCTDは、FDAの医薬品評価研究センター(CDER)および生物製剤評価研究センター(CBER)に申請、修正、補足および報告を提出するための標準フォーマットである。', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': フォーマット, 'head.id': 35}, は: {'token_id': '1', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': eCTD, 'head.id': 0}, 、: {'token_id': '2', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': eCTD, 'head.id': 0}, FDA: {'token_id': '3', 'token': FDA, 'lemma': 'FDA', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': センター, 'head.id': 8}, の: {'token_id': '4', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 3}, 医薬品: {'token_id': '5', 'token': 医薬品, 'lemma': '医薬品', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': センター, 'head.id': 8}, 評価: {'token_id': '6', 'token': 評価, 'lemma': '評価', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': センター, 'head.id': 8}, 研究: {'token_id': '7', 'token': 研究, 'lemma': '研究', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': センター, 'head.id': 8}, センター: {'token_id': '8', 'token': センター, 'lemma': 'センター', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': センター, 'head.id': 17}, (: {'token_id': '9', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': センター, 'head.id': 8}, CDER: {'token_id': '10', 'token': CDER, 'lemma': 'cder', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': センター, 'head.id': 8}, ): {'token_id': '11', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': センター, 'head.id': 8}, および: {'token_id': '12', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': センター, 'head.id': 17}, 生物: {'token_id': '13', 'token': 生物, 'lemma': '生物', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': センター, 'head.id': 17}, 製剤: {'token_id': '14', 'token': 製剤, 'lemma': '製剤', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': センター, 'head.id': 17}, 評価: {'token_id': '15', 'token': 評価, 'lemma': '評価', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': センター, 'head.id': 17}, 研究: {'token_id': '16', 'token': 研究, 'lemma': '研究', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': センター, 'head.id': 17}, センター: {'token_id': '17', 'token': センター, 'lemma': 'センター', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': ため, 'head.id': 32}, (: {'token_id': '18', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': センター, 'head.id': 17}, CBER: {'token_id': '19', 'token': CBER, 'lemma': 'cber', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': センター, 'head.id': 17}, ): {'token_id': '20', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': センター, 'head.id': 17}, に: {'token_id': '21', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': センター, 'head.id': 17}, 申請: {'token_id': '22', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 修正, 'head.id': 24}, 、: {'token_id': '23', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 申請, 'head.id': 22}, 修正: {'token_id': '24', 'token': 修正, 'lemma': '修正', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 補足, 'head.id': 26}, 、: {'token_id': '25', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 修正, 'head.id': 24}, 補足: {'token_id': '26', 'token': 補足, 'lemma': '補足', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 報告, 'head.id': 28}, および: {'token_id': '27', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 報告, 'head.id': 28}, 報告: {'token_id': '28', 'token': 報告, 'lemma': '報告', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obj', 'head': ため, 'head.id': 32}, を: {'token_id': '29', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 報告, 'head.id': 28}, 提出: {'token_id': '30', 'token': 提出, 'lemma': '提出', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': ため, 'head.id': 32}, する: {'token_id': '31', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': ため, 'head.id': 32}, ため: {'token_id': '32', 'token': ため, 'lemma': 'ため', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nmod', 'head': フォーマット, 'head.id': 35}, の: {'token_id': '33', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'fixed', 'head': ため, 'head.id': 32}, 標準: {'token_id': '34', 'token': 標準, 'lemma': '標準', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': フォーマット, 'head.id': 35}, フォーマット: {'token_id': '35', 'token': フォーマット, 'lemma': 'フォーマット', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': フォーマット, 'head.id': 35}, で: {'token_id': '36', 'token': で, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cop', 'head': フォーマット, 'head.id': 35}, ある: {'token_id': '37', 'token': ある, 'lemma': 'ある', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': で, 'head.id': 36}, 。: {'token_id': '38', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': フォーマット, 'head.id': 35}}, '2': {'sent_id': '2', 'sent': '重要な日付', 重要: {'token_id': '0', 'token': 重要, 'lemma': '重要', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': 日付, 'head.id': 2}, な: {'token_id': '1', 'token': な, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 重要, 'head.id': 0}, 日付: {'token_id': '2', 'token': 日付, 'lemma': '日付', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': 日付, 'head.id': 2}}, '3': {'sent_id': '3', 'sent': '注意:eCTDガイダンスに従い、NDA、BLA、ANDAおよびCommercial IND申請にはFDA記入可能フォーム(例:356h、PHONE、PHONE)を含める必要があります。', 注意: {'token_id': '0', 'token': 注意, 'lemma': '注意', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': フォーム, 'head.id': 21}, :: {'token_id': '1', 'token': :, 'lemma': ':', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'dep', 'head': 注意, 'head.id': 0}, eCTD: {'token_id': '2', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ガイダンス, 'head.id': 3}, ガイダンス: {'token_id': '3', 'token': ガイダンス, 'lemma': 'ガイダンス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 従い, 'head.id': 5}, に: {'token_id': '4', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ガイダンス, 'head.id': 3}, 従い: {'token_id': '5', 'token': 従い, 'lemma': '従う', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': フォーム, 'head.id': 21}, 、: {'token_id': '6', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 従い, 'head.id': 5}, NDA: {'token_id': '7', 'token': NDA, 'lemma': 'nda', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': BLA, 'head.id': 9}, 、: {'token_id': '8', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': NDA, 'head.id': 7}, BLA: {'token_id': '9', 'token': BLA, 'lemma': 'bla', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': ANDA, 'head.id': 11}, 、: {'token_id': '10', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': BLA, 'head.id': 9}, ANDA: {'token_id': '11', 'token': ANDA, 'lemma': 'anda', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 申請, 'head.id': 15}, および: {'token_id': '12', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 申請, 'head.id': 15}, Commercial: {'token_id': '13', 'token': Commercial, 'lemma': 'Commercial', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 申請, 'head.id': 15}, IND: {'token_id': '14', 'token': IND, 'lemma': 'IND', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 申請, 'head.id': 15}, 申請: {'token_id': '15', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': フォーム, 'head.id': 21}, に: {'token_id': '16', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 申請, 'head.id': 15}, は: {'token_id': '17', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 申請, 'head.id': 15}, FDA: {'token_id': '18', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'compound', 'head': 記入, 'head.id': 19}, 記入: {'token_id': '19', 'token': 記入, 'lemma': '記入', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': フォーム, 'head.id': 21}, 可能: {'token_id': '20', 'token': 可能, 'lemma': '可能', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': フォーム, 'head.id': 21}, フォーム: {'token_id': '21', 'token': フォーム, 'lemma': 'フォーム', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 含める, 'head.id': 33}, (: {'token_id': '22', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': フォーム, 'head.id': 21}, 例: {'token_id': '23', 'token': 例, 'lemma': '例', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': フォーム, 'head.id': 21}, :: {'token_id': '24', 'token': :, 'lemma': ':', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'dep', 'head': フォーム, 'head.id': 21}, 356: {'token_id': '25', 'token': 356, 'lemma': '356', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': フォーム, 'head.id': 21}, h: {'token_id': '26', 'token': h, 'lemma': 'H', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変形状詞可能', 'dep': 'compound', 'head': フォーム, 'head.id': 21}, 、: {'token_id': '27', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': フォーム, 'head.id': 21}, PHONE: {'token_id': '28', 'token': PHONE, 'lemma': 'phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '人名', 'dep': 'compound', 'head': フォーム, 'head.id': 21}, 、: {'token_id': '29', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': フォーム, 'head.id': 21}, PHONE: {'token_id': '30', 'token': PHONE, 'lemma': 'phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '人名', 'dep': 'compound', 'head': フォーム, 'head.id': 21}, ): {'token_id': '31', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': フォーム, 'head.id': 21}, を: {'token_id': '32', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': フォーム, 'head.id': 21}, 含める: {'token_id': '33', 'token': 含める, 'lemma': '含める', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': 必要, 'head.id': 34}, 必要: {'token_id': '34', 'token': 必要, 'lemma': '必要', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '形状詞可能', 'dep': 'nsubj', 'head': あり, 'head.id': 36}, が: {'token_id': '35', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 必要, 'head.id': 34}, あり: {'token_id': '36', 'token': あり, 'lemma': 'ある', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'ROOT', 'head': あり, 'head.id': 36}, ます: {'token_id': '37', 'token': ます, 'lemma': 'ます', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': あり, 'head.id': 36}, 。: {'token_id': '38', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': あり, 'head.id': 36}}, '4': {'sent_id': '4', 'sent': 'FDAはPHONE年7月27日から記入可能フォームの検証チェックを実施する予定です。', FDA: {'token_id': '0', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 予定, 'head.id': 18}, は: {'token_id': '1', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 0}, PHONE: {'token_id': '2', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 日, 'head.id': 7}, 年: {'token_id': '3', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 7}, 7: {'token_id': '4', 'token': 7, 'lemma': '7', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 日, 'head.id': 7}, 月: {'token_id': '5', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 7}, 27: {'token_id': '6', 'token': 27, 'lemma': '27', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 日, 'head.id': 7}, 日: {'token_id': '7', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '助数詞', 'dep': 'obl', 'head': 実施, 'head.id': 16}, から: {'token_id': '8', 'token': から, 'lemma': 'から', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 日, 'head.id': 7}, 記入: {'token_id': '9', 'token': 記入, 'lemma': '記入', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 可能, 'head.id': 10}, 可能: {'token_id': '10', 'token': 可能, 'lemma': '可能', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'amod', 'head': フォーム, 'head.id': 11}, フォーム: {'token_id': '11', 'token': フォーム, 'lemma': 'フォーム', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': チェック, 'head.id': 14}, の: {'token_id': '12', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': フォーム, 'head.id': 11}, 検証: {'token_id': '13', 'token': 検証, 'lemma': '検証', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': チェック, 'head.id': 14}, チェック: {'token_id': '14', 'token': チェック, 'lemma': 'チェック', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obj', 'head': 実施, 'head.id': 16}, を: {'token_id': '15', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': チェック, 'head.id': 14}, 実施: {'token_id': '16', 'token': 実施, 'lemma': '実施', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': 予定, 'head.id': 18}, する: {'token_id': '17', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 実施, 'head.id': 16}, 予定: {'token_id': '18', 'token': 予定, 'lemma': '予定', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 予定, 'head.id': 18}, です: {'token_id': '19', 'token': です, 'lemma': 'です', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cop', 'head': 予定, 'head.id': 18}, 。: {'token_id': '20', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 予定, 'head.id': 18}}, '5': {'sent_id': '5', 'sent': 'この検証に合格しない申請は却下の対象となります。', この: {'token_id': '0', 'token': この, 'lemma': 'この', 'pos': 'DET', 'pos1': '連体詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'det', 'head': 検証, 'head.id': 1}, 検証: {'token_id': '1', 'token': 検証, 'lemma': '検証', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': 合格, 'head.id': 3}, に: {'token_id': '2', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 検証, 'head.id': 1}, 合格: {'token_id': '3', 'token': 合格, 'lemma': '合格', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': 申請, 'head.id': 6}, し: {'token_id': '4', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 合格, 'head.id': 3}, ない: {'token_id': '5', 'token': ない, 'lemma': 'ない', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 合格, 'head.id': 3}, 申請: {'token_id': '6', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nsubj', 'head': なり, 'head.id': 12}, は: {'token_id': '7', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 申請, 'head.id': 6}, 却下: {'token_id': '8', 'token': 却下, 'lemma': '却下', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 対象, 'head.id': 10}, の: {'token_id': '9', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 却下, 'head.id': 8}, 対象: {'token_id': '10', 'token': 対象, 'lemma': '対象', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': なり, 'head.id': 12}, と: {'token_id': '11', 'token': と, 'lemma': 'と', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 対象, 'head.id': 10}, なり: {'token_id': '12', 'token': なり, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'ROOT', 'head': なり, 'head.id': 12}, ます: {'token_id': '13', 'token': ます, 'lemma': 'ます', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': なり, 'head.id': 12}, 。: {'token_id': '14', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': なり, 'head.id': 12}}, '6': {'sent_id': '6', 'sent': '詳細については、eCTDガイダンスおよびeCTD検証基準(エラーコード7)を参照してください。', 詳細: {'token_id': '0', 'token': 詳細, 'lemma': '詳細', 'pos': 'ADJ', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '形状詞可能', 'dep': 'obl', 'head': 参照, 'head.id': 17}, に: {'token_id': '1', 'token': に, 'lemma': 'だ', 'pos': 'ADP', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'case', 'head': 詳細, 'head.id': 0}, つい: {'token_id': '2', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 1}, て: {'token_id': '3', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 1}, は: {'token_id': '4', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 詳細, 'head.id': 0}, 、: {'token_id': '5', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 詳細, 'head.id': 0}, eCTD: {'token_id': '6', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ガイダンス, 'head.id': 7}, ガイダンス: {'token_id': '7', 'token': ガイダンス, 'lemma': 'ガイダンス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 基準, 'head.id': 11}, および: {'token_id': '8', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 基準, 'head.id': 11}, eCTD: {'token_id': '9', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 基準, 'head.id': 11}, 検証: {'token_id': '10', 'token': 検証, 'lemma': '検証', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 基準, 'head.id': 11}, 基準: {'token_id': '11', 'token': 基準, 'lemma': '基準', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 参照, 'head.id': 17}, (: {'token_id': '12', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 基準, 'head.id': 11}, エラーコード: {'token_id': '13', 'token': エラーコード, 'lemma': 'エラーコード', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 基準, 'head.id': 11}, 7: {'token_id': '14', 'token': 7, 'lemma': '7', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 基準, 'head.id': 11}, ): {'token_id': '15', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 基準, 'head.id': 11}, を: {'token_id': '16', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 基準, 'head.id': 11}, 参照: {'token_id': '17', 'token': 参照, 'lemma': '参照', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 参照, 'head.id': 17}, し: {'token_id': '18', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 参照, 'head.id': 17}, て: {'token_id': '19', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 参照, 'head.id': 17}, ください: {'token_id': '20', 'token': ください, 'lemma': 'くださる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 19}, 。: {'token_id': '21', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 参照, 'head.id': 17}}, '7': {'sent_id': '7', 'sent': '以下の日付以降は、CDERおよびCBERへの申請に対するeCTD要件が有効となり、eCTDを使用しない申請は提出または受領されない。', 以下: {'token_id': '0', 'token': 以下, 'lemma': '以下', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 以降, 'head.id': 3}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 以下, 'head.id': 0}, 日付: {'token_id': '2', 'token': 日付, 'lemma': '日付', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 以降, 'head.id': 3}, 以降: {'token_id': '3', 'token': 以降, 'lemma': '以降', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'obl', 'head': なり, 'head.id': 19}, は: {'token_id': '4', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 以降, 'head.id': 3}, 、: {'token_id': '5', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 以降, 'head.id': 3}, CDER: {'token_id': '6', 'token': CDER, 'lemma': 'cder', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': CBER, 'head.id': 8}, および: {'token_id': '7', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': CBER, 'head.id': 8}, CBER: {'token_id': '8', 'token': CBER, 'lemma': 'cber', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 申請, 'head.id': 11}, へ: {'token_id': '9', 'token': へ, 'lemma': 'へ', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': CBER, 'head.id': 8}, の: {'token_id': '10', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': CBER, 'head.id': 8}, 申請: {'token_id': '11', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 要件, 'head.id': 15}, に: {'token_id': '12', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 申請, 'head.id': 11}, 対する: {'token_id': '13', 'token': 対する, 'lemma': '対する', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 12}, eCTD: {'token_id': '14', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 要件, 'head.id': 15}, 要件: {'token_id': '15', 'token': 要件, 'lemma': '要件', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': なり, 'head.id': 19}, が: {'token_id': '16', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 要件, 'head.id': 15}, 有効: {'token_id': '17', 'token': 有効, 'lemma': '有効', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'advcl', 'head': なり, 'head.id': 19}, と: {'token_id': '18', 'token': と, 'lemma': 'と', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 有効, 'head.id': 17}, なり: {'token_id': '19', 'token': なり, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'advcl', 'head': 受領, 'head.id': 31}, 、: {'token_id': '20', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': なり, 'head.id': 19}, eCTD: {'token_id': '21', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 使用, 'head.id': 23}, を: {'token_id': '22', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': eCTD, 'head.id': 21}, 使用: {'token_id': '23', 'token': 使用, 'lemma': '使用', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': 申請, 'head.id': 26}, し: {'token_id': '24', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 23}, ない: {'token_id': '25', 'token': ない, 'lemma': 'ない', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 23}, 申請: {'token_id': '26', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nsubj', 'head': 受領, 'head.id': 31}, は: {'token_id': '27', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 申請, 'head.id': 26}, 提出: {'token_id': '28', 'token': 提出, 'lemma': '提出', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': 受領, 'head.id': 31}, また: {'token_id': '29', 'token': また, 'lemma': 'また', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 受領, 'head.id': 31}, は: {'token_id': '30', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'fixed', 'head': また, 'head.id': 29}, 受領: {'token_id': '31', 'token': 受領, 'lemma': '受領', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 受領, 'head.id': 31}, さ: {'token_id': '32', 'token': さ, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 受領, 'head.id': 31}, れ: {'token_id': '33', 'token': れ, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 受領, 'head.id': 31}, ない: {'token_id': '34', 'token': ない, 'lemma': 'ない', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 受領, 'head.id': 31}, 。: {'token_id': '35', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 受領, 'head.id': 31}}, '8': {'sent_id': '8', 'sent': 'PHONE年5月5日:', PHONE: {'token_id': '0', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 日, 'head.id': 5}, 年: {'token_id': '1', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 5: {'token_id': '2', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 日, 'head.id': 5}, 月: {'token_id': '3', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 5: {'token_id': '4', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 日, 'head.id': 5}, 日: {'token_id': '5', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '助数詞', 'dep': 'ROOT', 'head': 日, 'head.id': 5}, :: {'token_id': '6', 'token': :, 'lemma': ':', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'dep', 'head': 日, 'head.id': 5}}, '9': {'sent_id': '9', 'sent': '新薬申請(NDA)、簡略化されたNDA(ANDA)、生物学的製剤承認申請(BLA)は、eCTD形式で提出しなければならない。', 新薬: {'token_id': '0', 'token': 新薬, 'lemma': '新薬', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 申請, 'head.id': 1}, 申請: {'token_id': '1', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': NDA, 'head.id': 11}, (: {'token_id': '2', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 申請, 'head.id': 1}, NDA: {'token_id': '3', 'token': NDA, 'lemma': 'nda', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 申請, 'head.id': 1}, ): {'token_id': '4', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 申請, 'head.id': 1}, 、: {'token_id': '5', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 申請, 'head.id': 1}, 簡略: {'token_id': '6', 'token': 簡略, 'lemma': '簡略', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'amod', 'head': 化, 'head.id': 7}, 化: {'token_id': '7', 'token': 化, 'lemma': '化', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': 'サ変可能', 'dep': 'acl', 'head': NDA, 'head.id': 11}, さ: {'token_id': '8', 'token': さ, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 化, 'head.id': 7}, れ: {'token_id': '9', 'token': れ, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 化, 'head.id': 7}, た: {'token_id': '10', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 化, 'head.id': 7}, NDA: {'token_id': '11', 'token': NDA, 'lemma': 'nda', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 生物学, 'head.id': 16}, (: {'token_id': '12', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': NDA, 'head.id': 11}, ANDA: {'token_id': '13', 'token': ANDA, 'lemma': 'anda', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': NDA, 'head.id': 11}, ): {'token_id': '14', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': NDA, 'head.id': 11}, 、: {'token_id': '15', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': NDA, 'head.id': 11}, 生物学: {'token_id': '16', 'token': 生物学, 'lemma': '生物学', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 提出, 'head.id': 29}, 的: {'token_id': '17', 'token': 的, 'lemma': '的', 'pos': 'PART', 'pos1': '接尾辞', 'pos2': '形状詞的', 'pos3': 'N', 'dep': 'mark', 'head': 生物学, 'head.id': 16}, 製剤: {'token_id': '18', 'token': 製剤, 'lemma': '製剤', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 生物学, 'head.id': 16}, 承認: {'token_id': '19', 'token': 承認, 'lemma': '承認', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 生物学, 'head.id': 16}, 申請: {'token_id': '20', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 生物学, 'head.id': 16}, (: {'token_id': '21', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 生物学, 'head.id': 16}, BLA: {'token_id': '22', 'token': BLA, 'lemma': 'bla', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 生物学, 'head.id': 16}, ): {'token_id': '23', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 生物学, 'head.id': 16}, は: {'token_id': '24', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 生物学, 'head.id': 16}, 、: {'token_id': '25', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 生物学, 'head.id': 16}, eCTD: {'token_id': '26', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 形式, 'head.id': 27}, 形式: {'token_id': '27', 'token': 形式, 'lemma': '形式', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 提出, 'head.id': 29}, で: {'token_id': '28', 'token': で, 'lemma': 'で', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 形式, 'head.id': 27}, 提出: {'token_id': '29', 'token': 提出, 'lemma': '提出', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 提出, 'head.id': 29}, し: {'token_id': '30', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 提出, 'head.id': 29}, なけれ: {'token_id': '31', 'token': なけれ, 'lemma': 'ない', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 提出, 'head.id': 29}, ば: {'token_id': '32', 'token': ば, 'lemma': 'ば', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': なけれ, 'head.id': 31}, なら: {'token_id': '33', 'token': なら, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': なけれ, 'head.id': 31}, ない: {'token_id': '34', 'token': ない, 'lemma': 'ない', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'fixed', 'head': なけれ, 'head.id': 31}, 。: {'token_id': '35', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 提出, 'head.id': 29}}, '10': {'sent_id': '10', 'sent': 'PHONE年5月5日:', PHONE: {'token_id': '0', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 日, 'head.id': 5}, 年: {'token_id': '1', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 5: {'token_id': '2', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 日, 'head.id': 5}, 月: {'token_id': '3', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 5: {'token_id': '4', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 日, 'head.id': 5}, 日: {'token_id': '5', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '助数詞', 'dep': 'ROOT', 'head': 日, 'head.id': 5}, :: {'token_id': '6', 'token': :, 'lemma': ':', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'dep', 'head': 日, 'head.id': 5}}, '11': {'sent_id': '11', 'sent': '商用治験薬申請(IND)およびマスター・ファイルはeCTD形式で提出しなければならない。', 商用: {'token_id': '0', 'token': 商用, 'lemma': '商用', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 治験薬, 'head.id': 1}, 治験薬: {'token_id': '1', 'token': 治験薬, 'lemma': '治験薬', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'acl', 'head': 申請, 'head.id': 2}, 申請: {'token_id': '2', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': ファイル, 'head.id': 9}, (: {'token_id': '3', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 申請, 'head.id': 2}, IND: {'token_id': '4', 'token': IND, 'lemma': 'IND', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 申請, 'head.id': 2}, ): {'token_id': '5', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 申請, 'head.id': 2}, および: {'token_id': '6', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': ファイル, 'head.id': 9}, マスター: {'token_id': '7', 'token': マスター, 'lemma': 'マスター', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': ファイル, 'head.id': 9}, ・: {'token_id': '8', 'token': ・, 'lemma': '・', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': ファイル, 'head.id': 9}, ファイル: {'token_id': '9', 'token': ファイル, 'lemma': 'ファイル', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nsubj', 'head': 提出, 'head.id': 14}, は: {'token_id': '10', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': ファイル, 'head.id': 9}, eCTD: {'token_id': '11', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 形式, 'head.id': 12}, 形式: {'token_id': '12', 'token': 形式, 'lemma': '形式', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 提出, 'head.id': 14}, で: {'token_id': '13', 'token': で, 'lemma': 'で', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 形式, 'head.id': 12}, 提出: {'token_id': '14', 'token': 提出, 'lemma': '提出', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 提出, 'head.id': 14}, し: {'token_id': '15', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 提出, 'head.id': 14}, なけれ: {'token_id': '16', 'token': なけれ, 'lemma': 'ない', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 提出, 'head.id': 14}, ば: {'token_id': '17', 'token': ば, 'lemma': 'ば', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': なけれ, 'head.id': 16}, なら: {'token_id': '18', 'token': なら, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': なけれ, 'head.id': 16}, ない: {'token_id': '19', 'token': ない, 'lemma': 'ない', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'fixed', 'head': なけれ, 'head.id': 16}, 。: {'token_id': '20', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 提出, 'head.id': 14}}, '12': {'sent_id': '12', 'sent': 'eCTD要件を満たすための詳細については、eCTDガイダンスを参照のこと。', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 要件, 'head.id': 1}, 要件: {'token_id': '1', 'token': 要件, 'lemma': '要件', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': ため, 'head.id': 4}, を: {'token_id': '2', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 要件, 'head.id': 1}, 満たす: {'token_id': '3', 'token': 満たす, 'lemma': '満たす', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': ため, 'head.id': 4}, ため: {'token_id': '4', 'token': ため, 'lemma': 'ため', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nmod', 'head': 詳細, 'head.id': 6}, の: {'token_id': '5', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'fixed', 'head': ため, 'head.id': 4}, 詳細: {'token_id': '6', 'token': 詳細, 'lemma': '詳細', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '形状詞可能', 'dep': 'obl', 'head': こと, 'head.id': 17}, に: {'token_id': '7', 'token': に, 'lemma': 'だ', 'pos': 'ADP', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'case', 'head': 詳細, 'head.id': 6}, つい: {'token_id': '8', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 7}, て: {'token_id': '9', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 7}, は: {'token_id': '10', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 詳細, 'head.id': 6}, 、: {'token_id': '11', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 詳細, 'head.id': 6}, eCTD: {'token_id': '12', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ガイダンス, 'head.id': 13}, ガイダンス: {'token_id': '13', 'token': ガイダンス, 'lemma': 'ガイダンス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 参照, 'head.id': 15}, を: {'token_id': '14', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ガイダンス, 'head.id': 13}, 参照: {'token_id': '15', 'token': 参照, 'lemma': '参照', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': こと, 'head.id': 17}, の: {'token_id': '16', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 参照, 'head.id': 15}, こと: {'token_id': '17', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': こと, 'head.id': 17}, 。: {'token_id': '18', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': こと, 'head.id': 17}}, '13': {'sent_id': '13', 'sent': 'eCTDを使用したアプリケーションの提出方法とESGアカウントの取得方法については、eCTDを使用した提出ページを参照してください。', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 使用, 'head.id': 2}, を: {'token_id': '1', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': eCTD, 'head.id': 0}, 使用: {'token_id': '2', 'token': 使用, 'lemma': '使用', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': アプリケーション, 'head.id': 5}, し: {'token_id': '3', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 2}, た: {'token_id': '4', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 2}, アプリケーション: {'token_id': '5', 'token': アプリケーション, 'lemma': 'アプリケーション', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出方法, 'head.id': 7}, の: {'token_id': '6', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': アプリケーション, 'head.id': 5}, 提出方法: {'token_id': '7', 'token': 提出方法, 'lemma': '提出方法', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 取得方法, 'head.id': 12}, と: {'token_id': '8', 'token': と, 'lemma': 'と', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 提出方法, 'head.id': 7}, ESG: {'token_id': '9', 'token': ESG, 'lemma': 'esg', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': アカウント, 'head.id': 10}, アカウント: {'token_id': '10', 'token': アカウント, 'lemma': 'アカウント', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 取得方法, 'head.id': 12}, の: {'token_id': '11', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': アカウント, 'head.id': 10}, 取得方法: {'token_id': '12', 'token': 取得方法, 'lemma': '取得方法', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 参照, 'head.id': 26}, に: {'token_id': '13', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 取得方法, 'head.id': 12}, つい: {'token_id': '14', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 13}, て: {'token_id': '15', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 13}, は: {'token_id': '16', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 取得方法, 'head.id': 12}, 、: {'token_id': '17', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 取得方法, 'head.id': 12}, eCTD: {'token_id': '18', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 使用, 'head.id': 20}, を: {'token_id': '19', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': eCTD, 'head.id': 18}, 使用: {'token_id': '20', 'token': 使用, 'lemma': '使用', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': ページ, 'head.id': 24}, し: {'token_id': '21', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 20}, た: {'token_id': '22', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 20}, 提出: {'token_id': '23', 'token': 提出, 'lemma': '提出', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': ページ, 'head.id': 24}, ページ: {'token_id': '24', 'token': ページ, 'lemma': 'ページ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'obj', 'head': 参照, 'head.id': 26}, を: {'token_id': '25', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ページ, 'head.id': 24}, 参照: {'token_id': '26', 'token': 参照, 'lemma': '参照', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 参照, 'head.id': 26}, し: {'token_id': '27', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 参照, 'head.id': 26}, て: {'token_id': '28', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 参照, 'head.id': 26}, ください: {'token_id': '29', 'token': ください, 'lemma': 'くださる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 28}, 。: {'token_id': '30', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 参照, 'head.id': 26}}, '14': {'sent_id': '14', 'sent': 'すべてのeCTD申請資料を表示するには、eCTD資料ページにアクセスしてください。', すべて: {'token_id': '0', 'token': すべて, 'lemma': 'すべて', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nmod', 'head': 資料, 'head.id': 4}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': すべて, 'head.id': 0}, eCTD: {'token_id': '2', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 資料, 'head.id': 4}, 申請: {'token_id': '3', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 資料, 'head.id': 4}, 資料: {'token_id': '4', 'token': 資料, 'lemma': '資料', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 表示, 'head.id': 6}, を: {'token_id': '5', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 資料, 'head.id': 4}, 表示: {'token_id': '6', 'token': 表示, 'lemma': '表示', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'advcl', 'head': アクセス, 'head.id': 15}, する: {'token_id': '7', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 表示, 'head.id': 6}, に: {'token_id': '8', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 表示, 'head.id': 6}, は: {'token_id': '9', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 表示, 'head.id': 6}, 、: {'token_id': '10', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 表示, 'head.id': 6}, eCTD: {'token_id': '11', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ページ, 'head.id': 13}, 資料: {'token_id': '12', 'token': 資料, 'lemma': '資料', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ページ, 'head.id': 13}, ページ: {'token_id': '13', 'token': ページ, 'lemma': 'ページ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'obl', 'head': アクセス, 'head.id': 15}, に: {'token_id': '14', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ページ, 'head.id': 13}, アクセス: {'token_id': '15', 'token': アクセス, 'lemma': 'アクセス', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': アクセス, 'head.id': 15}, し: {'token_id': '16', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': アクセス, 'head.id': 15}, て: {'token_id': '17', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': アクセス, 'head.id': 15}, ください: {'token_id': '18', 'token': ください, 'lemma': 'くださる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 17}, 。: {'token_id': '19', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': アクセス, 'head.id': 15}}, '15': {'sent_id': '15', 'sent': 'eCTD要件の対象となる申請の種類', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 要件, 'head.id': 1}, 要件: {'token_id': '1', 'token': 要件, 'lemma': '要件', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 対象, 'head.id': 3}, の: {'token_id': '2', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 要件, 'head.id': 1}, 対象: {'token_id': '3', 'token': 対象, 'lemma': '対象', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': なる, 'head.id': 5}, と: {'token_id': '4', 'token': と, 'lemma': 'と', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 対象, 'head.id': 3}, なる: {'token_id': '5', 'token': なる, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'acl', 'head': 申請, 'head.id': 6}, 申請: {'token_id': '6', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 種類, 'head.id': 8}, の: {'token_id': '7', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 申請, 'head.id': 6}, 種類: {'token_id': '8', 'token': 種類, 'lemma': '種類', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': 種類, 'head.id': 8}}, '16': {'sent_id': '16', 'sent': '電子提出要件は、以下の種類のCDER/CBERへの提出に適用する:', 電子提出: {'token_id': '0', 'token': 電子提出, 'lemma': '電子提出', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 要件, 'head.id': 1}, 要件: {'token_id': '1', 'token': 要件, 'lemma': '要件', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 適用, 'head.id': 15}, は: {'token_id': '2', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 要件, 'head.id': 1}, 、: {'token_id': '3', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 要件, 'head.id': 1}, 以下: {'token_id': '4', 'token': 以下, 'lemma': '以下', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 種類, 'head.id': 6}, の: {'token_id': '5', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 以下, 'head.id': 4}, 種類: {'token_id': '6', 'token': 種類, 'lemma': '種類', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出, 'head.id': 13}, の: {'token_id': '7', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 種類, 'head.id': 6}, CDER: {'token_id': '8', 'token': CDER, 'lemma': 'cder', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': CBER, 'head.id': 10}, /: {'token_id': '9', 'token': /, 'lemma': '/', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': CBER, 'head.id': 10}, CBER: {'token_id': '10', 'token': CBER, 'lemma': 'cber', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出, 'head.id': 13}, へ: {'token_id': '11', 'token': へ, 'lemma': 'へ', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': CBER, 'head.id': 10}, の: {'token_id': '12', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': CBER, 'head.id': 10}, 提出: {'token_id': '13', 'token': 提出, 'lemma': '提出', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': 適用, 'head.id': 15}, に: {'token_id': '14', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 提出, 'head.id': 13}, 適用: {'token_id': '15', 'token': 適用, 'lemma': '適用', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 適用, 'head.id': 15}, する: {'token_id': '16', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 適用, 'head.id': 15}, :: {'token_id': '17', 'token': :, 'lemma': ':', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'dep', 'head': 適用, 'head.id': 15}}, '17': {'sent_id': '17', 'sent': 'NDA', NDA: {'token_id': '0', 'token': NDA, 'lemma': 'nda', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': NDA, 'head.id': 0}}, '18': {'sent_id': '18', 'sent': 'ANDA社', ANDA: {'token_id': '0', 'token': ANDA, 'lemma': 'anda', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 社, 'head.id': 1}, 社: {'token_id': '1', 'token': 社, 'lemma': '社', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'ROOT', 'head': 社, 'head.id': 1}}, '19': {'sent_id': '19', 'sent': 'ブラス', ブラス: {'token_id': '0', 'token': ブラス, 'lemma': 'ブラス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': ブラス, 'head.id': 0}}, '20': {'sent_id': '20', 'sent': '市販のIND申請(市販されることを意図した製品)', 市販: {'token_id': '0', 'token': 市販, 'lemma': '市販', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 申請, 'head.id': 3}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 市販, 'head.id': 0}, IND: {'token_id': '2', 'token': IND, 'lemma': 'IND', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 申請, 'head.id': 3}, 申請: {'token_id': '3', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 申請, 'head.id': 3}, (: {'token_id': '4', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 申請, 'head.id': 3}, 市販: {'token_id': '5', 'token': 市販, 'lemma': '市販', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 申請, 'head.id': 3}, さ: {'token_id': '6', 'token': さ, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 申請, 'head.id': 3}, れる: {'token_id': '7', 'token': れる, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 申請, 'head.id': 3}, こと: {'token_id': '8', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 申請, 'head.id': 3}, を: {'token_id': '9', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 申請, 'head.id': 3}, 意図: {'token_id': '10', 'token': 意図, 'lemma': '意図', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 申請, 'head.id': 3}, し: {'token_id': '11', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 申請, 'head.id': 3}, た: {'token_id': '12', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 申請, 'head.id': 3}, 製品: {'token_id': '13', 'token': 製品, 'lemma': '製品', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 申請, 'head.id': 3}, ): {'token_id': '14', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 申請, 'head.id': 3}}, '21': {'sent_id': '21', 'sent': '最初の提出物が要件の施行前に提出された場合であっても,補正,補足及び報告を含めて,これらの種類の出願', 最初: {'token_id': '0', 'token': 最初, 'lemma': '最初', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nmod', 'head': 提出物, 'head.id': 2}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 最初, 'head.id': 0}, 提出物: {'token_id': '2', 'token': 提出物, 'lemma': '提出物', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 場合, 'head.id': 12}, が: {'token_id': '3', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 提出物, 'head.id': 2}, 要件: {'token_id': '4', 'token': 要件, 'lemma': '要件', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 施行前, 'head.id': 6}, の: {'token_id': '5', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 要件, 'head.id': 4}, 施行前: {'token_id': '6', 'token': 施行前, 'lemma': '施行前', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 提出, 'head.id': 8}, に: {'token_id': '7', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 施行前, 'head.id': 6}, 提出: {'token_id': '8', 'token': 提出, 'lemma': '提出', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': 場合, 'head.id': 12}, さ: {'token_id': '9', 'token': さ, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 提出, 'head.id': 8}, れ: {'token_id': '10', 'token': れ, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 提出, 'head.id': 8}, た: {'token_id': '11', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 提出, 'head.id': 8}, 場合: {'token_id': '12', 'token': 場合, 'lemma': '場合', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'advcl', 'head': 出願, 'head.id': 32}, で: {'token_id': '13', 'token': で, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cop', 'head': 場合, 'head.id': 12}, あっ: {'token_id': '14', 'token': あっ, 'lemma': 'ある', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': で, 'head.id': 13}, て: {'token_id': '15', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 場合, 'head.id': 12}, も: {'token_id': '16', 'token': も, 'lemma': 'も', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 場合, 'head.id': 12}, ,: {'token_id': '17', 'token': ,, 'lemma': ',', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 場合, 'head.id': 12}, 補正: {'token_id': '18', 'token': 補正, 'lemma': '補正', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 補足, 'head.id': 20}, ,: {'token_id': '19', 'token': ,, 'lemma': ',', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 補正, 'head.id': 18}, 補足: {'token_id': '20', 'token': 補足, 'lemma': '補足', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 報告, 'head.id': 22}, 及び: {'token_id': '21', 'token': 及び, 'lemma': '及び', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 報告, 'head.id': 22}, 報告: {'token_id': '22', 'token': 報告, 'lemma': '報告', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obj', 'head': 含め, 'head.id': 24}, を: {'token_id': '23', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 報告, 'head.id': 22}, 含め: {'token_id': '24', 'token': 含め, 'lemma': '含める', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': 出願, 'head.id': 32}, て: {'token_id': '25', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 含め, 'head.id': 24}, ,: {'token_id': '26', 'token': ,, 'lemma': ',', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 含め, 'head.id': 24}, これ: {'token_id': '27', 'token': これ, 'lemma': 'これ', 'pos': 'PRON', 'pos1': '代名詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'nmod', 'head': ら, 'head.id': 28}, ら: {'token_id': '28', 'token': ら, 'lemma': 'ら', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '一般', 'dep': 'nmod', 'head': 種類, 'head.id': 30}, の: {'token_id': '29', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ら, 'head.id': 28}, 種類: {'token_id': '30', 'token': 種類, 'lemma': '種類', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 出願, 'head.id': 32}, の: {'token_id': '31', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 種類, 'head.id': 30}, 出願: {'token_id': '32', 'token': 出願, 'lemma': '出願', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 出願, 'head.id': 32}}, '22': {'sent_id': '22', 'sent': 'その後の全ての提出物', その後: {'token_id': '0', 'token': その後, 'lemma': 'その後', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nmod', 'head': 提出物, 'head.id': 4}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': その後, 'head.id': 0}, 全て: {'token_id': '2', 'token': 全て, 'lemma': '全て', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nmod', 'head': 提出物, 'head.id': 4}, の: {'token_id': '3', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 全て, 'head.id': 2}, 提出物: {'token_id': '4', 'token': 提出物, 'lemma': '提出物', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': 提出物, 'head.id': 4}}, '23': {'sent_id': '23', 'sent': 'DM Fなど、IND、NDA、ANDAとみなされるDMFなどのマスター・ファイル', DM: {'token_id': '0', 'token': DM, 'lemma': 'DM', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': F, 'head.id': 1}, F: {'token_id': '1', 'token': F, 'lemma': 'f', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': NDA, 'head.id': 6}, など: {'token_id': '2', 'token': など, 'lemma': 'など', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '副助詞', 'pos3': 'N', 'dep': 'case', 'head': F, 'head.id': 1}, 、: {'token_id': '3', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': F, 'head.id': 1}, IND: {'token_id': '4', 'token': IND, 'lemma': 'IND', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': NDA, 'head.id': 6}, 、: {'token_id': '5', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': IND, 'head.id': 4}, NDA: {'token_id': '6', 'token': NDA, 'lemma': 'nda', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': ANDA, 'head.id': 8}, 、: {'token_id': '7', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': NDA, 'head.id': 6}, ANDA: {'token_id': '8', 'token': ANDA, 'lemma': 'anda', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': みなさ, 'head.id': 10}, と: {'token_id': '9', 'token': と, 'lemma': 'と', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ANDA, 'head.id': 8}, みなさ: {'token_id': '10', 'token': みなさ, 'lemma': 'みなす', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': DMF, 'head.id': 12}, れる: {'token_id': '11', 'token': れる, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': みなさ, 'head.id': 10}, DMF: {'token_id': '12', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': ファイル, 'head.id': 17}, など: {'token_id': '13', 'token': など, 'lemma': 'など', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '副助詞', 'pos3': 'N', 'dep': 'case', 'head': DMF, 'head.id': 12}, の: {'token_id': '14', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': DMF, 'head.id': 12}, マスター: {'token_id': '15', 'token': マスター, 'lemma': 'マスター', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': ファイル, 'head.id': 17}, ・: {'token_id': '16', 'token': ・, 'lemma': '・', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': ファイル, 'head.id': 17}, ファイル: {'token_id': '17', 'token': ファイル, 'lemma': 'ファイル', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': ファイル, 'head.id': 17}}, '24': {'sent_id': '24', 'sent': '電子申請基準は任意であるが、以下のカテゴリーについては推奨される。', 電子申請: {'token_id': '0', 'token': 電子申請, 'lemma': '電子申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 基準, 'head.id': 1}, 基準: {'token_id': '1', 'token': 基準, 'lemma': '基準', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 任意, 'head.id': 3}, は: {'token_id': '2', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 基準, 'head.id': 1}, 任意: {'token_id': '3', 'token': 任意, 'lemma': '任意', 'pos': 'ADJ', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'advcl', 'head': 推奨, 'head.id': 15}, で: {'token_id': '4', 'token': で, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 任意, 'head.id': 3}, ある: {'token_id': '5', 'token': ある, 'lemma': 'ある', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': で, 'head.id': 4}, が: {'token_id': '6', 'token': が, 'lemma': 'が', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 任意, 'head.id': 3}, 、: {'token_id': '7', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 任意, 'head.id': 3}, 以下: {'token_id': '8', 'token': 以下, 'lemma': '以下', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': カテゴリー, 'head.id': 10}, の: {'token_id': '9', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 以下, 'head.id': 8}, カテゴリー: {'token_id': '10', 'token': カテゴリー, 'lemma': 'カテゴリー', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 推奨, 'head.id': 15}, に: {'token_id': '11', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': カテゴリー, 'head.id': 10}, つい: {'token_id': '12', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 11}, て: {'token_id': '13', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 11}, は: {'token_id': '14', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': カテゴリー, 'head.id': 10}, 推奨: {'token_id': '15', 'token': 推奨, 'lemma': '推奨', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 推奨, 'head.id': 15}, さ: {'token_id': '16', 'token': さ, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 推奨, 'head.id': 15}, れる: {'token_id': '17', 'token': れる, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 推奨, 'head.id': 15}, 。: {'token_id': '18', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 推奨, 'head.id': 15}}, '25': {'sent_id': '25', 'sent': '治験責任医師が治験を依頼するINDや拡大アクセスINDなどの非営利IND', 治験: {'token_id': '0', 'token': 治験, 'lemma': '治験', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 医師, 'head.id': 2}, 責任: {'token_id': '1', 'token': 責任, 'lemma': '責任', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 医師, 'head.id': 2}, 医師: {'token_id': '2', 'token': 医師, 'lemma': '医師', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 依頼, 'head.id': 6}, が: {'token_id': '3', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 医師, 'head.id': 2}, 治験: {'token_id': '4', 'token': 治験, 'lemma': '治験', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 依頼, 'head.id': 6}, を: {'token_id': '5', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 治験, 'head.id': 4}, 依頼: {'token_id': '6', 'token': 依頼, 'lemma': '依頼', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': IND, 'head.id': 8}, する: {'token_id': '7', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 依頼, 'head.id': 6}, IND: {'token_id': '8', 'token': IND, 'lemma': 'IND', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': IND, 'head.id': 12}, や: {'token_id': '9', 'token': や, 'lemma': 'や', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '副助詞', 'pos3': 'N', 'dep': 'case', 'head': IND, 'head.id': 8}, 拡大: {'token_id': '10', 'token': 拡大, 'lemma': '拡大', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': IND, 'head.id': 12}, アクセス: {'token_id': '11', 'token': アクセス, 'lemma': 'アクセス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': IND, 'head.id': 12}, IND: {'token_id': '12', 'token': IND, 'lemma': 'IND', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': IND, 'head.id': 16}, など: {'token_id': '13', 'token': など, 'lemma': 'など', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '副助詞', 'pos3': 'N', 'dep': 'case', 'head': IND, 'head.id': 12}, の: {'token_id': '14', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': IND, 'head.id': 12}, 非営利: {'token_id': '15', 'token': 非営利, 'lemma': '非営利', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': IND, 'head.id': 16}, IND: {'token_id': '16', 'token': IND, 'lemma': 'IND', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': IND, 'head.id': 16}}, '26': {'sent_id': '26', 'sent': '原血漿を含む血液及び血液成分の提出', 原: {'token_id': '0', 'token': 原, 'lemma': '原', 'pos': 'NOUN', 'pos1': '接頭辞', 'pos2': 'N', 'pos3': 'N', 'dep': 'compound', 'head': 血漿, 'head.id': 1}, 血漿: {'token_id': '1', 'token': 血漿, 'lemma': '血漿', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 含む, 'head.id': 3}, を: {'token_id': '2', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 血漿, 'head.id': 1}, 含む: {'token_id': '3', 'token': 含む, 'lemma': '含む', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': 血液, 'head.id': 4}, 血液: {'token_id': '4', 'token': 血液, 'lemma': '血液', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 成分, 'head.id': 7}, 及び: {'token_id': '5', 'token': 及び, 'lemma': '及び', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 成分, 'head.id': 7}, 血液: {'token_id': '6', 'token': 血液, 'lemma': '血液', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 成分, 'head.id': 7}, 成分: {'token_id': '7', 'token': 成分, 'lemma': '成分', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出, 'head.id': 9}, の: {'token_id': '8', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 成分, 'head.id': 7}, 提出: {'token_id': '9', 'token': 提出, 'lemma': '提出', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 提出, 'head.id': 9}}, '27': {'sent_id': '27', 'sent': '医療用医薬品の販売促進資料の提出', 医療用: {'token_id': '0', 'token': 医療用, 'lemma': '医療用', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 医薬品, 'head.id': 1}, 医薬品: {'token_id': '1', 'token': 医薬品, 'lemma': '医薬品', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 資料, 'head.id': 4}, の: {'token_id': '2', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 医薬品, 'head.id': 1}, 販売促進: {'token_id': '3', 'token': 販売促進, 'lemma': '販売促進', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 資料, 'head.id': 4}, 資料: {'token_id': '4', 'token': 資料, 'lemma': '資料', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出, 'head.id': 6}, の: {'token_id': '5', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 資料, 'head.id': 4}, 提出: {'token_id': '6', 'token': 提出, 'lemma': '提出', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 提出, 'head.id': 6}}, '28': {'sent_id': '28', 'sent': '現在のバージョンと更新', 現在: {'token_id': '0', 'token': 現在, 'lemma': '現在', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nmod', 'head': バージョン, 'head.id': 2}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 現在, 'head.id': 0}, バージョン: {'token_id': '2', 'token': バージョン, 'lemma': 'バージョン', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 更新, 'head.id': 4}, と: {'token_id': '3', 'token': と, 'lemma': 'と', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': バージョン, 'head.id': 2}, 更新: {'token_id': '4', 'token': 更新, 'lemma': '更新', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 更新, 'head.id': 4}}, '29': {'sent_id': '29', 'sent': '電子申請には、FDAが現在サポートしているバージョンのeCTDを使用する必要がある。', 電子申請: {'token_id': '0', 'token': 電子申請, 'lemma': '電子申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': ある, 'head.id': 19}, に: {'token_id': '1', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 電子申請, 'head.id': 0}, は: {'token_id': '2', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 電子申請, 'head.id': 0}, 、: {'token_id': '3', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 電子申請, 'head.id': 0}, FDA: {'token_id': '4', 'token': FDA, 'lemma': 'FDA', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': サポート, 'head.id': 7}, が: {'token_id': '5', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 4}, 現在: {'token_id': '6', 'token': 現在, 'lemma': '現在', 'pos': 'ADV', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'advmod', 'head': サポート, 'head.id': 7}, サポート: {'token_id': '7', 'token': サポート, 'lemma': 'サポート', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': バージョン, 'head.id': 11}, し: {'token_id': '8', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': サポート, 'head.id': 7}, て: {'token_id': '9', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': サポート, 'head.id': 7}, いる: {'token_id': '10', 'token': いる, 'lemma': 'いる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 9}, バージョン: {'token_id': '11', 'token': バージョン, 'lemma': 'バージョン', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': eCTD, 'head.id': 13}, の: {'token_id': '12', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': バージョン, 'head.id': 11}, eCTD: {'token_id': '13', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 使用, 'head.id': 15}, を: {'token_id': '14', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': eCTD, 'head.id': 13}, 使用: {'token_id': '15', 'token': 使用, 'lemma': '使用', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': 必要, 'head.id': 17}, する: {'token_id': '16', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 15}, 必要: {'token_id': '17', 'token': 必要, 'lemma': '必要', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '形状詞可能', 'dep': 'nsubj', 'head': ある, 'head.id': 19}, が: {'token_id': '18', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 必要, 'head.id': 17}, ある: {'token_id': '19', 'token': ある, 'lemma': 'ある', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'ROOT', 'head': ある, 'head.id': 19}, 。: {'token_id': '20', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': ある, 'head.id': 19}}, '30': {'sent_id': '30', 'sent': 'eCTDは、Study Data Standards Resources', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': Resources, 'head.id': 6}, は: {'token_id': '1', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': eCTD, 'head.id': 0}, 、: {'token_id': '2', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': eCTD, 'head.id': 0}, Study: {'token_id': '3', 'token': Study, 'lemma': 'Study', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': Resources, 'head.id': 6}, Data: {'token_id': '4', 'token': Data, 'lemma': 'DATA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Resources, 'head.id': 6}, Standards: {'token_id': '5', 'token': Standards, 'lemma': 'standards', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Resources, 'head.id': 6}, Resources: {'token_id': '6', 'token': Resources, 'lemma': 'resources', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': Resources, 'head.id': 6}}, '31': {'sent_id': '31', 'sent': 'ページのFDA Data Standards Catalogに指定されている。', ページ: {'token_id': '0', 'token': ページ, 'lemma': 'ページ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'nmod', 'head': Data, 'head.id': 3}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ページ, 'head.id': 0}, FDA: {'token_id': '2', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Data, 'head.id': 3}, Data: {'token_id': '3', 'token': Data, 'lemma': 'DATA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Standards, 'head.id': 4}, Standards: {'token_id': '4', 'token': Standards, 'lemma': 'standards', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Catalog, 'head.id': 5}, Catalog: {'token_id': '5', 'token': Catalog, 'lemma': 'catalog', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 指定, 'head.id': 7}, に: {'token_id': '6', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': Catalog, 'head.id': 5}, 指定: {'token_id': '7', 'token': 指定, 'lemma': '指定', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 指定, 'head.id': 7}, さ: {'token_id': '8', 'token': さ, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 指定, 'head.id': 7}, れ: {'token_id': '9', 'token': れ, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 指定, 'head.id': 7}, て: {'token_id': '10', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 指定, 'head.id': 7}, いる: {'token_id': '11', 'token': いる, 'lemma': 'いる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 10}, 。: {'token_id': '12', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 指定, 'head.id': 7}}, '32': {'sent_id': '32', 'sent': '規格の更新は、FDAのウェブサイトで発表され、官報に掲載される。', 規格: {'token_id': '0', 'token': 規格, 'lemma': '規格', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 更新, 'head.id': 2}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 規格, 'head.id': 0}, 更新: {'token_id': '2', 'token': 更新, 'lemma': '更新', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nsubj', 'head': 発表, 'head.id': 9}, は: {'token_id': '3', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 更新, 'head.id': 2}, 、: {'token_id': '4', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 更新, 'head.id': 2}, FDA: {'token_id': '5', 'token': FDA, 'lemma': 'FDA', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': ウェブサイト, 'head.id': 7}, の: {'token_id': '6', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 5}, ウェブサイト: {'token_id': '7', 'token': ウェブサイト, 'lemma': 'ウェブサイト', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 発表, 'head.id': 9}, で: {'token_id': '8', 'token': で, 'lemma': 'で', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ウェブサイト, 'head.id': 7}, 発表: {'token_id': '9', 'token': 発表, 'lemma': '発表', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'advcl', 'head': 掲載, 'head.id': 15}, さ: {'token_id': '10', 'token': さ, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 発表, 'head.id': 9}, れ: {'token_id': '11', 'token': れ, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 発表, 'head.id': 9}, 、: {'token_id': '12', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 発表, 'head.id': 9}, 官報: {'token_id': '13', 'token': 官報, 'lemma': '官報', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 掲載, 'head.id': 15}, に: {'token_id': '14', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 官報, 'head.id': 13}, 掲載: {'token_id': '15', 'token': 掲載, 'lemma': '掲載', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 掲載, 'head.id': 15}, さ: {'token_id': '16', 'token': さ, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 掲載, 'head.id': 15}, れる: {'token_id': '17', 'token': れる, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 掲載, 'head.id': 15}, 。: {'token_id': '18', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 掲載, 'head.id': 15}}, '33': {'sent_id': '33', 'sent': '通知には、新しいバージョンが有効になる日付が含まれる。', 通知: {'token_id': '0', 'token': 通知, 'lemma': '通知', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': 含ま, 'head.id': 12}, に: {'token_id': '1', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 通知, 'head.id': 0}, は: {'token_id': '2', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 通知, 'head.id': 0}, 、: {'token_id': '3', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 通知, 'head.id': 0}, 新しい: {'token_id': '4', 'token': 新しい, 'lemma': '新しい', 'pos': 'ADJ', 'pos1': '形容詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': バージョン, 'head.id': 5}, バージョン: {'token_id': '5', 'token': バージョン, 'lemma': 'バージョン', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': なる, 'head.id': 9}, が: {'token_id': '6', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': バージョン, 'head.id': 5}, 有効: {'token_id': '7', 'token': 有効, 'lemma': '有効', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'advcl', 'head': なる, 'head.id': 9}, に: {'token_id': '8', 'token': に, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 有効, 'head.id': 7}, なる: {'token_id': '9', 'token': なる, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'acl', 'head': 日付, 'head.id': 10}, 日付: {'token_id': '10', 'token': 日付, 'lemma': '日付', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 含ま, 'head.id': 12}, が: {'token_id': '11', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 日付, 'head.id': 10}, 含ま: {'token_id': '12', 'token': 含ま, 'lemma': '含む', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'ROOT', 'head': 含ま, 'head.id': 12}, れる: {'token_id': '13', 'token': れる, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 含ま, 'head.id': 12}, 。: {'token_id': '14', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 含ま, 'head.id': 12}}, '34': {'sent_id': '34', 'sent': 'eCTDに関連する仕様書、サポートファイル、M1バージョン1.3および2.3文書の一覧については、eCTD申請基準(XLS - 57 KB)またはeCTD申請基準(PDF - 91 KB)を参照のこと。', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 関連, 'head.id': 2}, に: {'token_id': '1', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': eCTD, 'head.id': 0}, 関連: {'token_id': '2', 'token': 関連, 'lemma': '関連', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': 仕様書, 'head.id': 4}, する: {'token_id': '3', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 関連, 'head.id': 2}, 仕様書: {'token_id': '4', 'token': 仕様書, 'lemma': '仕様書', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': ファイル, 'head.id': 7}, 、: {'token_id': '5', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 仕様書, 'head.id': 4}, サポート: {'token_id': '6', 'token': サポート, 'lemma': 'サポート', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': ファイル, 'head.id': 7}, ファイル: {'token_id': '7', 'token': ファイル, 'lemma': 'ファイル', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 1.3, 'head.id': 12}, 、: {'token_id': '8', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': ファイル, 'head.id': 7}, M: {'token_id': '9', 'token': M, 'lemma': 'm', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 1.3, 'head.id': 12}, 1: {'token_id': '10', 'token': 1, 'lemma': '1', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 1.3, 'head.id': 12}, バージョン: {'token_id': '11', 'token': バージョン, 'lemma': 'バージョン', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 1.3, 'head.id': 12}, 1.3: {'token_id': '12', 'token': 1.3, 'lemma': '1.3', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 文書, 'head.id': 15}, および: {'token_id': '13', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 文書, 'head.id': 15}, 2.3: {'token_id': '14', 'token': 2.3, 'lemma': '2.3', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 文書, 'head.id': 15}, 文書: {'token_id': '15', 'token': 文書, 'lemma': '文書', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 一覧, 'head.id': 17}, の: {'token_id': '16', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 文書, 'head.id': 15}, 一覧: {'token_id': '17', 'token': 一覧, 'lemma': '一覧', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': こと, 'head.id': 46}, に: {'token_id': '18', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 一覧, 'head.id': 17}, つい: {'token_id': '19', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 18}, て: {'token_id': '20', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 18}, は: {'token_id': '21', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 一覧, 'head.id': 17}, 、: {'token_id': '22', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 一覧, 'head.id': 17}, eCTD: {'token_id': '23', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 基準, 'head.id': 25}, 申請: {'token_id': '24', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 基準, 'head.id': 25}, 基準: {'token_id': '25', 'token': 基準, 'lemma': '基準', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': こと, 'head.id': 46}, (: {'token_id': '26', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 基準, 'head.id': 25}, XLS: {'token_id': '27', 'token': XLS, 'lemma': 'xls', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 基準, 'head.id': 25}, -: {'token_id': '28', 'token': -, 'lemma': '-', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'dep', 'head': 基準, 'head.id': 25}, 57: {'token_id': '29', 'token': 57, 'lemma': '57', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 基準, 'head.id': 25}, KB: {'token_id': '30', 'token': KB, 'lemma': 'Kb', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'nmod', 'head': 基準, 'head.id': 25}, ): {'token_id': '31', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 基準, 'head.id': 25}, また: {'token_id': '32', 'token': また, 'lemma': 'また', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': こと, 'head.id': 46}, は: {'token_id': '33', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'fixed', 'head': また, 'head.id': 32}, eCTD: {'token_id': '34', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 基準, 'head.id': 36}, 申請: {'token_id': '35', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 基準, 'head.id': 36}, 基準: {'token_id': '36', 'token': 基準, 'lemma': '基準', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 参照, 'head.id': 44}, (: {'token_id': '37', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 基準, 'head.id': 36}, PDF: {'token_id': '38', 'token': PDF, 'lemma': 'PDF', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 基準, 'head.id': 36}, -: {'token_id': '39', 'token': -, 'lemma': '-', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': 基準, 'head.id': 36}, 91: {'token_id': '40', 'token': 91, 'lemma': '91', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 基準, 'head.id': 36}, KB: {'token_id': '41', 'token': KB, 'lemma': 'Kb', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 基準, 'head.id': 36}, ): {'token_id': '42', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 基準, 'head.id': 36}, を: {'token_id': '43', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 基準, 'head.id': 36}, 参照: {'token_id': '44', 'token': 参照, 'lemma': '参照', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': こと, 'head.id': 46}, の: {'token_id': '45', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 参照, 'head.id': 44}, こと: {'token_id': '46', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': こと, 'head.id': 46}, 。: {'token_id': '47', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': こと, 'head.id': 46}}, '35': {'sent_id': '35', 'sent': '注意事項', 注意事項: {'token_id': '0', 'token': 注意事項, 'lemma': '注意事項', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': 注意事項, 'head.id': 0}}, '36': {'sent_id': '36', 'sent': '通知', 通知: {'token_id': '0', 'token': 通知, 'lemma': '通知', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 通知, 'head.id': 0}}, '37': {'sent_id': '37', 'sent': 'PHONE年1月30日', PHONE: {'token_id': '0', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 日, 'head.id': 5}, 年: {'token_id': '1', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 1: {'token_id': '2', 'token': 1, 'lemma': '1', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 日, 'head.id': 5}, 月: {'token_id': '3', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 30: {'token_id': '4', 'token': 30, 'lemma': '30', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 日, 'head.id': 5}, 日: {'token_id': '5', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'ROOT', 'head': 日, 'head.id': 5}}, '38': {'sent_id': '38', 'sent': 'FDA、DMFタイプIIIのeCTD提出期限を延長', FDA: {'token_id': '0', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': III, 'head.id': 4}, 、: {'token_id': '1', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': FDA, 'head.id': 0}, DMF: {'token_id': '2', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': III, 'head.id': 4}, タイプ: {'token_id': '3', 'token': タイプ, 'lemma': 'タイプ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': III, 'head.id': 4}, III: {'token_id': '4', 'token': III, 'lemma': 'iii', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出期限, 'head.id': 7}, の: {'token_id': '5', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': III, 'head.id': 4}, eCTD: {'token_id': '6', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 提出期限, 'head.id': 7}, 提出期限: {'token_id': '7', 'token': 提出期限, 'lemma': '提出期限', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 延長, 'head.id': 9}, を: {'token_id': '8', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 提出期限, 'head.id': 7}, 延長: {'token_id': '9', 'token': 延長, 'lemma': '延長', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 延長, 'head.id': 9}}, '39': {'sent_id': '39', 'sent': 'FDAは、DMF Type lllのeCTD形式による提出期限をPHONE年5月5日に延長した。', FDA: {'token_id': '0', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 延長, 'head.id': 20}, は: {'token_id': '1', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 0}, 、: {'token_id': '2', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': FDA, 'head.id': 0}, DMF: {'token_id': '3', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': Type, 'head.id': 4}, Type: {'token_id': '4', 'token': Type, 'lemma': 'Type', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 形式, 'head.id': 8}, lll: {'token_id': '5', 'token': lll, 'lemma': 'lll', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'case', 'head': Type, 'head.id': 4}, の: {'token_id': '6', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': Type, 'head.id': 4}, eCTD: {'token_id': '7', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 形式, 'head.id': 8}, 形式: {'token_id': '8', 'token': 形式, 'lemma': '形式', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出期限, 'head.id': 11}, に: {'token_id': '9', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 形式, 'head.id': 8}, よる: {'token_id': '10', 'token': よる, 'lemma': 'よる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 9}, 提出期限: {'token_id': '11', 'token': 提出期限, 'lemma': '提出期限', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': PHONE, 'head.id': 13}, を: {'token_id': '12', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 提出期限, 'head.id': 11}, PHONE: {'token_id': '13', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 日, 'head.id': 18}, 年: {'token_id': '14', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 18}, 5: {'token_id': '15', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 日, 'head.id': 18}, 月: {'token_id': '16', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 18}, 5: {'token_id': '17', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 日, 'head.id': 18}, 日: {'token_id': '18', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '助数詞', 'dep': 'obl', 'head': 延長, 'head.id': 20}, に: {'token_id': '19', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 日, 'head.id': 18}, 延長: {'token_id': '20', 'token': 延長, 'lemma': '延長', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 延長, 'head.id': 20}, し: {'token_id': '21', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 延長, 'head.id': 20}, た: {'token_id': '22', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 延長, 'head.id': 20}, 。: {'token_id': '23', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 延長, 'head.id': 20}}, '40': {'sent_id': '40', 'sent': 'DMFに関する追加情報についてはFDAガイダンス文書を、DMFに関する追加情報についてはFDAのDrug Master Fileページを参照のこと。', DMF: {'token_id': '0', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 情報, 'head.id': 4}, に: {'token_id': '1', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': DMF, 'head.id': 0}, 関する: {'token_id': '2', 'token': 関する, 'lemma': '関する', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 1}, 追加: {'token_id': '3', 'token': 追加, 'lemma': '追加', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 情報, 'head.id': 4}, 情報: {'token_id': '4', 'token': 情報, 'lemma': '情報', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': こと, 'head.id': 31}, に: {'token_id': '5', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 情報, 'head.id': 4}, つい: {'token_id': '6', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 5}, て: {'token_id': '7', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 5}, は: {'token_id': '8', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 情報, 'head.id': 4}, FDA: {'token_id': '9', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'compound', 'head': 文書, 'head.id': 11}, ガイダンス: {'token_id': '10', 'token': ガイダンス, 'lemma': 'ガイダンス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 文書, 'head.id': 11}, 文書: {'token_id': '11', 'token': 文書, 'lemma': '文書', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': Drug, 'head.id': 25}, を: {'token_id': '12', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 文書, 'head.id': 11}, 、: {'token_id': '13', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 文書, 'head.id': 11}, DMF: {'token_id': '14', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 情報, 'head.id': 18}, に: {'token_id': '15', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': DMF, 'head.id': 14}, 関する: {'token_id': '16', 'token': 関する, 'lemma': '関する', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 15}, 追加: {'token_id': '17', 'token': 追加, 'lemma': '追加', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 情報, 'head.id': 18}, 情報: {'token_id': '18', 'token': 情報, 'lemma': '情報', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': Drug, 'head.id': 25}, に: {'token_id': '19', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 情報, 'head.id': 18}, つい: {'token_id': '20', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 19}, て: {'token_id': '21', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 19}, は: {'token_id': '22', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 情報, 'head.id': 18}, FDA: {'token_id': '23', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Drug, 'head.id': 25}, の: {'token_id': '24', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 23}, Drug: {'token_id': '25', 'token': Drug, 'lemma': 'drug', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'punct', 'head': 情報, 'head.id': 4}, Master File: {'token_id': '26', 'token': Master File, 'lemma': 'master file', 'pos': 'SYM', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'dep', 'head': Drug, 'head.id': 25}, ページ: {'token_id': '27', 'token': ページ, 'lemma': 'ページ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'obj', 'head': 参照, 'head.id': 29}, を: {'token_id': '28', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ページ, 'head.id': 27}, 参照: {'token_id': '29', 'token': 参照, 'lemma': '参照', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': こと, 'head.id': 31}, の: {'token_id': '30', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 参照, 'head.id': 29}, こと: {'token_id': '31', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': こと, 'head.id': 31}, 。: {'token_id': '32', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': こと, 'head.id': 31}}, '41': {'sent_id': '41', 'sent': '通知', 通知: {'token_id': '0', 'token': 通知, 'lemma': '通知', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 通知, 'head.id': 0}}, '42': {'sent_id': '42', 'sent': 'PHONE年11月30日', PHONE: {'token_id': '0', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 日, 'head.id': 5}, 年: {'token_id': '1', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 11: {'token_id': '2', 'token': 11, 'lemma': '11', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 日, 'head.id': 5}, 月: {'token_id': '3', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 30: {'token_id': '4', 'token': 30, 'lemma': '30', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 日, 'head.id': 5}, 日: {'token_id': '5', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'ROOT', 'head': 日, 'head.id': 5}}, '43': {'sent_id': '43', 'sent': 'FDAは、submission-type.xmlおよびM1Specifications(eCTD申請基準に含まれている)を参照のこと。', FDA: {'token_id': '0', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': こと, 'head.id': 25}, は: {'token_id': '1', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 0}, 、: {'token_id': '2', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': FDA, 'head.id': 0}, submission: {'token_id': '3', 'token': submission, 'lemma': 'submission', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': xml, 'head.id': 7}, -: {'token_id': '4', 'token': -, 'lemma': '-', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'dep', 'head': submission, 'head.id': 3}, type: {'token_id': '5', 'token': type, 'lemma': 'Type', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': xml, 'head.id': 7}, .: {'token_id': '6', 'token': ., 'lemma': '.', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'compound', 'head': xml, 'head.id': 7}, xml: {'token_id': '7', 'token': xml, 'lemma': 'XML', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Specifications, 'head.id': 11}, および: {'token_id': '8', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': Specifications, 'head.id': 11}, M: {'token_id': '9', 'token': M, 'lemma': 'm', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': Specifications, 'head.id': 11}, 1: {'token_id': '10', 'token': 1, 'lemma': '1', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': Specifications, 'head.id': 11}, Specifications: {'token_id': '11', 'token': Specifications, 'lemma': 'specifications', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 含ま, 'head.id': 17}, (: {'token_id': '12', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': Specifications, 'head.id': 11}, eCTD: {'token_id': '13', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': Specifications, 'head.id': 11}, 申請: {'token_id': '14', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': Specifications, 'head.id': 11}, 基準: {'token_id': '15', 'token': 基準, 'lemma': '基準', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': Specifications, 'head.id': 11}, に: {'token_id': '16', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': Specifications, 'head.id': 11}, 含ま: {'token_id': '17', 'token': 含ま, 'lemma': '含む', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'obj', 'head': 参照, 'head.id': 23}, れ: {'token_id': '18', 'token': れ, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 含ま, 'head.id': 17}, て: {'token_id': '19', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 含ま, 'head.id': 17}, いる: {'token_id': '20', 'token': いる, 'lemma': 'いる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 19}, ): {'token_id': '21', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 含ま, 'head.id': 17}, を: {'token_id': '22', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 含ま, 'head.id': 17}, 参照: {'token_id': '23', 'token': 参照, 'lemma': '参照', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': こと, 'head.id': 25}, の: {'token_id': '24', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 参照, 'head.id': 23}, こと: {'token_id': '25', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': こと, 'head.id': 25}, 。: {'token_id': '26', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': こと, 'head.id': 25}}, '44': {'sent_id': '44', 'sent': 'PHONE年年6月1日', PHONE: {'token_id': '0', 'token': PHONE, 'lemma': 'phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '人名', 'dep': 'compound', 'head': 年年, 'head.id': 1}, 年年: {'token_id': '1', 'token': 年年, 'lemma': '年年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nmod', 'head': 1日, 'head.id': 4}, 6: {'token_id': '2', 'token': 6, 'lemma': '6', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 1日, 'head.id': 4}, 月: {'token_id': '3', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 1日, 'head.id': 4}, 1日: {'token_id': '4', 'token': 1日, 'lemma': '1日', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'ROOT', 'head': 1日, 'head.id': 4}}, '45': {'sent_id': '45', 'sent': 'FDAのeCTDアクセスデータウェブサイトは、PHONE年9月1日に製造段階の暗号およびSSLプロトコルを更新することお知らせします。', FDA: {'token_id': '0', 'token': FDA, 'lemma': 'FDA', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': ウェブサイト, 'head.id': 5}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 0}, eCTD: {'token_id': '2', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 5}, アクセス: {'token_id': '3', 'token': アクセス, 'lemma': 'アクセス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 5}, データ: {'token_id': '4', 'token': データ, 'lemma': 'データ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 5}, ウェブサイト: {'token_id': '5', 'token': ウェブサイト, 'lemma': 'ウェブサイト', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': お知らせ, 'head.id': 25}, は: {'token_id': '6', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': ウェブサイト, 'head.id': 5}, 、: {'token_id': '7', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': ウェブサイト, 'head.id': 5}, PHONE: {'token_id': '8', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 1日, 'head.id': 12}, 年: {'token_id': '9', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 1日, 'head.id': 12}, 9: {'token_id': '10', 'token': 9, 'lemma': '9', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 1日, 'head.id': 12}, 月: {'token_id': '11', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 1日, 'head.id': 12}, 1日: {'token_id': '12', 'token': 1日, 'lemma': '1日', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'obl', 'head': 更新, 'head.id': 22}, に: {'token_id': '13', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 1日, 'head.id': 12}, 製造: {'token_id': '14', 'token': 製造, 'lemma': '製造', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 段階, 'head.id': 15}, 段階: {'token_id': '15', 'token': 段階, 'lemma': '段階', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 暗号, 'head.id': 17}, の: {'token_id': '16', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 段階, 'head.id': 15}, 暗号: {'token_id': '17', 'token': 暗号, 'lemma': '暗号', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': プロトコル, 'head.id': 20}, および: {'token_id': '18', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': プロトコル, 'head.id': 20}, SSL: {'token_id': '19', 'token': SSL, 'lemma': 'SSL', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': プロトコル, 'head.id': 20}, プロトコル: {'token_id': '20', 'token': プロトコル, 'lemma': 'プロトコル', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 更新, 'head.id': 22}, を: {'token_id': '21', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': プロトコル, 'head.id': 20}, 更新: {'token_id': '22', 'token': 更新, 'lemma': '更新', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': こと, 'head.id': 24}, する: {'token_id': '23', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 更新, 'head.id': 22}, こと: {'token_id': '24', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': お知らせ, 'head.id': 25}, お知らせ: {'token_id': '25', 'token': お知らせ, 'lemma': 'お知らせ', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': お知らせ, 'head.id': 25}, し: {'token_id': '26', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': お知らせ, 'head.id': 25}, ます: {'token_id': '27', 'token': ます, 'lemma': 'ます', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': お知らせ, 'head.id': 25}, 。: {'token_id': '28', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': お知らせ, 'head.id': 25}}, '46': {'sent_id': '46', 'sent': 'FDAのeCTDアクセスデータウェブサイトに接続するために使用しているシステムが、下記の互換性のある安全な暗号とSSLプロトコルで接続できることを確認してください。', FDA: {'token_id': '0', 'token': FDA, 'lemma': 'FDA', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': ウェブサイト, 'head.id': 5}, の: {'token_id': '1', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 0}, eCTD: {'token_id': '2', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 5}, アクセス: {'token_id': '3', 'token': アクセス, 'lemma': 'アクセス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 5}, データ: {'token_id': '4', 'token': データ, 'lemma': 'データ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 5}, ウェブサイト: {'token_id': '5', 'token': ウェブサイト, 'lemma': 'ウェブサイト', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 接続, 'head.id': 7}, に: {'token_id': '6', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ウェブサイト, 'head.id': 5}, 接続: {'token_id': '7', 'token': 接続, 'lemma': '接続', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'advcl', 'head': 使用, 'head.id': 11}, する: {'token_id': '8', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 接続, 'head.id': 7}, ため: {'token_id': '9', 'token': ため, 'lemma': 'ため', 'pos': 'SCONJ', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'mark', 'head': 接続, 'head.id': 7}, に: {'token_id': '10', 'token': に, 'lemma': 'に', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'fixed', 'head': ため, 'head.id': 9}, 使用: {'token_id': '11', 'token': 使用, 'lemma': '使用', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': システム, 'head.id': 15}, し: {'token_id': '12', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 11}, て: {'token_id': '13', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 使用, 'head.id': 11}, いる: {'token_id': '14', 'token': いる, 'lemma': 'いる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 13}, システム: {'token_id': '15', 'token': システム, 'lemma': 'システム', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 接続, 'head.id': 30}, が: {'token_id': '16', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': システム, 'head.id': 15}, 、: {'token_id': '17', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': システム, 'head.id': 15}, 下記: {'token_id': '18', 'token': 下記, 'lemma': '下記', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 暗号, 'head.id': 25}, の: {'token_id': '19', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 下記, 'head.id': 18}, 互換性: {'token_id': '20', 'token': 互換性, 'lemma': '互換性', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': ある, 'head.id': 22}, の: {'token_id': '21', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 互換性, 'head.id': 20}, ある: {'token_id': '22', 'token': ある, 'lemma': 'ある', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'acl', 'head': 暗号, 'head.id': 25}, 安全: {'token_id': '23', 'token': 安全, 'lemma': '安全', 'pos': 'ADJ', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '形状詞可能', 'dep': 'acl', 'head': 暗号, 'head.id': 25}, な: {'token_id': '24', 'token': な, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 安全, 'head.id': 23}, 暗号: {'token_id': '25', 'token': 暗号, 'lemma': '暗号', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': プロトコル, 'head.id': 28}, と: {'token_id': '26', 'token': と, 'lemma': 'と', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 暗号, 'head.id': 25}, SSL: {'token_id': '27', 'token': SSL, 'lemma': 'SSL', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'compound', 'head': プロトコル, 'head.id': 28}, プロトコル: {'token_id': '28', 'token': プロトコル, 'lemma': 'プロトコル', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 接続, 'head.id': 30}, で: {'token_id': '29', 'token': で, 'lemma': 'で', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': プロトコル, 'head.id': 28}, 接続: {'token_id': '30', 'token': 接続, 'lemma': '接続', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': こと, 'head.id': 32}, できる: {'token_id': '31', 'token': できる, 'lemma': 'できる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 接続, 'head.id': 30}, こと: {'token_id': '32', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 確認, 'head.id': 34}, を: {'token_id': '33', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': こと, 'head.id': 32}, 確認: {'token_id': '34', 'token': 確認, 'lemma': '確認', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 確認, 'head.id': 34}, し: {'token_id': '35', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 確認, 'head.id': 34}, て: {'token_id': '36', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 確認, 'head.id': 34}, ください: {'token_id': '37', 'token': ください, 'lemma': 'くださる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 36}, 。: {'token_id': '38', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 確認, 'head.id': 34}}, '47': {'sent_id': '47', 'sent': 'SSLプロトコル/暗号スイート', SSL: {'token_id': '0', 'token': SSL, 'lemma': 'SSL', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': スイート, 'head.id': 4}, プロトコル: {'token_id': '1', 'token': プロトコル, 'lemma': 'プロトコル', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': スイート, 'head.id': 4}, /: {'token_id': '2', 'token': /, 'lemma': '/', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': スイート, 'head.id': 4}, 暗号: {'token_id': '3', 'token': 暗号, 'lemma': '暗号', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': スイート, 'head.id': 4}, スイート: {'token_id': '4', 'token': スイート, 'lemma': 'スイート', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': スイート, 'head.id': 4}}, '48': {'sent_id': '48', 'sent': 'TLS1.1以降', TLS: {'token_id': '0', 'token': TLS, 'lemma': 'tls', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 以降, 'head.id': 2}, 1.1: {'token_id': '1', 'token': 1.1, 'lemma': '1.1', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 以降, 'head.id': 2}, 以降: {'token_id': '2', 'token': 以降, 'lemma': '以降', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'ROOT', 'head': 以降, 'head.id': 2}}, '49': {'sent_id': '49', 'sent': 'eCTDアクセスデータウェブサイトへのリンク例:', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 3}, アクセス: {'token_id': '1', 'token': アクセス, 'lemma': 'アクセス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 3}, データ: {'token_id': '2', 'token': データ, 'lemma': 'データ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 3}, ウェブサイト: {'token_id': '3', 'token': ウェブサイト, 'lemma': 'ウェブサイト', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 例, 'head.id': 7}, へ: {'token_id': '4', 'token': へ, 'lemma': 'へ', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ウェブサイト, 'head.id': 3}, の: {'token_id': '5', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ウェブサイト, 'head.id': 3}, リンク: {'token_id': '6', 'token': リンク, 'lemma': 'リンク', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 例, 'head.id': 7}, 例: {'token_id': '7', 'token': 例, 'lemma': '例', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': 例, 'head.id': 7}, :: {'token_id': '8', 'token': :, 'lemma': ':', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'dep', 'head': 例, 'head.id': 7}}, '50': {'sent_id': '50', 'sent': 'URL - 3.dtd', URL: {'token_id': '0', 'token': URL, 'lemma': 'URL', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': -, 'head.id': 1}, -: {'token_id': '1', 'token': -, 'lemma': '-', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'dep', 'head': dtd, 'head.id': 4}, 3: {'token_id': '2', 'token': 3, 'lemma': '3', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'dep', 'head': dtd, 'head.id': 4}, .: {'token_id': '3', 'token': ., 'lemma': '.', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 3, 'head.id': 2}, dtd: {'token_id': '4', 'token': dtd, 'lemma': 'dtd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': dtd, 'head.id': 4}}, '51': {'sent_id': '51', 'sent': 'URL', URL: {'token_id': '0', 'token': URL, 'lemma': 'URL', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': URL, 'head.id': 0}}, '52': {'sent_id': '52', 'sent': 'どのような対応が必要ですか?', どのような: {'token_id': '0', 'token': どのような, 'lemma': 'どのような', 'pos': 'DET', 'pos1': '連体詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'acl', 'head': 対応, 'head.id': 1}, 対応: {'token_id': '1', 'token': 対応, 'lemma': '対応', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nsubj', 'head': 必要, 'head.id': 3}, が: {'token_id': '2', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 対応, 'head.id': 1}, 必要: {'token_id': '3', 'token': 必要, 'lemma': '必要', 'pos': 'ADJ', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '形状詞可能', 'dep': 'ROOT', 'head': 必要, 'head.id': 3}, です: {'token_id': '4', 'token': です, 'lemma': 'です', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 必要, 'head.id': 3}, か: {'token_id': '5', 'token': か, 'lemma': 'か', 'pos': 'PART', 'pos1': '助詞', 'pos2': '終助詞', 'pos3': 'N', 'dep': 'mark', 'head': 必要, 'head.id': 3}, ?: {'token_id': '6', 'token': ?, 'lemma': '?', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 必要, 'head.id': 3}}, '53': {'sent_id': '53', 'sent': 'eCTDアクセス・データのWebサイトへのアクセスを継続する場合は、ブラウザ/サーバでTLS1.1以上が有効になっていることを確認する必要があります。', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': アクセス, 'head.id': 1}, アクセス: {'token_id': '1', 'token': アクセス, 'lemma': 'アクセス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': 継続, 'head.id': 10}, ・: {'token_id': '2', 'token': ・, 'lemma': '・', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': アクセス, 'head.id': 1}, データ: {'token_id': '3', 'token': データ, 'lemma': 'データ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': アクセス, 'head.id': 8}, の: {'token_id': '4', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': データ, 'head.id': 3}, Webサイト: {'token_id': '5', 'token': Webサイト, 'lemma': 'Webサイト', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': アクセス, 'head.id': 8}, へ: {'token_id': '6', 'token': へ, 'lemma': 'へ', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': Webサイト, 'head.id': 5}, の: {'token_id': '7', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': Webサイト, 'head.id': 5}, アクセス: {'token_id': '8', 'token': アクセス, 'lemma': 'アクセス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obj', 'head': 継続, 'head.id': 10}, を: {'token_id': '9', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': アクセス, 'head.id': 8}, 継続: {'token_id': '10', 'token': 継続, 'lemma': '継続', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': 場合, 'head.id': 12}, する: {'token_id': '11', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 継続, 'head.id': 10}, 場合: {'token_id': '12', 'token': 場合, 'lemma': '場合', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'obl', 'head': なっ, 'head.id': 25}, は: {'token_id': '13', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 場合, 'head.id': 12}, 、: {'token_id': '14', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 場合, 'head.id': 12}, ブラウザ: {'token_id': '15', 'token': ブラウザ, 'lemma': 'ブラウザ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': サーバ, 'head.id': 17}, /: {'token_id': '16', 'token': /, 'lemma': '/', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': サーバ, 'head.id': 17}, サーバ: {'token_id': '17', 'token': サーバ, 'lemma': 'サーバ', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': なっ, 'head.id': 25}, で: {'token_id': '18', 'token': で, 'lemma': 'で', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': サーバ, 'head.id': 17}, TLS: {'token_id': '19', 'token': TLS, 'lemma': 'tls', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'compound', 'head': 以上, 'head.id': 21}, 1.1: {'token_id': '20', 'token': 1.1, 'lemma': '1.1', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 以上, 'head.id': 21}, 以上: {'token_id': '21', 'token': 以上, 'lemma': '以上', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nsubj', 'head': なっ, 'head.id': 25}, が: {'token_id': '22', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 以上, 'head.id': 21}, 有効: {'token_id': '23', 'token': 有効, 'lemma': '有効', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'advcl', 'head': なっ, 'head.id': 25}, に: {'token_id': '24', 'token': に, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 有効, 'head.id': 23}, なっ: {'token_id': '25', 'token': なっ, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'acl', 'head': こと, 'head.id': 28}, て: {'token_id': '26', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': なっ, 'head.id': 25}, いる: {'token_id': '27', 'token': いる, 'lemma': 'いる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 26}, こと: {'token_id': '28', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 確認, 'head.id': 30}, を: {'token_id': '29', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': こと, 'head.id': 28}, 確認: {'token_id': '30', 'token': 確認, 'lemma': '確認', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': 必要, 'head.id': 32}, する: {'token_id': '31', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 確認, 'head.id': 30}, 必要: {'token_id': '32', 'token': 必要, 'lemma': '必要', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '形状詞可能', 'dep': 'nsubj', 'head': あり, 'head.id': 34}, が: {'token_id': '33', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 必要, 'head.id': 32}, あり: {'token_id': '34', 'token': あり, 'lemma': 'ある', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'ROOT', 'head': あり, 'head.id': 34}, ます: {'token_id': '35', 'token': ます, 'lemma': 'ます', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': あり, 'head.id': 34}, 。: {'token_id': '36', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': あり, 'head.id': 34}}, '54': {'sent_id': '54', 'sent': 'FDAがこの変更を行った後、ブラウザ/サーバでTLS1.1以上が有効になっていない場合、これらのeCTD Webサイトにアクセスできなくなります。', FDA: {'token_id': '0', 'token': FDA, 'lemma': 'FDA', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 行っ, 'head.id': 5}, が: {'token_id': '1', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 0}, この: {'token_id': '2', 'token': この, 'lemma': 'この', 'pos': 'DET', 'pos1': '連体詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'det', 'head': 変更, 'head.id': 3}, 変更: {'token_id': '3', 'token': 変更, 'lemma': '変更', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obj', 'head': 行っ, 'head.id': 5}, を: {'token_id': '4', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 変更, 'head.id': 3}, 行っ: {'token_id': '5', 'token': 行っ, 'lemma': '行う', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': 後, 'head.id': 7}, た: {'token_id': '6', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 行っ, 'head.id': 5}, 後: {'token_id': '7', 'token': 後, 'lemma': '後', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'obl', 'head': なっ, 'head.id': 19}, 、: {'token_id': '8', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 後, 'head.id': 7}, ブラウザ: {'token_id': '9', 'token': ブラウザ, 'lemma': 'ブラウザ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': サーバ, 'head.id': 11}, /: {'token_id': '10', 'token': /, 'lemma': '/', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': サーバ, 'head.id': 11}, サーバ: {'token_id': '11', 'token': サーバ, 'lemma': 'サーバ', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': なっ, 'head.id': 19}, で: {'token_id': '12', 'token': で, 'lemma': 'で', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': サーバ, 'head.id': 11}, TLS: {'token_id': '13', 'token': TLS, 'lemma': 'tls', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'compound', 'head': 以上, 'head.id': 15}, 1.1: {'token_id': '14', 'token': 1.1, 'lemma': '1.1', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 以上, 'head.id': 15}, 以上: {'token_id': '15', 'token': 以上, 'lemma': '以上', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nsubj', 'head': なっ, 'head.id': 19}, が: {'token_id': '16', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 以上, 'head.id': 15}, 有効: {'token_id': '17', 'token': 有効, 'lemma': '有効', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'advcl', 'head': なっ, 'head.id': 19}, に: {'token_id': '18', 'token': に, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 有効, 'head.id': 17}, なっ: {'token_id': '19', 'token': なっ, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'acl', 'head': 場合, 'head.id': 23}, て: {'token_id': '20', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': なっ, 'head.id': 19}, い: {'token_id': '21', 'token': い, 'lemma': 'いる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'fixed', 'head': て, 'head.id': 20}, ない: {'token_id': '22', 'token': ない, 'lemma': 'ない', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': なっ, 'head.id': 19}, 場合: {'token_id': '23', 'token': 場合, 'lemma': '場合', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'obl', 'head': なり, 'head.id': 34}, 、: {'token_id': '24', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 場合, 'head.id': 23}, これ: {'token_id': '25', 'token': これ, 'lemma': 'これ', 'pos': 'PRON', 'pos1': '代名詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'nmod', 'head': ら, 'head.id': 26}, ら: {'token_id': '26', 'token': ら, 'lemma': 'ら', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '一般', 'dep': 'nmod', 'head': Webサイト, 'head.id': 29}, の: {'token_id': '27', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ら, 'head.id': 26}, eCTD: {'token_id': '28', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': Webサイト, 'head.id': 29}, Webサイト: {'token_id': '29', 'token': Webサイト, 'lemma': 'Webサイト', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': アクセス, 'head.id': 31}, に: {'token_id': '30', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': Webサイト, 'head.id': 29}, アクセス: {'token_id': '31', 'token': アクセス, 'lemma': 'アクセス', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'advcl', 'head': なり, 'head.id': 34}, でき: {'token_id': '32', 'token': でき, 'lemma': 'できる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': アクセス, 'head.id': 31}, なく: {'token_id': '33', 'token': なく, 'lemma': 'ない', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': アクセス, 'head.id': 31}, なり: {'token_id': '34', 'token': なり, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'ROOT', 'head': なり, 'head.id': 34}, ます: {'token_id': '35', 'token': ます, 'lemma': 'ます', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': なり, 'head.id': 34}, 。: {'token_id': '36', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': なり, 'head.id': 34}}, '55': {'sent_id': '55', 'sent': 'eCTDアクセスデータウェブサイトのリンクと通信するバックエンドサーバも、TLS1.1以上を使用して通信する必要があります。', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 3}, アクセス: {'token_id': '1', 'token': アクセス, 'lemma': 'アクセス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 3}, データ: {'token_id': '2', 'token': データ, 'lemma': 'データ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': ウェブサイト, 'head.id': 3}, ウェブサイト: {'token_id': '3', 'token': ウェブサイト, 'lemma': 'ウェブサイト', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': リンク, 'head.id': 5}, の: {'token_id': '4', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ウェブサイト, 'head.id': 3}, リンク: {'token_id': '5', 'token': リンク, 'lemma': 'リンク', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': 通信, 'head.id': 7}, と: {'token_id': '6', 'token': と, 'lemma': 'と', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': リンク, 'head.id': 5}, 通信: {'token_id': '7', 'token': 通信, 'lemma': '通信', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': サーバ, 'head.id': 10}, する: {'token_id': '8', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 通信, 'head.id': 7}, バックエンド: {'token_id': '9', 'token': バックエンド, 'lemma': 'バックエンド', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': サーバ, 'head.id': 10}, サーバ: {'token_id': '10', 'token': サーバ, 'lemma': 'サーバ', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'dislocated', 'head': あり, 'head.id': 24}, も: {'token_id': '11', 'token': も, 'lemma': 'も', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': サーバ, 'head.id': 10}, 、: {'token_id': '12', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': サーバ, 'head.id': 10}, TLS: {'token_id': '13', 'token': TLS, 'lemma': 'tls', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 以上, 'head.id': 15}, 1.1: {'token_id': '14', 'token': 1.1, 'lemma': '1.1', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 以上, 'head.id': 15}, 以上: {'token_id': '15', 'token': 以上, 'lemma': '以上', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'obj', 'head': 使用, 'head.id': 17}, を: {'token_id': '16', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 以上, 'head.id': 15}, 使用: {'token_id': '17', 'token': 使用, 'lemma': '使用', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'advcl', 'head': 通信, 'head.id': 20}, し: {'token_id': '18', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 17}, て: {'token_id': '19', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'mark', 'head': 使用, 'head.id': 17}, 通信: {'token_id': '20', 'token': 通信, 'lemma': '通信', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'acl', 'head': 必要, 'head.id': 22}, する: {'token_id': '21', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 通信, 'head.id': 20}, 必要: {'token_id': '22', 'token': 必要, 'lemma': '必要', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '形状詞可能', 'dep': 'nsubj', 'head': あり, 'head.id': 24}, が: {'token_id': '23', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 必要, 'head.id': 22}, あり: {'token_id': '24', 'token': あり, 'lemma': 'ある', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'ROOT', 'head': あり, 'head.id': 24}, ます: {'token_id': '25', 'token': ます, 'lemma': 'ます', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': あり, 'head.id': 24}, 。: {'token_id': '26', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': あり, 'head.id': 24}}, '56': {'sent_id': '56', 'sent': 'サーバを有効化/アップグレードする適切な方法については、ITシステム管理者またはテクノロジーサポート担当者にお問い合わせください。', サーバ: {'token_id': '0', 'token': サーバ, 'lemma': 'サーバ', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': アップグレード, 'head.id': 5}, を: {'token_id': '1', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': サーバ, 'head.id': 0}, 有効: {'token_id': '2', 'token': 有効, 'lemma': '有効', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'amod', 'head': 化, 'head.id': 3}, 化: {'token_id': '3', 'token': 化, 'lemma': '化', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': 'サ変可能', 'dep': 'compound', 'head': アップグレード, 'head.id': 5}, /: {'token_id': '4', 'token': /, 'lemma': '/', 'pos': 'SYM', 'pos1': '補助記号', 'pos2': '一般', 'pos3': 'N', 'dep': 'compound', 'head': アップグレード, 'head.id': 5}, アップグレード: {'token_id': '5', 'token': アップグレード, 'lemma': 'アップグレード', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 方法, 'head.id': 9}, する: {'token_id': '6', 'token': する, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': アップグレード, 'head.id': 5}, 適切: {'token_id': '7', 'token': 適切, 'lemma': '適切', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': 方法, 'head.id': 9}, な: {'token_id': '8', 'token': な, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 適切, 'head.id': 7}, 方法: {'token_id': '9', 'token': 方法, 'lemma': '方法', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 問い合わせ, 'head.id': 25}, に: {'token_id': '10', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 方法, 'head.id': 9}, つい: {'token_id': '11', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 10}, て: {'token_id': '12', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 10}, は: {'token_id': '13', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 方法, 'head.id': 9}, 、: {'token_id': '14', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 方法, 'head.id': 9}, IT: {'token_id': '15', 'token': IT, 'lemma': 'IT', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 管理者, 'head.id': 17}, システム: {'token_id': '16', 'token': システム, 'lemma': 'システム', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 管理者, 'head.id': 17}, 管理者: {'token_id': '17', 'token': 管理者, 'lemma': '管理者', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 担当者, 'head.id': 22}, また: {'token_id': '18', 'token': また, 'lemma': 'また', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 担当者, 'head.id': 22}, は: {'token_id': '19', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'fixed', 'head': また, 'head.id': 18}, テクノロジー: {'token_id': '20', 'token': テクノロジー, 'lemma': 'テクノロジー', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 担当者, 'head.id': 22}, サポート: {'token_id': '21', 'token': サポート, 'lemma': 'サポート', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 担当者, 'head.id': 22}, 担当者: {'token_id': '22', 'token': 担当者, 'lemma': '担当者', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 問い合わせ, 'head.id': 25}, に: {'token_id': '23', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 担当者, 'head.id': 22}, お: {'token_id': '24', 'token': お, 'lemma': 'お', 'pos': 'NOUN', 'pos1': '接頭辞', 'pos2': 'N', 'pos3': 'N', 'dep': 'compound', 'head': 問い合わせ, 'head.id': 25}, 問い合わせ: {'token_id': '25', 'token': 問い合わせ, 'lemma': '問い合わせる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'ROOT', 'head': 問い合わせ, 'head.id': 25}, ください: {'token_id': '26', 'token': ください, 'lemma': 'くださる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 問い合わせ, 'head.id': 25}, 。: {'token_id': '27', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 問い合わせ, 'head.id': 25}}, '57': {'sent_id': '57', 'sent': '通知', 通知: {'token_id': '0', 'token': 通知, 'lemma': '通知', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 通知, 'head.id': 0}}, '58': {'sent_id': '58', 'sent': 'PHONE年4月24日', PHONE: {'token_id': '0', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 日, 'head.id': 5}, 年: {'token_id': '1', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 4: {'token_id': '2', 'token': 4, 'lemma': '4', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 日, 'head.id': 5}, 月: {'token_id': '3', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 24: {'token_id': '4', 'token': 24, 'lemma': '24', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 日, 'head.id': 5}, 日: {'token_id': '5', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '助数詞', 'dep': 'ROOT', 'head': 日, 'head.id': 5}}, '59': {'sent_id': '59', 'sent': 'FDA、DMFタイプIIIのeCTD提出期限を延長', FDA: {'token_id': '0', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': III, 'head.id': 4}, 、: {'token_id': '1', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': FDA, 'head.id': 0}, DMF: {'token_id': '2', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': III, 'head.id': 4}, タイプ: {'token_id': '3', 'token': タイプ, 'lemma': 'タイプ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': III, 'head.id': 4}, III: {'token_id': '4', 'token': III, 'lemma': 'iii', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出期限, 'head.id': 7}, の: {'token_id': '5', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': III, 'head.id': 4}, eCTD: {'token_id': '6', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 提出期限, 'head.id': 7}, 提出期限: {'token_id': '7', 'token': 提出期限, 'lemma': '提出期限', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': 延長, 'head.id': 9}, を: {'token_id': '8', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 提出期限, 'head.id': 7}, 延長: {'token_id': '9', 'token': 延長, 'lemma': '延長', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 延長, 'head.id': 9}}, '60': {'sent_id': '60', 'sent': 'FDAは、DMF Type lllのeCTD形式による提出期限をPHONE年5月5日に延長した。', FDA: {'token_id': '0', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 延長, 'head.id': 20}, は: {'token_id': '1', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 0}, 、: {'token_id': '2', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': FDA, 'head.id': 0}, DMF: {'token_id': '3', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': Type, 'head.id': 4}, Type: {'token_id': '4', 'token': Type, 'lemma': 'Type', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 形式, 'head.id': 8}, lll: {'token_id': '5', 'token': lll, 'lemma': 'lll', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'case', 'head': Type, 'head.id': 4}, の: {'token_id': '6', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': Type, 'head.id': 4}, eCTD: {'token_id': '7', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 形式, 'head.id': 8}, 形式: {'token_id': '8', 'token': 形式, 'lemma': '形式', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出期限, 'head.id': 11}, に: {'token_id': '9', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 形式, 'head.id': 8}, よる: {'token_id': '10', 'token': よる, 'lemma': 'よる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 9}, 提出期限: {'token_id': '11', 'token': 提出期限, 'lemma': '提出期限', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': PHONE, 'head.id': 13}, を: {'token_id': '12', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 提出期限, 'head.id': 11}, PHONE: {'token_id': '13', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 日, 'head.id': 18}, 年: {'token_id': '14', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 18}, 5: {'token_id': '15', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 日, 'head.id': 18}, 月: {'token_id': '16', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 18}, 5: {'token_id': '17', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 日, 'head.id': 18}, 日: {'token_id': '18', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '助数詞', 'dep': 'obl', 'head': 延長, 'head.id': 20}, に: {'token_id': '19', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 日, 'head.id': 18}, 延長: {'token_id': '20', 'token': 延長, 'lemma': '延長', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 延長, 'head.id': 20}, し: {'token_id': '21', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 延長, 'head.id': 20}, た: {'token_id': '22', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 延長, 'head.id': 20}, 。: {'token_id': '23', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 延長, 'head.id': 20}}, '61': {'sent_id': '61', 'sent': 'DMFに関する追加情報についてはFDAガイダンス文書を、DMFに関する追加情報についてはFDAのDrug Master Fileページを参照のこと。', DMF: {'token_id': '0', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 情報, 'head.id': 4}, に: {'token_id': '1', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': DMF, 'head.id': 0}, 関する: {'token_id': '2', 'token': 関する, 'lemma': '関する', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 1}, 追加: {'token_id': '3', 'token': 追加, 'lemma': '追加', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 情報, 'head.id': 4}, 情報: {'token_id': '4', 'token': 情報, 'lemma': '情報', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': こと, 'head.id': 31}, に: {'token_id': '5', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 情報, 'head.id': 4}, つい: {'token_id': '6', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 5}, て: {'token_id': '7', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 5}, は: {'token_id': '8', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 情報, 'head.id': 4}, FDA: {'token_id': '9', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'compound', 'head': 文書, 'head.id': 11}, ガイダンス: {'token_id': '10', 'token': ガイダンス, 'lemma': 'ガイダンス', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 文書, 'head.id': 11}, 文書: {'token_id': '11', 'token': 文書, 'lemma': '文書', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obj', 'head': Drug, 'head.id': 25}, を: {'token_id': '12', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 文書, 'head.id': 11}, 、: {'token_id': '13', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 文書, 'head.id': 11}, DMF: {'token_id': '14', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 情報, 'head.id': 18}, に: {'token_id': '15', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': DMF, 'head.id': 14}, 関する: {'token_id': '16', 'token': 関する, 'lemma': '関する', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 15}, 追加: {'token_id': '17', 'token': 追加, 'lemma': '追加', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 情報, 'head.id': 18}, 情報: {'token_id': '18', 'token': 情報, 'lemma': '情報', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': Drug, 'head.id': 25}, に: {'token_id': '19', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 情報, 'head.id': 18}, つい: {'token_id': '20', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 19}, て: {'token_id': '21', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 19}, は: {'token_id': '22', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 情報, 'head.id': 18}, FDA: {'token_id': '23', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Drug, 'head.id': 25}, の: {'token_id': '24', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': FDA, 'head.id': 23}, Drug: {'token_id': '25', 'token': Drug, 'lemma': 'drug', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'punct', 'head': 情報, 'head.id': 4}, Master File: {'token_id': '26', 'token': Master File, 'lemma': 'master file', 'pos': 'SYM', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'dep', 'head': Drug, 'head.id': 25}, ページ: {'token_id': '27', 'token': ページ, 'lemma': 'ページ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'obj', 'head': 参照, 'head.id': 29}, を: {'token_id': '28', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': ページ, 'head.id': 27}, 参照: {'token_id': '29', 'token': 参照, 'lemma': '参照', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': こと, 'head.id': 31}, の: {'token_id': '30', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 参照, 'head.id': 29}, こと: {'token_id': '31', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': こと, 'head.id': 31}, 。: {'token_id': '32', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': こと, 'head.id': 31}}, '62': {'sent_id': '62', 'sent': '重要なお知らせ', 重要: {'token_id': '0', 'token': 重要, 'lemma': '重要', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': お知らせ, 'head.id': 2}, な: {'token_id': '1', 'token': な, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 重要, 'head.id': 0}, お知らせ: {'token_id': '2', 'token': お知らせ, 'lemma': 'お知らせ', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': お知らせ, 'head.id': 2}}, '63': {'sent_id': '63', 'sent': 'PHONE年5月18日', PHONE: {'token_id': '0', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 日, 'head.id': 5}, 年: {'token_id': '1', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 5: {'token_id': '2', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 日, 'head.id': 5}, 月: {'token_id': '3', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 日, 'head.id': 5}, 18: {'token_id': '4', 'token': 18, 'lemma': '18', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 日, 'head.id': 5}, 日: {'token_id': '5', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '助数詞', 'dep': 'ROOT', 'head': 日, 'head.id': 5}}, '64': {'sent_id': '64', 'sent': 'eCTD申請の成功に対する3回目の承認', eCTD: {'token_id': '0', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 申請, 'head.id': 1}, 申請: {'token_id': '1', 'token': 申請, 'lemma': '申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 成功, 'head.id': 3}, の: {'token_id': '2', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 申請, 'head.id': 1}, 成功: {'token_id': '3', 'token': 成功, 'lemma': '成功', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 承認, 'head.id': 10}, に: {'token_id': '4', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 成功, 'head.id': 3}, 対する: {'token_id': '5', 'token': 対する, 'lemma': '対する', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 4}, 3: {'token_id': '6', 'token': 3, 'lemma': '3', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 目, 'head.id': 8}, 回: {'token_id': '7', 'token': 回, 'lemma': '回', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 目, 'head.id': 8}, 目: {'token_id': '8', 'token': 目, 'lemma': '目', 'pos': 'NOUN', 'pos1': '接尾辞', 'pos2': '名詞的', 'pos3': '一般', 'dep': 'nmod', 'head': 承認, 'head.id': 10}, の: {'token_id': '9', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 目, 'head.id': 8}, 承認: {'token_id': '10', 'token': 承認, 'lemma': '承認', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 承認, 'head.id': 10}}, '65': {'sent_id': '65', 'sent': 'PHONE年5月31日以降、CDERは、NDA、ANDA、BLA、INDまたはDMFの提出が正常に検証および処理を完了し、割り当てられた審査部門が使用できるようになった時点で、FDA Electronic Submissions Gateway(ESG)ユーザーに対して承認の発行を開始します。', PHONE: {'token_id': '0', 'token': PHONE, 'lemma': 'Phone', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 以降, 'head.id': 6}, 年: {'token_id': '1', 'token': 年, 'lemma': '年', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 以降, 'head.id': 6}, 5: {'token_id': '2', 'token': 5, 'lemma': '5', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 以降, 'head.id': 6}, 月: {'token_id': '3', 'token': 月, 'lemma': '月', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 以降, 'head.id': 6}, 31: {'token_id': '4', 'token': 31, 'lemma': '31', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 以降, 'head.id': 6}, 日: {'token_id': '5', 'token': 日, 'lemma': '日', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '助数詞可能', 'dep': 'compound', 'head': 以降, 'head.id': 6}, 以降: {'token_id': '6', 'token': 以降, 'lemma': '以降', 'pos': 'ADV', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'advmod', 'head': 開始, 'head.id': 63}, 、: {'token_id': '7', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 以降, 'head.id': 6}, CDER: {'token_id': '8', 'token': CDER, 'lemma': 'cder', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 時点, 'head.id': 45}, は: {'token_id': '9', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': CDER, 'head.id': 8}, 、: {'token_id': '10', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': CDER, 'head.id': 8}, NDA: {'token_id': '11', 'token': NDA, 'lemma': 'nda', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': ANDA, 'head.id': 13}, 、: {'token_id': '12', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': NDA, 'head.id': 11}, ANDA: {'token_id': '13', 'token': ANDA, 'lemma': 'anda', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': BLA, 'head.id': 15}, 、: {'token_id': '14', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': ANDA, 'head.id': 13}, BLA: {'token_id': '15', 'token': BLA, 'lemma': 'bla', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': IND, 'head.id': 17}, 、: {'token_id': '16', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': BLA, 'head.id': 15}, IND: {'token_id': '17', 'token': IND, 'lemma': 'IND', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': DMF, 'head.id': 20}, また: {'token_id': '18', 'token': また, 'lemma': 'また', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': DMF, 'head.id': 20}, は: {'token_id': '19', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'fixed', 'head': また, 'head.id': 18}, DMF: {'token_id': '20', 'token': DMF, 'lemma': 'dmf', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 提出, 'head.id': 22}, の: {'token_id': '21', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': DMF, 'head.id': 20}, 提出: {'token_id': '22', 'token': 提出, 'lemma': '提出', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nsubj', 'head': 完了, 'head.id': 30}, が: {'token_id': '23', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 提出, 'head.id': 22}, 正常: {'token_id': '24', 'token': 正常, 'lemma': '正常', 'pos': 'ADJ', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '形状詞可能', 'dep': 'advcl', 'head': 完了, 'head.id': 30}, に: {'token_id': '25', 'token': に, 'lemma': 'だ', 'pos': 'ADP', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'case', 'head': 正常, 'head.id': 24}, 検証: {'token_id': '26', 'token': 検証, 'lemma': '検証', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 処理, 'head.id': 28}, および: {'token_id': '27', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 処理, 'head.id': 28}, 処理: {'token_id': '28', 'token': 処理, 'lemma': '処理', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obj', 'head': 完了, 'head.id': 30}, を: {'token_id': '29', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 処理, 'head.id': 28}, 完了: {'token_id': '30', 'token': 完了, 'lemma': '完了', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'advcl', 'head': 割り当て, 'head.id': 33}, し: {'token_id': '31', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 完了, 'head.id': 30}, 、: {'token_id': '32', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 完了, 'head.id': 30}, 割り当て: {'token_id': '33', 'token': 割り当て, 'lemma': '割り当てる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'acl', 'head': 部門, 'head.id': 37}, られ: {'token_id': '34', 'token': られ, 'lemma': 'られる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 割り当て, 'head.id': 33}, た: {'token_id': '35', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 割り当て, 'head.id': 33}, 審査: {'token_id': '36', 'token': 審査, 'lemma': '審査', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 部門, 'head.id': 37}, 部門: {'token_id': '37', 'token': 部門, 'lemma': '部門', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nsubj', 'head': 使用, 'head.id': 39}, が: {'token_id': '38', 'token': が, 'lemma': 'が', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 部門, 'head.id': 37}, 使用: {'token_id': '39', 'token': 使用, 'lemma': '使用', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'advcl', 'head': なっ, 'head.id': 43}, できる: {'token_id': '40', 'token': できる, 'lemma': 'できる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 39}, よう: {'token_id': '41', 'token': よう, 'lemma': 'よう', 'pos': 'AUX', 'pos1': '形状詞', 'pos2': '助動詞語幹', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 39}, に: {'token_id': '42', 'token': に, 'lemma': 'だ', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 使用, 'head.id': 39}, なっ: {'token_id': '43', 'token': なっ, 'lemma': 'なる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'dep', 'head': CDER, 'head.id': 8}, た: {'token_id': '44', 'token': た, 'lemma': 'た', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': なっ, 'head.id': 43}, 時点: {'token_id': '45', 'token': 時点, 'lemma': '時点', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 開始, 'head.id': 63}, で: {'token_id': '46', 'token': で, 'lemma': 'で', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 時点, 'head.id': 45}, 、: {'token_id': '47', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 時点, 'head.id': 45}, FDA: {'token_id': '48', 'token': FDA, 'lemma': 'FDA', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '固有名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Electronic, 'head.id': 49}, Electronic: {'token_id': '49', 'token': Electronic, 'lemma': 'Electronic', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Submissions, 'head.id': 50}, Submissions: {'token_id': '50', 'token': Submissions, 'lemma': 'submissions', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Gateway, 'head.id': 51}, Gateway: {'token_id': '51', 'token': Gateway, 'lemma': 'gateway', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 開始, 'head.id': 63}, (: {'token_id': '52', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': Gateway, 'head.id': 51}, ESG: {'token_id': '53', 'token': ESG, 'lemma': 'esg', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': Gateway, 'head.id': 51}, ): {'token_id': '54', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': Gateway, 'head.id': 51}, ユーザー: {'token_id': '55', 'token': ユーザー, 'lemma': 'ユーザー', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': Gateway, 'head.id': 51}, に: {'token_id': '56', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': Gateway, 'head.id': 51}, 対し: {'token_id': '57', 'token': 対し, 'lemma': '対する', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 56}, て: {'token_id': '58', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 56}, 承認: {'token_id': '59', 'token': 承認, 'lemma': '承認', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 発行, 'head.id': 61}, の: {'token_id': '60', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 承認, 'head.id': 59}, 発行: {'token_id': '61', 'token': 発行, 'lemma': '発行', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obj', 'head': 開始, 'head.id': 63}, を: {'token_id': '62', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 発行, 'head.id': 61}, 開始: {'token_id': '63', 'token': 開始, 'lemma': '開始', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 開始, 'head.id': 63}, し: {'token_id': '64', 'token': し, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 開始, 'head.id': 63}, ます: {'token_id': '65', 'token': ます, 'lemma': 'ます', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 開始, 'head.id': 63}, 。: {'token_id': '66', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 開始, 'head.id': 63}}, '66': {'sent_id': '66', 'sent': 'この承認は、ESG Message Delivery Notification承認(第1承認)およびOfficial Center承認(第2承認)に追加され、「第3承認」と呼ばれます。', この: {'token_id': '0', 'token': この, 'lemma': 'この', 'pos': 'DET', 'pos1': '連体詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'det', 'head': 承認, 'head.id': 1}, 承認: {'token_id': '1', 'token': 承認, 'lemma': '承認', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nsubj', 'head': 追加, 'head.id': 24}, は: {'token_id': '2', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 承認, 'head.id': 1}, 、: {'token_id': '3', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 承認, 'head.id': 1}, ESG: {'token_id': '4', 'token': ESG, 'lemma': 'esg', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Message, 'head.id': 5}, Message: {'token_id': '5', 'token': Message, 'lemma': 'Message', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Delivery, 'head.id': 6}, Delivery: {'token_id': '6', 'token': Delivery, 'lemma': 'Delivery', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': Notification, 'head.id': 7}, Notification: {'token_id': '7', 'token': Notification, 'lemma': 'notification', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 承認, 'head.id': 8}, 承認: {'token_id': '8', 'token': 承認, 'lemma': '承認', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 承認, 'head.id': 17}, (: {'token_id': '9', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 承認, 'head.id': 8}, 第: {'token_id': '10', 'token': 第, 'lemma': '第', 'pos': 'NOUN', 'pos1': '接頭辞', 'pos2': 'N', 'pos3': 'N', 'dep': 'compound', 'head': 承認, 'head.id': 8}, 1: {'token_id': '11', 'token': 1, 'lemma': '1', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 承認, 'head.id': 8}, 承認: {'token_id': '12', 'token': 承認, 'lemma': '承認', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': 承認, 'head.id': 8}, ): {'token_id': '13', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 承認, 'head.id': 8}, および: {'token_id': '14', 'token': および, 'lemma': 'および', 'pos': 'CCONJ', 'pos1': '接続詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'cc', 'head': 承認, 'head.id': 17}, Official: {'token_id': '15', 'token': Official, 'lemma': 'official', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 承認, 'head.id': 17}, Center: {'token_id': '16', 'token': Center, 'lemma': 'Center', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 承認, 'head.id': 17}, 承認: {'token_id': '17', 'token': 承認, 'lemma': '承認', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': 追加, 'head.id': 24}, (: {'token_id': '18', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 承認, 'head.id': 17}, 第: {'token_id': '19', 'token': 第, 'lemma': '第', 'pos': 'NOUN', 'pos1': '接頭辞', 'pos2': 'N', 'pos3': 'N', 'dep': 'compound', 'head': 承認, 'head.id': 17}, 2: {'token_id': '20', 'token': 2, 'lemma': '2', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'compound', 'head': 承認, 'head.id': 17}, 承認: {'token_id': '21', 'token': 承認, 'lemma': '承認', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 承認, 'head.id': 17}, ): {'token_id': '22', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 承認, 'head.id': 17}, に: {'token_id': '23', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 承認, 'head.id': 17}, 追加: {'token_id': '24', 'token': 追加, 'lemma': '追加', 'pos': 'VERB', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'advcl', 'head': 呼ば, 'head.id': 34}, さ: {'token_id': '25', 'token': さ, 'lemma': 'する', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 追加, 'head.id': 24}, れ: {'token_id': '26', 'token': れ, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 追加, 'head.id': 24}, 、: {'token_id': '27', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 追加, 'head.id': 24}, 「: {'token_id': '28', 'token': 「, 'lemma': '「', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 承認, 'head.id': 31}, 第: {'token_id': '29', 'token': 第, 'lemma': '第', 'pos': 'NOUN', 'pos1': '接頭辞', 'pos2': 'N', 'pos3': 'N', 'dep': 'compound', 'head': 承認, 'head.id': 31}, 3: {'token_id': '30', 'token': 3, 'lemma': '3', 'pos': 'NUM', 'pos1': '名詞', 'pos2': '数詞', 'pos3': 'N', 'dep': 'nummod', 'head': 承認, 'head.id': 31}, 承認: {'token_id': '31', 'token': 承認, 'lemma': '承認', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': 呼ば, 'head.id': 34}, 」: {'token_id': '32', 'token': 」, 'lemma': '」', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 承認, 'head.id': 31}, と: {'token_id': '33', 'token': と, 'lemma': 'と', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 承認, 'head.id': 31}, 呼ば: {'token_id': '34', 'token': 呼ば, 'lemma': '呼ぶ', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'ROOT', 'head': 呼ば, 'head.id': 34}, れ: {'token_id': '35', 'token': れ, 'lemma': 'れる', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 呼ば, 'head.id': 34}, ます: {'token_id': '36', 'token': ます, 'lemma': 'ます', 'pos': 'AUX', 'pos1': '助動詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'aux', 'head': 呼ば, 'head.id': 34}, 。: {'token_id': '37', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 呼ば, 'head.id': 34}}, '67': {'sent_id': '67', 'sent': 'その他の通知については、eCTD重要通知を参照のこと。', その: {'token_id': '0', 'token': その, 'lemma': 'その', 'pos': 'DET', 'pos1': '連体詞', 'pos2': 'N', 'pos3': 'N', 'dep': 'det', 'head': 他, 'head.id': 1}, 他: {'token_id': '1', 'token': 他, 'lemma': '他', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'nmod', 'head': 通知, 'head.id': 3}, の: {'token_id': '2', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 他, 'head.id': 1}, 通知: {'token_id': '3', 'token': 通知, 'lemma': '通知', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obl', 'head': こと, 'head.id': 15}, に: {'token_id': '4', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 通知, 'head.id': 3}, つい: {'token_id': '5', 'token': つい, 'lemma': 'つく', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 4}, て: {'token_id': '6', 'token': て, 'lemma': 'て', 'pos': 'SCONJ', 'pos1': '助詞', 'pos2': '接続助詞', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 4}, は: {'token_id': '7', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 通知, 'head.id': 3}, 、: {'token_id': '8', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 通知, 'head.id': 3}, eCTD: {'token_id': '9', 'token': eCTD, 'lemma': 'ectd', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 通知, 'head.id': 11}, 重要: {'token_id': '10', 'token': 重要, 'lemma': '重要', 'pos': 'ADJ', 'pos1': '形状詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'amod', 'head': 通知, 'head.id': 11}, 通知: {'token_id': '11', 'token': 通知, 'lemma': '通知', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'obj', 'head': 参照, 'head.id': 13}, を: {'token_id': '12', 'token': を, 'lemma': 'を', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 通知, 'head.id': 11}, 参照: {'token_id': '13', 'token': 参照, 'lemma': '参照', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nmod', 'head': こと, 'head.id': 15}, の: {'token_id': '14', 'token': の, 'lemma': 'の', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': 参照, 'head.id': 13}, こと: {'token_id': '15', 'token': こと, 'lemma': 'こと', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': こと, 'head.id': 15}, 。: {'token_id': '16', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': こと, 'head.id': 15}}, '68': {'sent_id': '68', 'sent': '常時接続', 常時: {'token_id': '0', 'token': 常時, 'lemma': '常時', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '副詞可能', 'dep': 'compound', 'head': 接続, 'head.id': 1}, 接続: {'token_id': '1', 'token': 接続, 'lemma': '接続', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 接続, 'head.id': 1}}, '69': {'sent_id': '69', 'sent': 'CDERに関するご質問は、CDER電子申請(ESUB)サポートチーム(MAIL)までお問い合わせください。', CDER: {'token_id': '0', 'token': CDER, 'lemma': 'cder', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 質問, 'head.id': 4}, に: {'token_id': '1', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': CDER, 'head.id': 0}, 関する: {'token_id': '2', 'token': 関する, 'lemma': '関する', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 1}, ご: {'token_id': '3', 'token': ご, 'lemma': 'ご', 'pos': 'NOUN', 'pos1': '接頭辞', 'pos2': 'N', 'pos3': 'N', 'dep': 'compound', 'head': 質問, 'head.id': 4}, 質問: {'token_id': '4', 'token': 質問, 'lemma': '質問', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'nsubj', 'head': 問い合わせ, 'head.id': 19}, は: {'token_id': '5', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 質問, 'head.id': 4}, 、: {'token_id': '6', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 質問, 'head.id': 4}, CDER: {'token_id': '7', 'token': CDER, 'lemma': 'cder', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 電子申請, 'head.id': 8}, 電子申請: {'token_id': '8', 'token': 電子申請, 'lemma': '電子申請', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 問い合わせ, 'head.id': 19}, (: {'token_id': '9', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 電子申請, 'head.id': 8}, ESUB: {'token_id': '10', 'token': ESUB, 'lemma': 'esub', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 電子申請, 'head.id': 8}, ): {'token_id': '11', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 電子申請, 'head.id': 8}, サポート: {'token_id': '12', 'token': サポート, 'lemma': 'サポート', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 電子申請, 'head.id': 8}, チーム: {'token_id': '13', 'token': チーム, 'lemma': 'チーム', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'compound', 'head': 電子申請, 'head.id': 8}, (: {'token_id': '14', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': 電子申請, 'head.id': 8}, MAIL: {'token_id': '15', 'token': MAIL, 'lemma': 'mail', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': 電子申請, 'head.id': 8}, ): {'token_id': '16', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': 電子申請, 'head.id': 8}, まで: {'token_id': '17', 'token': まで, 'lemma': 'まで', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '副助詞', 'pos3': 'N', 'dep': 'case', 'head': 電子申請, 'head.id': 8}, お: {'token_id': '18', 'token': お, 'lemma': 'お', 'pos': 'NOUN', 'pos1': '接頭辞', 'pos2': 'N', 'pos3': 'N', 'dep': 'compound', 'head': 問い合わせ, 'head.id': 19}, 問い合わせ: {'token_id': '19', 'token': 問い合わせ, 'lemma': '問い合わせる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'ROOT', 'head': 問い合わせ, 'head.id': 19}, ください: {'token_id': '20', 'token': ください, 'lemma': 'くださる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 問い合わせ, 'head.id': 19}, 。: {'token_id': '21', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 問い合わせ, 'head.id': 19}}, '70': {'sent_id': '70', 'sent': 'CBERに関するご質問は、CBER ESUBサポートチーム(MAIL)までお問い合わせください。', CBER: {'token_id': '0', 'token': CBER, 'lemma': 'cber', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'nmod', 'head': 質問, 'head.id': 4}, に: {'token_id': '1', 'token': に, 'lemma': 'に', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '格助詞', 'pos3': 'N', 'dep': 'case', 'head': CBER, 'head.id': 0}, 関する: {'token_id': '2', 'token': 関する, 'lemma': '関する', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'fixed', 'head': に, 'head.id': 1}, ご: {'token_id': '3', 'token': ご, 'lemma': 'ご', 'pos': 'NOUN', 'pos1': '接頭辞', 'pos2': 'N', 'pos3': 'N', 'dep': 'compound', 'head': 質問, 'head.id': 4}, 質問: {'token_id': '4', 'token': 質問, 'lemma': '質問', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'ROOT', 'head': 質問, 'head.id': 4}, は: {'token_id': '5', 'token': は, 'lemma': 'は', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '係助詞', 'pos3': 'N', 'dep': 'case', 'head': 質問, 'head.id': 4}, 、: {'token_id': '6', 'token': 、, 'lemma': '、', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '読点', 'pos3': 'N', 'dep': 'punct', 'head': 質問, 'head.id': 4}, CBER: {'token_id': '7', 'token': CBER, 'lemma': 'cber', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'dep', 'head': 質問, 'head.id': 4}, ESUB: {'token_id': '8', 'token': ESUB, 'lemma': 'esub', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'ROOT', 'head': ESUB, 'head.id': 8}, サポート: {'token_id': '9', 'token': サポート, 'lemma': 'サポート', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': チーム, 'head.id': 10}, チーム: {'token_id': '10', 'token': チーム, 'lemma': 'チーム', 'pos': 'NOUN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': '一般', 'dep': 'obl', 'head': 問い合わせ, 'head.id': 16}, (: {'token_id': '11', 'token': (, 'lemma': '(', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧開', 'pos3': 'N', 'dep': 'punct', 'head': チーム, 'head.id': 10}, MAIL: {'token_id': '12', 'token': MAIL, 'lemma': 'mail', 'pos': 'PROPN', 'pos1': '名詞', 'pos2': '普通名詞', 'pos3': 'サ変可能', 'dep': 'compound', 'head': チーム, 'head.id': 10}, ): {'token_id': '13', 'token': ), 'lemma': ')', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '括弧閉', 'pos3': 'N', 'dep': 'punct', 'head': チーム, 'head.id': 10}, まで: {'token_id': '14', 'token': まで, 'lemma': 'まで', 'pos': 'ADP', 'pos1': '助詞', 'pos2': '副助詞', 'pos3': 'N', 'dep': 'case', 'head': チーム, 'head.id': 10}, お: {'token_id': '15', 'token': お, 'lemma': 'お', 'pos': 'NOUN', 'pos1': '接頭辞', 'pos2': 'N', 'pos3': 'N', 'dep': 'compound', 'head': 問い合わせ, 'head.id': 16}, 問い合わせ: {'token_id': '16', 'token': 問い合わせ, 'lemma': '問い合わせる', 'pos': 'VERB', 'pos1': '動詞', 'pos2': '一般', 'pos3': 'N', 'dep': 'ROOT', 'head': 問い合わせ, 'head.id': 16}, ください: {'token_id': '17', 'token': ください, 'lemma': 'くださる', 'pos': 'AUX', 'pos1': '動詞', 'pos2': '非自立可能', 'pos3': 'N', 'dep': 'aux', 'head': 問い合わせ, 'head.id': 16}, 。: {'token_id': '18', 'token': 。, 'lemma': '。', 'pos': 'PUNCT', 'pos1': '補助記号', 'pos2': '句点', 'pos3': 'N', 'dep': 'punct', 'head': 問い合わせ, 'head.id': 16}}}\n"
     ]
    }
   ],
   "source": [
    "# e.g., 00000088-B-2-X-9.txt\n",
    "# 文分割(タイトルや見出しはそのまま)\n",
    "import spacy\n",
    "import re\n",
    "\n",
    "url = r\"https?://\\S+\" # URL\n",
    "email = r\"[a-zA-Z0-9._%+-]+@[a-zA-Z0-9.-]+\\.[a-zA-Z]{2,}\" # メールアドレス\n",
    "phone = r\"\\+?\\d{1,4}[-.\\s]?\\(?\\d{1,4}\\)?[-.\\s]?\\d{1,4}[-.\\s]?\\d{1,4}(?:[-.\\s]?\\d{1,4})?\" # 電話番号\n",
    "\n",
    "nlp = spacy.load(\"ja_ginza\")\n",
    "mt_file = mt_folder + '/' + '00000088-B-2-X-9.txt'\n",
    "mt_sent = []\n",
    "mt_info = {}\n",
    "with open(mt_file, 'r') as f:\n",
    "    for line in f:\n",
    "        for sent in nlp(line.strip()).sents:\n",
    "            sent = str(sent)\n",
    "            sent = re.sub(url, \"URL\", sent)\n",
    "            sent = re.sub(email, \"MAIL\", sent)\n",
    "            sent = re.sub(phone, \"PHONE\", sent)\n",
    "            mt_sent.append(str(sent))\n",
    "for i, sent in enumerate(mt_sent):\n",
    "    sent_info = {'sent_id': str(i), 'sent': sent}\n",
    "    #print(sent)\n",
    "    for j, token in enumerate(nlp(sent)):\n",
    "        ja_pos = token.tag_.split('-')\n",
    "        if len(ja_pos) == 1:\n",
    "            pos1, pos2, pos3 = ja_pos[0], 'N', 'N'\n",
    "        elif len(ja_pos) == 2:\n",
    "            pos1, pos2, pos3 = ja_pos[0], ja_pos[1], 'N'\n",
    "        else: # len(ja_pos) == 3:\n",
    "            pos1, pos2, pos3 = ja_pos[0], ja_pos[1], ja_pos[2]\n",
    "        token_info = {'token_id': str(j),\n",
    "                      'token': token,\n",
    "                      'lemma': token.lemma_,\n",
    "                      'pos': token.pos_,\n",
    "                      'pos1': pos1,\n",
    "                      'pos2': pos2,\n",
    "                      'pos3': pos3, \n",
    "                      'dep': token.dep_, # 依存関係\n",
    "                      'head': token.head, # 係り先\n",
    "                      'head.id': token.head.i} # 係り先のインデックス\n",
    "        #print(f\"{token}\\t{token.lemma_}\\t{token.pos_}\\t{token.tag_}\\t{token.dep_}\\t{token.head}\\t{token.head.i}\")\n",
    "        sent_info[token] = token_info\n",
    "    mt_info[str(i)] = sent_info\n",
    "print(mt_info)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
